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Abstract
An evaluation of the effectiveness of annual health checks
and quality of health care for adults with intellectual
disability: an observational study using a primary
care database
Iain M Carey,* Fay J Hosking, Tess Harris, Stephen DeWilde,
Carole Beighton and Derek G Cook
Population Health Research Institute, St George’s, University of London, London, UK
*Corresponding author i.carey@sgul.ac.uk
Background: People with intellectual disability (ID) have poorer health than the general population;
however, there is a lack of comprehensive national data describing their health-care needs and utilisation.
Annual health checks for adults with ID have been incentivised through primary care since 2009, but only
half of those eligible for such a health check receive one. It is unclear what impact health checks have had
on important health outcomes, such as emergency hospitalisation.
Objectives: To evaluate whether or not annual health checks for adults with ID have reduced emergency
hospitalisation, and to describe health, health care and mortality for adults with ID.
Design: A retrospective matched cohort study using primary care data linked to national hospital
admissions and mortality data sets.
Setting: A total of 451 English general practices contributing data to Clinical Practice Research
Datalink (CPRD).
Participants: A total of 21,859 adults with ID compared with 152,846 age-, gender- and practice-
matched controls without ID registered during 2009–13.
Interventions: None.
Main outcome measures: Emergency hospital admissions. Other outcomes – preventable admissions for
ambulatory care sensitive conditions, and mortality.
Data sources: CPRD, Hospital Episodes Statistics and Office for National Statistics.
Results: Compared with the general population, adults with ID had higher levels of recorded comorbidity
and were more likely to consult in primary care. However, they were less likely to have long doctor
consultations, and had lower continuity of care. They had higher mortality rates [hazard ratio (HR) 3.6,
95% confidence interval (CI) 3.3 to 3.9], with 37.0% of deaths classified as being amenable to health-care
intervention (HR 5.9, 95% CI 5.1 to 6.8). They were more likely to have emergency hospital admissions
[incidence rate ratio (IRR) 2.82, 95% CI 2.66 to 2.98], with 33.7% deemed preventable compared with
17.3% in controls (IRR 5.62, 95% CI 5.14 to 6.13). Health checks for adults with ID had no effect on
overall emergency admissions compared with controls (IRR 0.96, 95% CI 0.87 to 1.07), although there
was a relative reduction in emergency admissions for ambulatory care-sensitive conditions (IRR 0.82,
95% CI 0.69 to 0.99). Practices with high health check participation also showed a relative fall in preventable
emergency admissions for their patients with ID, compared with practices with minimal participation
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(IRR 0.73, 95% CI 0.57 to 0.95). There were large variations in the health check-related content that was
recorded on electronic records.
Limitations: Patients with milder ID not known to health services were not identified. We could not
comment on the quality of health checks.
Conclusions: Compared with the general population, adults with ID have more chronic diseases and
greater primary and secondary care utilisation. With more than one-third of deaths potentially amenable to
health-care interventions, improvements in access to, and quality of, health care are required. In primary
care, better continuity of care and longer appointment times are important examples that we identified.
Although annual health checks can also improve access, not every eligible adult with ID receives one, and
health check content varies by practice. Health checks had no impact on overall emergency admissions,
but they appeared influential in reducing preventable emergency admissions.
Future work: No formal cost-effectiveness analysis of annual health checks was performed, but this could
be attempted in relation to our estimates of a reduction in preventable emergency admissions.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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Plain English summary
People with a learning disability, such as Down syndrome, have more health problems than the generalpopulation, leading to more unplanned visits to hospital, which can be very distressing. In response to
concerns about health care for this group, NHS England introduced annual health checks for all adults with a
learning disability, with general practitioners (GPs) being paid to provide them; however, only half of adults
with a learning disability eligible for a health check have received one. It is unknown whether or not health
checks make any important lasting difference to health, such as preventing hospital admissions. Using large
anonymous databases of GP and hospital records, we investigated whether or not the introduction of health
checks led to any reduction in unplanned hospital admissions for adults with a learning disability. We also
described the health characteristics of these patients, addressing gaps in knowledge. Our main finding was
that although health checks did not reduce overall unplanned admissions, they were associated with a
reduction in potentially preventable hospital admissions. We also showed that adults with a learning
disability had more recorded illnesses such as epilepsy and mental health problems, and consulted with their
GP more, than the general population. However, they were less likely to have long GP consultations or to
see the same doctor. Last, we found that health information recorded during health checks varied across
practices. The main implications from our study are that health checks for patients with a learning disability
can be effective in preventing some unnecessary hospital visits, and that practices should be encouraged to
ensure that more eligible patients receive them.
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Scientific summary
Background
People with intellectual disability (ID) have more significant health risks and major health problems than
the general population and, as a result, are more likely to die at a younger age. However, there is a lack of
comprehensive national data describing their needs, primary and secondary care utilisation and patterns of
mortality. To address concerns regarding the quality of primary care access and health care, NHS England
have incentivised general practices to carry out annual health checks for adults with ID since 2009.
However, approximately only half of those eligible for a health check are thought to have received one.
It is unclear what exactly happens during these health checks, and what impact they have on important
health outcomes, such as emergency hospitalisation.
Objectives
The study had two overall aims.
1. To describe the health, health-care quality, equity of health care, mortality rates and NHS costs for
adults with ID in a national sample.
2. To evaluate the process and outcome effectiveness of annual health checks for adults with ID in
primary care.
Methods
We carried out a retrospective matched cohort study using a large primary care database (Clinical Practice
Research Datalink) linked to national hospital admissions (Hospital Episode Statistics) and mortality data
sets (Office for National Statistics). Overall, from 451 English general practices, we initially identified 21,859
adults with ID registered during 2009–13 using an extended list of Read codes for ID and associated
conditions. Each adult with ID was matched on age, gender and practice to a maximum of seven controls
without ID or associated conditions (n = 152,846). Specific analyses were based on smaller subgroups of
adults with ID: a cross-sectional analysis of health and health-care quality on 1 January 2012 (n = 14,751),
a longitudinal analysis of mortality and hospital admissions during 2009–13 (n = 16,666) and individual
health checks (n = 7510). A practice-based analysis of health checks compared a subset of predominantly
participating practices (n = 126) with non-participating ones (n = 68). Analyses of health checks further
considered adults with ID without health checks (n = 6922), assigning a random index date based on the
distribution of the dates recorded in the 7510 adults with health checks during the study.
The outcomes considered for the cross-sectional analyses included chronic disease prevalence, selected
health process measures, number of consultations, consultation length, continuity of care and prescribing
levels during 2011. NHS costs were also estimated in 2011, with published costings assigned to primary
and secondary care events when these were clearly identifiable. The outcomes for longitudinal analyses
were mortality and emergency hospital admissions using the linked Office for National Statistics and
Hospital Episode Statistics data, respectively, to further derive cause of death and primary reason for
admission. We also considered emergency admissions for ambulatory care-sensitive conditions (ACSCs),
which are thought to be potentially preventable with better clinical management. The main outcome
studied in relation to the impact health checks was emergency hospital admissions, but we also analysed
the subgroup of ACSCs. For the analyses of process measures, we identified and categorised key health
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areas that health checks were intended to address, as well as general screening tests. We also analysed the
recording of a health check as an outcome among all adults with ID in participating practices.
Throughout the study we engaged with two established service user groups, one a network of adults with
ID and staff members at St George’s, University of London, who collaboratively undertake research
(ResearchNet), and the other a local group of family carers of adults with an ID (Carers Support Merton).
These meetings initially helped us to identify and modify important outcomes for our study, and later
provided assistance with interpreting and disseminating findings.
Statistical analyses comparing adults with ID with matched controls included conditional Poisson models
to derive prevalence ratios (PRs) and rate ratios (RRs), conditional models for odds ratios (ORs) and Cox
models stratified on the matched sets to obtain hazard ratios (HRs). Further adjustment was made for
selected comorbidities, smoking and area deprivation, when appropriate.
Results
Cross-sectional comparison with the general population
Adults with ID had high levels of recorded comorbidity compared with the general population, in particular
epilepsy [18.5%; PR 25.33, 95% confidence interval (CI) 23.29 to 27.57] and severe mental illness (8.6%;
PR 9.10, 95% CI 8.34 to 9.92). Large relative differences were also seen for dementia (PR 7.52, 95% CI
5.95 to 9.49), dysphagia (PR 3.30, 95% CI 3.01 to 3.61) and hypothyroidism (PR 2.69, 95% CI 2.52 to
2.87). However, adults with ID were less likely to have recordings of coronary heart disease (PR 0.65,
95% CI 0.57 to 0.74) and cancer (PR 0.70, 95% CI 0.61 to 0.80) in their primary care record. Nearly one
in four adults (23.9%) with ID was classified as having severe or profound ID, or had severe health needs.
The recording of disability, continence, vision and hearing impairment was higher among adults with ID
than among the general population, as was the recording of other key health indicators (smoking, body
mass index, alcohol consumption and blood pressure). Eligible women with ID were less likely to have
had a cervical smear during the last 5 years (PR 0.64, 95% CI 0.61 to 0.66) or a mammogram during the
last 3 years (PR 0.75, 95% CI 0.72 to 0.78). Adults with ID were nearly twice as likely as controls to have
received repeat medication during 2011 (PR 1.82, 95% CI 1.79 to 1.84). They were almost three times as
likely to be prescribed a psychotropic drug (PR 2.73, 95% CI 2.66 to 2.81), with almost 4 in 10 (38.2%)
receiving at least one psychotropic prescription during the year. Adults with ID had a higher primary care
consultation rate during 2011 (RR 1.70, 95% CI 1.66 to 1.74) but, once this was accounted for, they
were less likely to have had a doctor consultation of > 10 minutes (OR 0.73, 95% CI 0.69 to 0.77),
and had lower continuity of care with the same doctor (OR 0.77, 95% CI 0.73 to 0.82). Overall, their
estimated NHS costs during 2011 were estimated to be twice those of patients of the same age and
gender without ID (RR 2.05, 95% CI 2.01 to 2.10). Only 46.8% of adults with ID had received a health
check by 1 January 2012.
Longitudinal analysis of hospital admissions and mortality
Adults with ID had higher mortality rates (HR 3.62, 95% CI 3.33 to 3.93) during 2009–13 than matched
controls, and these remained high after adjustment for differences in comorbidity (HR 3.05, 95% CI 2.73
to 3.41). The higher risk was seen across all causes of death, except some cancers and transport accidents.
Adults with Down syndrome were at a much higher risk (HR 9.21, 95% CI 7.22 to 11.76) than their
controls, with one in four who died (25.4%) having Down syndrome erroneously recorded as the
underlying cause of death. In total, 37.0% of deaths were classified as being amenable to health-care
intervention, compared with 22.5% in the matched controls. However, as current definitions of amenable
mortality do not include urinary tract infection and aspiration pneumonia, it is possible that the true figure
for amenable deaths among adults with ID is higher. Despite this, the rate of such deaths was estimated as
being almost six times higher among adults with ID than among adults of the same age and gender in the
general population without ID (HR 5.86, 95% CI 5.06 to 6.80). For almost 7 in 10 deaths (69.1%) among
adults with ID there was no recording of ID in the death certification data.
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Adults with ID were more likely to have had an emergency hospital admission during 2009–13 [incidence
rate ratio (IRR) 2.82, 95% CI 2.66 to 2.98], with 33.7% being for admitted for ACSCs compared with
17.3% of controls (IRR 5.62, 95% CI 5.14 to 6.13). The most common ACSCs resulting in admission for
adults with ID were epilepsy (35.6%), lower respiratory tract infections (18.6%) and urinary tract infections
(11.4%). We found no evidence of differences in primary care utilisation, investigation and management
preceding admission for common infections between adults with ID and the general population.
Health checks and emergency hospital admissions
No difference was seen in the change in overall emergency admissions between adults with ID with a first
health check recorded during 2009–13 and controls (IRR 0.96, 95% CI 0.87 to 1.07). However, there was
evidence for a relative reduction among those with severe health needs (IRR 0.80, 95% CI 0.67 to 0.95).
When emergency admissions for ACSCs were solely considered, there was evidence of a reduced change
in admission rate post health check compared with controls (IRR 0.82, 95% CI 0.69 to 0.99). Sensitivity
analyses using adults with ID without health checks did not replicate this reduction over the same time
period, providing further evidence that our findings for ACSCs were specific to health checks. An analysis
of health checks at practice level found that practices with high health check participation showed no
change in emergency admission rate among patients with ID over time, compared with non-participating
practices (IRR 0.97, 95% CI 0.78 to 1.19), but emergency admissions for ACSCs did fall (IRR 0.74, 95% CI
0.58 to 0.95), consistent with the individual-level analysis.
Health checks and process measures
Among practices carrying out health checks, adults with ID who had more severe health needs or who
were living in communal establishments were more likely to receive a first health check during 2009–11.
The patients who subsequently received health checks were already being seen more often in primary care,
and being prescribed more medication prior to the introduction of health checks, than patients who did
not receive health checks by 2011. Although we failed to detect any evidence that health checks had a
significant impact on the overall level of consultations or diagnoses between adults with ID with health
checks and adult with ID without health checks, prescribing levels and associated costs did increase, and
specific process measures relating to health checks were much more commonly recorded in those with
health checks. However, there were large variations in what was being recorded on patient records around
the time of the health checks, with notable low recording for health issues concerning mental health
(13.8%) and bowels or bladder (13.2%). Among those with a first health check during 2009–10, patients
living in more deprived areas were less likely to get a repeated check during the following year (p < 0.001).
Conclusions
The study has identified the following implications for health care.
l Adults with ID are at high risk of emergency hospitalisation, particularly potentially preventable
admissions, which represent one-third of all emergency hospitalisations for these patients. The finding
that the introduction of health checks for adults with ID may have reduced preventable emergency
admissions to hospital during the study is important for future planning and policy-making.
l Not every eligible adult with ID is offered a health check or receives one, and the experience and
recorded content of health checks varies considerably by practice. Encouraging practices to increase the
uptake of health checks could reduce health inequalities for adults with ID, as well as ensuring better
standardisation of the overall process.
l With more than one-third of deaths potentially amenable to health-care interventions, this suggests
that improvements of access to, and quality of, health care among adults with ID are possible and
desirable. In primary care, better continuity of care and longer appointment times are important
examples that we have identified.
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l The high prescribing levels of psychotropic drugs to adults with ID, combined with low levels of
recorded medication reviews, suggest that improvements in monitoring could be made, assessing the
appropriateness of long-term prescribing for these patients.
l The low level of recording of ID on death certification has implications for the surveillance of this
population and consideration is needed of ways in which this could be improved. Even when ID is
recorded, the questionable coding of it as an underlying cause for many deaths suggests that more
consistent guidance would be helpful.
The study has also identified the following implications for further research.
l Although adults with ID have greater levels of chronic disease than the general population, recording
of cancer and coronary heart disease was found to be lower, and further investigation is warranted as
to whether this represents missed diagnoses or lower risk due to a difference in lifestyle risk factors.
l The variation in recording in the patient record around the time of the health check needs further
explanation, particularly the low recordings in key areas such as mental health and medication reviews.
If these findings represent how health checks are being administered, further research could also
identify barriers to carrying out standardised health checks, and suggest recommendations for
improvement.
l As we did not undertake a formal cost analysis in this study, future research could helpfully estimate
whether or not the cost of health checks is offset by savings from fewer emergency hospitalisations.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
National Institute for Health Research.
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Chapter 1 Introduction
Background
The World Health Organization defines intellectual disability (ID) as ‘. . . a condition of arrested or
incomplete development of the mind, which is especially characterized by impairment of skills manifested
during the developmental period, which contribute to the overall level of intelligence, i.e. cognitive,
language, motor, and social abilities’.1 In the UK, ID is commonly referred to as learning disability.2 This
should be viewed distinct from the term ‘learning difficulty’, commonly used across UK education, which
can encompass conditions such as dyslexia that do not necessarily imply intellectual impairment and,
hence, learning disability. Throughout this report we will refer to learning disability as intellectual disability
or ID, except when we are explicitly referring to UK documents or outputs that have used learning
disability as their preferred term.
There are three core criteria that must be met for a person to be considered to have an ID:3
1. intellectual impairment (‘a significantly reduced ability to understand new or complex information’3)
2. with social or adaptive dysfunction (‘a reduced ability to cope independently’3)
3. that has started before adulthood (‘with a lasting effect on development’3).
The most common genetic cause of ID is Down syndrome,4 and every child born with Down syndrome will
be considered to have some level of ID. Neurological conditions such as cerebral palsy will be strongly
associated with ID,5 although they do not necessarily imply low intelligence and, hence, ID. People with
other neurodevelopmental disorders such as autism may or may not satisfy all of these criteria depending
on where on the autism spectrum they lie. Estimates of the prevalence of ID at all ages vary widely
between 1% and 3% of the general population across the UK, the USA and other high-income countries.6
People with ID have more significant health risks and major health problems than the general population
and, as a result, are more likely to die younger.7 In the NHS, there is evidence that people with ID receive
suboptimal care, and this inequity contributes to poor health outcomes, including avoidable mortality.5
In 2008, an independent inquiry into access to health care for people with learning disability, led by
Sir Jonathan Michael, concluded that people with ID receive less effective care, leading to avoidable
suffering and death.8 In addition, the report highlighted the paucity of information on NHS health care
for people with ID.
A key focus of national policy has been improving the quality of primary care for people with ID. In 2006,
the Disability Rights Commission recommended the introduction of annual health checks,7 which was
further supported by Sir Jonathan’s inquiry.8 Subsequently, in 2009, a national Directed Enhanced Service
(DES) was introduced in England, which funds general practices to provide annual health checks to adults
with ID and requires that staff receive appropriate training.9 The health check is intended to identify
undetected health problems and improve prescribing and co-ordination with secondary care.10 Recent
systematic reviews have confirmed that health checks are effective in identifying health problems but
found a paucity of evidence on their impact on health status and outcomes,11 and have stated the need
for an increase in quantity and quality of research on health interventions for people with ID.12
This study, therefore, aims to fill key knowledge gaps with a large sample evaluation of the effectiveness
of annual health checks and a comprehensive study of health and health care in a national sample of
adults with ID.
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Health of people with intellectual disability
People with ID experience poorer health outcomes than the general population, such as increased
emergency admission to hospital13 and mortality.14 The reasons for this poorer health are complex but are
not solely explained by unavoidable biological manifestations of the cause of ID. Local ID register-based
studies have identified markedly higher mortality, with estimates in the age-adjusted risk of death ranging
between 3 and 18 times higher than those of the general population.5,15,16 This increased risk of death is
seen across a range of conditions and is not limited to causes related to the underlying ID. Studies on
disease prevalence and morbidity among people with ID, although limited, provide a similar picture,
with an increased risk of epilepsy, diabetes, cardiovascular disease, infections, accidents and sensory
impairment.17–21 For example, it is estimated that about one in four people with ID suffer from epilepsy,
compared with < 1% of the general population.18 The concerns over the health of people with ID have been
reinforced by findings from the Confidential Inquiry into Premature Deaths of People with Learning Disability
(CIPOLD), which confirmed high premature mortality with a high proportion of unexpected deaths.22
There is evidence to suggest that the quality of health care received by people with ID contributes to
poorer health. This may be due to difficulties in communication that lead to unmet health needs, poorer
access to health services and discrimination.7 Sir Jonathan’s inquiry into access for health care for people
with ID concluded that high levels of need were not being met, that people with ID receive less effective
care than they are entitled to and that this leads to avoidable suffering and death.8 The high proportion
of unexpected deaths reported by CIPOLD may also indicate that serious health problems are not fully
identified in people with ID, leading to poor outcomes.22
In addition, Sir Jonathan’s inquiry highlighted the paucity of information on NHS health care for people with
ID.8 These data gaps were further summarised and described by the Learning Disabilities Observatory in
2011.23 Current national systems do not routinely allow a description of primary care use, quality of chronic
disease care, hospital utilisation and major health outcomes for people with ID. Specifically, national systems
such as cancer registration, Hospital Episode Statistics (HES), mortality registration or general practice data
collections (such as the General Practice Extraction Service) either do not systematically record ID or cannot
provide analyses separately for people with ID. An initial analysis in 2010 of a primary care database was
commissioned as part of the independent inquiry. It reported on a range of measures in people with ID and
found evidence for higher rates of obesity, poor seizure control and poorer treatment of urinary tract
infections (UTIs).24 However, this limited analysis was not developed further or submitted for peer-reviewed
publication, as far as we are aware. Thus, knowledge of the health of people with ID in the UK up to 2015
has still been primarily based either on selective recording, for example in hospital data, or on selected
populations from local ID registers.25 Similarly, we know very little about the cost implications of providing
NHS care for people with ID.
Annual health checks
A key recommendation of Sir Jonathan’s inquiry was the creation of a scheme in primary care to provide
annual health checks for people with ID, which was outlined in the 2009 national strategy for learning
disability.26 The primary purpose of annual health checks is to address access barriers experienced by
people with ID and to allow the identification of unmet health needs.9 Health checks also aim to improve
prescribing and co-ordination with secondary care and are identified as a reasonable adjustment in
accordance with the Disability Discrimination Act 1995.27
Annual health checks for adults with ID were implemented as a DES for primary care in 2009.28 This DES
funds practices to provide annual health checks to adults with ID, with an emphasis on those who have
higher levels of need and who are known to the local authority services. It also requires that senior practice
staff attend an approved multiprofessional educational session and that all practice staff receive training to
reduce attitudinal barriers and improve communication with this group of patients.
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Annual health checks are currently the main NHS intervention to improve the quality of primary care for
people with ID.29 However, estimates from 2011–12 suggested that only 53% of eligible adults with ID
had received an annual health check.30 It may be that more have been invited for a health check, and for a
variety of reasons had either refused or missed their arranged appointment, but this is not known. As of
2016, practices participating in the DES are required to invite registered patients on their learning
disabilities register, who are aged ≥ 14 years, for an annual health check.
Evidence base for annual health checks
The presumed long-term benefit of health checks assumes that the identification of unmet health needs
will lead to appropriate intervention and improvements in well-being and health outcomes. The Learning
Disabilities Observatory undertook a systematic review of the evidence base for annual health checks in
2011,11 subsequently updated in 2014,12 which summarised health gains and impacts from similar
interventions both in the UK and internationally. The initial review identified 38 studies (45 in the later
review) that comprised a total of > 5000 individuals receiving a health check. Most studies were small and
the majority were uncontrolled, with only four randomised controlled trials and two controlled studies.
The higher-quality studies clearly demonstrated that health checks led to the improved detection of new
health problems, with one randomised controlled trial reporting a 60% increase in the diagnosis of new
problems and a matched controlled study reporting 2.54 additional health problems identified, on average,
in people receiving health checks.31,32 These studies also reported an increase in the uptake of preventative
interventions such as vaccination, cancer screening and sensory testing. These conclusions are also
supported by the larger number of uncontrolled studies.11,12
Evidence on health outcomes relating to health checks is far more limited and of poorer quality. Uncontrolled
studies in the UK have reported a variety of benefits of health checks, including improved seizure control
and weight management.33–36 These UK studies were small, with fewer than 100 participants. One
larger before-and-after study of a domiciliary preventative intervention in the USA found a reduction
in self-reported pain, falls and emergency room visits,37 whereas another larger US study suggested that
health screening may help to resolve psychiatric problems by identifying physical problems.38
The systematic reviews by Robertson et al.11,12 concluded that there was limited evidence on the effect of
health checks on health status and that further work was required to establish the effectiveness of health
checks. It is highly plausible that health checks, through identifying unmet health needs and preventative
interventions, will lead to an improvement in health outcomes, but evidence to confirm this is important.
However, it is also possible that health needs identified in health checks may not be adequately addressed,
and that implementation of health checks by non-enthusiasts, outside study settings, will not yield the
same benefit in terms of newly identified health needs. For example, health checks may lead to the
recording of poor seizure control in epilepsy, but appropriate management may require expertise or
specialist input to review anticonvulsant medication, which may not be available.
Aims of the study
The study had two overall aims.
l Aim 1 was to describe the health, health-care quality, equity of health care, mortality rates and NHS
costs for adults with ID in a national sample.
l Aim 2 was to evaluate the process and outcome effectiveness of annual health checks for adults with
ID in primary care.
The original objectives associated with these aims are shown in Table 1.
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The first aim of our study, to provide a descriptive analysis of health and health-care quality for adults with
ID, is explored via two distinct analyses. First, we take a snapshot of the health of the adult population
with ID on 1 January 2012, registered in a large primary care database, and describe their chronic disease
prevalence compared with an age- and gender-matched control group without ID (from the same general
practices). Similarly, we will describe and compare the primary care utilisation of adults with ID in terms of
consultations, as well as process measures and prescribing. We will provide a best estimate of annual
health-care costs by applying NHS reference costs and drug tariffs for health-care events recorded,
including primary care consultations, prescribing, hospital admissions and outpatient consultations.
The second distinct series of analyses encompassing the first aim will follow a group of adults with ID
from 2009 to 2013 to describe their secondary care utilisation. Here, we will compare and summarise
emergency hospitalisations with an age-, gender- and practice-matched control group of adults without ID.
For two indicator conditions [UTIs and lower respiratory tract infections (LRTIs)], which are likely to be
common reasons for hospitalisation for adults with ID, we will compare their primary care utilisation in the
period before the hospital admission with similarly recorded admissions within the general population.
Finally, we will describe mortality patterns between 2009 and 2013 and summarise the key differences
between adults with and adults without ID.
The primary outcome for the second aim (evaluation of annual health checks) was identified as emergency
hospital admissions. As the evidence base suggests that health checks improve the detection of unmet
health needs, the management of chronic disease and the uptake of preventative care,12 the possible
longer-term health benefits of health checks may occur across a range of conditions, such as better seizure
control in epilepsy, reduced cardiovascular risk and the early treatment or prevention of infection. For all of
these conditions, delayed, incomplete or poor management will lead to an emergency hospital admission.
Thus, emergency hospital admissions may be an important measure of quality of care for a range of
conditions and a common pathway for the benefits of annual health checks. An associated reduction in
emergency hospital admissions is likely to be a key measurable and valued benefit from annual health
checks, as people with ID experience high levels of emergency admissions.39 Additionally, unplanned
TABLE 1 Original aims and objectives of the study
Aim Objective Location in report
(1) To describe the health,
health care quality, equity
of health care and NHS
costs for adults with ID in a
national sample
Quantify primary and secondary care utilisation by adults with ID,
including prescribing
See Chapters 3 and 5
Describe and quantify specific health risks for adults with ID See Chapters 3 and 4
Describe the quality of primary care received by adults with ID See Chapter 3
Determine whether or not adults with ID experience greater
socioeconomic inequities than the general population
See Chapter 3
Determine annual health service costs for people with ID compared
with the general population
See Chapter 3
(2) To evaluate the process
and outcome effectiveness
of annual health checks for
adults with ID in primary
care
Determine whether or not individuals receiving annual health
checks experience improvement in health-care process measures
and health problem identification
See Chapter 7
Determine whether or not individuals receiving annual health
checks experience improvement in health outcomes
See Chapter 6
Determine whether or not practice participation in the annual
health check DES improves outcomes for people with ID
See Chapter 6
Identify determinants and equity of uptake of annual health checks
in practices that participate in the directed enhanced service
See Chapter 7
Determine the change in health service costs in the year before and
the year after an annual health check
See Chapter 7
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admissions to hospital for patients with ID can be particularly stressful events, and unnecessary delays and
omissions in treatment can compromise patient safety.40
Many unplanned admissions to hospital would be expected to occur even if health checks really were
having an underlying beneficial effect. Thus, we will also investigate a subgroup of emergency admissions
for ambulatory care-sensitive conditions (ACSCs).41 These admissions are thought to be potentially
preventable with better clinical management in primary care. There is some variation in how ACSCs are
explicitly defined,42 particularly as they were originally developed in the USA.43 However, most definitions
will include a combination of conditions for which acute management should prevent an admission (e.g.
pyelonephritis) and other chronic conditions, such as chronic obstructive pulmonary disease (COPD), for
which effective preventative care may prevent admissions. However, the preventable concept of an ACSC
may ultimately depend on the availability of, and referral to, alternative services such as respite care.44 Some
suggested interventions to prevent ACSCs, such as improvements in self-management education and
telemedicine,44 may be less effective for patients with ID. Annual health checks may have a role to play
here, and although we will have reduced power to investigate this outcome compared with all emergency
admissions, emergency admissions for ACSCs may provide a more relevant estimate of effectiveness.
We will also explore a limited economic costing analyses, when our data allow. A more formal cost-effectiveness
analysis is not possible using the resources in this study. In addition, a cost-effectiveness analysis would have
presumed evidence of effectiveness, and it would have been premature to commit resources to such an analysis
before we had determined effectiveness.
Secondary outcomes in relation to health checks included disease-specific and generic process and
outcome measures. We will describe what is recorded on a patient’s electronic record at the time of a
health check, and then summarise the overall impact that a health check has on a selection of process
measures being carried out over time. This will include, for example, the recording of cardiovascular risk
factors such as body mass index (BMI), blood pressure and smoking, as well as the recording of the uptake
of cervical and breast cancer screening and influenza vaccination. We will also summarise the recording of
key health areas for patients with ID, such as incontinence, constipation, mobility, vision and hearing.
Why is the research needed now?
Concerns over the quality and equity of NHS health care received by people with ID are long-standing,7
and the last few years have seen an increase in targeted NHS action to address these concerns. Specifically,
in 2009, funding for annual health checks in primary care was introduced in England,30 and since 2016 the
NHS has remained committed to the current DES scheme.29 The rate of uptake of the scheme among
eligible adults in 2011–12 was 53%, only a small increase since 2010–11 (48%).30 For both clinicians and
NHS policy-makers, the current economic climate may be a barrier to the wider adoption of annual health
checks in primary care, or whether or not the scheme is renewed.
However, the development of Clinical Commissioning Groups may act as a catalyst for the wider
implementation of annual health checks, as these groups standardise services offered by primary care in
their area. Given this, an evaluation of the outcome effectiveness of annual health checks has the potential
to influence policy decisions. If our study can demonstrate a clear benefit from health checks, this will
strengthen the case for implementation and for ensuring access for all people with ID. Lack of evidence of
any measurable benefit will not invalidate health checks, but it will raise questions over the quality of
current implementation and the effectiveness of the service response to identified health needs. Our study
should be able to differentiate between these two explanations and guide development of services to
maximise health gain from annual health checks.
In summary, our study will evaluate the effectiveness of health checks in improving outcomes as well as
processes of care and will also address the paucity of information on the quality of health care for adults with ID.
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Chapter 2 Methods
The Clinical Practice Research Datalink
The Clinical Practice Research Datalink (CPRD) is a large, validated primary care database that has been
collecting anonymous patient data from participating UK general practices since 1987.45 It includes a full
longitudinal medical record for each registered patient that contains coded information on medical
diagnoses, prescribing and tests carried out within the practice. Additionally, referrals to specialists and
secondary care settings, and lifestyle information such as smoking and alcohol status, are recorded in the
CPRD. By 2015, it had been estimated to include over 4 million active patients, approximately 7% of the
UK population.45
Subject to the practice’s approval, the CPRD patient data are routinely linked to other national
administrative databases by a ‘trusted third party’ via their NHS number, gender, date of birth and
postcode. These databases include:
l the Index of Multiple Deprivation (IMD), a small-area measure of deprivation used in England for the
allocation of resources46
l the HES database, which routinely records clinical, patient, administrative and geographical information
on all NHS-funded inpatient episodes in the UK
l Office for National Statistics (ONS) death certification data.
Quality and Outcomes Framework and learning disability
Medical diagnoses on the CPRD are recorded using Read codes. Before we extracted data from the CPRD,
we carried out an extensive review of which Read codes we would use to identify patients with ID. The
starting point for this was the Quality and Outcomes Framework (QOF).47 The QOF was introduced in
April 2004 as part of a new general medical services contract in the UK, which would remunerate practices
based on performance. One key element was the creation of disease registers for many important
comorbidities, such as coronary heart disease (CHD) and COPD, using sets of nationally agreed Read
codes. This has had a notable impact on the recording of these diseases, such as for CHD,48 with the
assumption being that it has led to diagnostic accuracy overall (e.g. for COPD).49
Intellectual disability, classified as learning disability, has been part of the QOF since 2006. Originally there
was only one indicator related to this, LD1 (‘The practice can produce a register of people with learning
disability’). Although the rubric for the register suggests that all patients with ID were included, the exact
specification of business rules from around this time suggested that only patients aged ≥ 18 years were
included.47 In 2014, the disease register indicator was modified to LD001 (‘The contractor establishes and
maintains a register of patients aged 18 or over with learning disabilities’) to make the age criteria more
explicit. However, this was changed in 2014–15 to LD003 (‘The contractor establishes and maintains a
register of patients with learning disabilities’), and the associated business rules now (from version 30
onwards) allow for patients of any age to be included.
Although published national figures for the QOF learning disability register of patients are available (see
Appendix 1), the change in the definition makes it difficult to consistently estimate the prevalence of ID
over time. First, published denominators for the first 2 years (2006–7 and 2007–8) appear to be based on
all patients, so we have had to estimate the total number of adults to obtain the prevalence of ID within
adults only. The addition of non-adults to the QOF learning disability register in 2014–15 meant that no
separate adult-only figures were estimated. The fall in the published prevalence from 0.48% in adults in
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2013–14 to 0.44% in 2014–15 for all patients suggests that there may be still be a period of catching up
for some practices to include all their patients with ID on the register.
It has been argued that the QOF learning disability register provides a poor estimate of the actual number
of adults with ID in England.39,50 This may be because the majority of these patients do not use specialised
services for adults with ID and, as a result, are not well known to primary care. The prevalence estimate of
2.17% calculated by Public Health England in 201350 would mean that three out of four patients with ID
are not currently on QOF learning disability registers.51 It seems unlikely that those with a severe or
profound ID would not have this recorded on their medical record, so this ‘hidden majority’ would
presumably consist of patients with milder disabilities.
Identification of adults with intellectual disability in the Clinical Practice
Research Datalink
Rather than rely on the QOF learning disability register to find all patients with ID in CPRD, we electronically
searched the full medical record of all adults using an extended range of Read codes. Although there are
over 50 Read codes used for QOF definition of learning disability (see Appendix 2), they have been chosen
from the main ‘mental retardation’ hierarchical structure and, as a result, are not an exhaustive list in
terms of conditions usually associated with ID. For example, a Read code for Down syndrome would not
automatically put a patient on the QOF learning disability register. There are also some anomalies (e.g. the
code ZS34.11 ‘learning disability’ is not on the QOF list) that we would want to account for.
To create a more extensive list of candidate Read codes for our definition of ID, we manually reviewed
Read codes within relevant hierarchies, in addition to performing word searches using key terms on the full
set of codes. We included a wide range of chromosomal and metabolic disorders usually associated with
ID. Our intention was first to extract a group of patients with these codes, but then to refine the definition,
based on all available information in the individual medical record. The key to our approach was ensuring
that we were not missing a significant group of people with ID by relying on QOF codes alone.
A Read code list of 232 codes was sent to CPRD in October 2013 to identify all patients who had any of
these codes recorded anywhere in their medical record. We also required patients who:
l were fully registered with an English practice for at least 1 day between 1 April 2007 and
31 March 2013 (we subsequently defined study time from 1 January 2009)
l were ‘acceptable’ according to CPRD data criteria that identify patients who have been fully registered
with their general practitioner (GP) and who have passed CPRD data quality control checks
l had a birth year of 1995 or earlier.
An initial group of 32,876 patients from a total of 520 English practices (Figure 1) were extracted from the
complete version of CPRD. Sixty-nine practices were subsequently excluded from further consideration,
as they had stopped providing data to the CPRD by 2009 or did not pass CPRD quality controls for data
recording during our study period.
The initial group of 32,876 candidate patients with ID was used to help refine our Read code list. The final
list included 186 Read codes (see Appendix 2), 125 of which are not part of the QOF learning disability
code set. However, many of these additional codes were infrequently used because they represent very
rare conditions. For these additions, we chose to include diagnoses (e.g. Down syndrome, Fragile X
syndrome) and observations (e.g. ‘mental handicap problem’, ‘low IQ’), which are strongly related to ID
(see Appendix 2 for more examples). We also included administration codes that directly implied that a
patient had ID (e.g. ‘learning disability health exam’, ‘learning disabilities annual health assessment’). In
theory, practices should be using administration codes for health checks only if a patient is on their
learning disability register, but this was not absolute. Adopting the refined Read code list plus a series of
METHODS
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exclusions (see Figure 1) allowed us to now identify 24,855 patients with ID, or with conditions associated
with ID, for whom we wanted to extract age-, gender- and practice-matched controls.
Exclusions identified after first data extraction
One data issue we identified was with the erroneous historical use of some Read codes for phenylketonuria
and Down syndrome in some practices. It appeared that these codes had been used in the past (mainly
during 1994–6) to record screening tests for these conditions in pregnancy and infancy, and were applied
inappropriately to > 2000 (≈5%) patients who would have been wrongly identified with these conditions
based on a simple search for the disease codes. This was one of the main reasons for our two-stage
extraction, as clustering of these patients in some practices would compromise matching in these practices.
Phenylketonuria is a cause of ID but it can also be successfully treated. In addition, all newborn babies are
screened for phenylketonuria, which may explain the extra codes in the same way as the Down syndrome
codes. As the prevalence of phenylketonuria is about 1 in 10,000, it was implausible for a single practice
to have ≥ 100 cases (sometimes all born within 2 or 3 years). The clustering of this phenomenon by
Turns 18 years old outside UTSa period (n = 1148)
Have transferred out by 1 January 2009 (n = 1978)
Practice is never UTSa between 2007 and 2013 (n = 628)
Zero registration time (n = 1)
Initially provided by CPRD
(520 practices)
(n = 32,876)
Eligible patients registered 
during 2007–13 (451 practices)
(n = 26,833)
Met initial specification
(n = 31,099)
Down syndrome/PKU code during pregnancy (n = 1842)
Practice with < 365 UTSa days post 2009 (n = 1401)
Sole PKU or referral code (n = 1023)
Patients eligible for matching
(n = 24,855)
Patients with ID
(n = 21,859)
Other condition associated with ID (n = 469)
Autism without ID (n = 2352)
Further exclusions (n = 37)
Read codes not associated with ID on further 
review (n = 138)
• Pregnancy miscoding, n = 27 
• Fictitious, n = 8 
• Dead, n = 2
FIGURE 1 Summary of identification of patients with ID. a, CPRD data criterion for when a practice starts recording
data for acceptable quality. PKU, phenylketonuria; UTS, up to speed.
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practice allowed us to quickly identify the problem and create an automated strategy for correcting it.
Briefly, using electronic searches of the medical record, we identified calendar years in which a patient was
pregnant (or had given birth). If during this year (or an adjacent year) this patient was recorded as having
phenylketonuria or Down syndrome without any other evidence of ID in her record, she was excluded
from our definition of ID. A total of 1842 patients were excluded in this way (see Figure 1). We also
excluded a further 1023 patients who had a sole phenylketonuria Read code during infancy without any
further confirmation. Ultimately, we decided not to include phenylketonuria in our definition of ID, so any
remaining patients who were solely classified by this Read code were classed among the 469 patients
designated as ‘other condition associated with ID’ (see Figure 1).
Matched population controls
A list of 24,855 potential patients with ID (‘cases’) was sent to CPRD in December 2013 (see Figure 1), and
corresponding age-, gender- and practice-matched controls were extracted and sent to us in March 2014.
The matching was done in house by CPRD following our specification. We required any matched control
to be alive and registered on a pre-specified index date. For cases who were actively registered on
1 January 2009, and were at least 18 years old by the end of 2009, we chose 1 January 2009 as the index
date. For cases who registered after this date, we chose their registration date if they were aged 18 years
in that year. For cases who turned 18 years old after 2009, we chose 1 January of that year as the index
date. Our choice of index date ensured that virtually all patients with ID would have a full complement of
matched controls at the start of our planned longitudinal analyses. For patients with ID who remained
registered from 2009 to 2013, we anticipated losing an average of about one control per patient with ID,
owing to deregistration or death.
In total, 173,797 age-, gender- and practice-matched controls were extracted for the initial set of 24,855
patients who had ID or associated conditions, with 99.7% successfully matched to seven controls. Failure
to match to seven controls was generally due to a few large clusters of young patients with ID in
some practices.
Defining subcohorts for analyses
Further validation work after the extraction of controls identified some further exclusions (see Figure 1):
27 adults with ID who were pregnant and received their only code for ID in the year before pregnancy,
eight adults with ID whose medical record appeared fictitious and two adults with ID whose record clearly
indicated that they were deceased before 2009. Although we initially planned to include 2352 patients
with ‘autism without ID’, as well as a further group with other related conditions (but no evidence of ID),
we chose not to use these groups any further in the study. Therefore, the remainder of the report
considers only the 21,859 patients with ID (see Figure 1).
Depending on the specific analysis (e.g. cross-sectional or longitudinal), the number of adults with ID
included varied (Figure 2). All analyses of individuals required a minimum registration period of 30 days
with their general practice before the patient was eligible to be in our study. As anticipated, very few
elderly patients aged > 85 years with ID were identified during the study, and owing to doubts over the
validity of the recording of their health status, we made the pragmatic decision to include only patients
aged 18–84 years at the beginning of follow-up.
l The cross-sectional descriptions of disease prevalence, health promotion and consultations in primary
care (see Chapter 3) were based on 14,751 adults with ID who were alive and still registered on
1 January 2012 (and 86,211 matched controls). Thirty-one practices were no longer providing data to
the CPRD by this date, so only 408 practices were included in this analysis.
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l The longitudinal analyses of mortality (see Chapter 4) and hospital admissions (see Chapter 5) were
based on 16,666 adults with ID from the 343 practices with linkage to HES or ONS data (and 113,562
matched controls). Study follow-up time for these patients started from 1 January 2009 for those
already registered and aged 18 years, or a later date for those registering later or turning 18 years old
in a later year.
l The analyses of health checks and hospital admissions had two distinct components (see Chapter 6).
For the analysis carried out at practice level, we restricted to 289 practices with complete recording in
CPRD during 2009–12, which identified a total of 14,409 adults with ID. For the analysis specific to
individuals, we identified 7487 adults with ID with a first health check during 2009–12 (and 46,408
matched controls). A further 6922 adults with ID without health checks (and 47,662 matched controls)
are also included in these analyses.
Adults with ID 
(n = 21,859, 451 practices)
Eligible for further analysis
(n = 21,292, 439 practices)
Practices with linked data only
(n = 343)
Registered for 
≥ 1 day 
during 2009–13,
aged 18–84 years,
with practice 
data 2009–12 
(n = 14,409, 
289 practices)
Registered for 
≥ 90 days during 
2009–13, aged 
18–84 years, with 
recorded 
health check
(n = 7487) 
With no 
health check
(n = 6922)
Registered for 
≥ 365 days on 
1 January 2009,
aged 18–84 years 
(in 2009), with 
recorded health 
check 2009–11 or 
still registered 
on 1 January 2012
(n = 8311)
Registered for 
≥ 30 days on 
1 January 2012,
aged 18–84 years
(in 2012), with 
≥ 1 eligible control 
(n = 14,751, 
408 practices)
Registered for
≥ 30 days during 
2009–13, aged 
18–84 years, with 
≥ 1 eligible control
(n = 16,666)
Health checks
and hospital
admissions
(practices)
(see Chapter 6)
Health checks 
and hospital 
admissions
(individuals)
(see Chapter 6)
Who gets health
checks and what 
is recorded?
(see Chapter 7)
Disease prevalence
and other 
cross-sectional 
descriptions 
(see Chapter 3)
Mortality and
hospital admissions
(see Chapters 4 
and 5)
Matched controls
(n = 46,408)/
(n = 47,662)
Matched controls
(n = 86,211)
Matched controls
(n = 113,562)
Excluded as practice was not 
eligible by 1 January 2009 or
patient had died/de-registered
by 1 January 2009
(n = 567)
Practices 
participating
in health checks
(n = 274)
FIGURE 2 Summary of subcohorts for analyses. Note that subcohorts are overlapping and individuals may appear
in multiple cohorts.
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l Finally, a further analysis of health checks (see Chapter 7) was based on a subset of 274 practices that
had some participation in the DES (20% of eligible adults with ID must have had a health check during
2009–11). This identified a total of 8311 adults with ID who were registered on 1 January 2009 for at
least 1 year.
Identification of health checks
Health checks were identified by specific Read codes used by practices to facilitate future payment (69DB.,
9HB3., 9HB5.; see Appendix 1). We specifically focused on first health checks carried out from 2009
onwards, as this was the point from which practices in England received remuneration for carrying them
out. A small number of patients had checks recorded prior to 2009 and were not included here. Health
checks up to the end of the CPRD data collection period (31 March 2013) were included. The numbers of
health checks included in the relevant analyses are shown in Figure 3.
The analyses were divided into two distinct sections: hospital admissions in relation to health checks
(see Chapter 6) and a descriptive summary of health checks (see Chapter 7). A total of 8933 first health
checks were included across both analyses (with 4137 of the health checks appearing in both).
For the analysis of hospital admissions, we first only included the subset of CPRD practices (n = 343) that
were actively recording data on 1 January 2009 and were linked to HES data. All patients were required to
be registered with the practice for at least 90 days prior to the health check, and to be alive for 90 days
after it. To be included, patients had to be aged 18–84 years at the time of their first health check. In this
analysis, all patients were followed to 31 December 2013, or to their death if this was earlier. We were
able to retain patients who had deregistered from their practice in the follow-up, as linkage to hospital
Hospital admissions
(see Chapter 6)
Practices with linked HES data 
and active on 1 January 2009
(n = 343)
Linked by index date
of health check or 
randomly assigned date
Non-health check patients
(n = 6922)
Adults with ID with no health check 
during 2009–13 and still registered 
on index date of health check
Descriptive analysis
(see Chapter 7)
Practices with ≥ 20% participation
in DES 2009–11
(n = 361)
Adults with ID with first health 
check 1 April 2009 to 31 March 2013 
registered for ≥ 90 days prior to 
health check and alive at least 
90 days after it
(n = 7487 health checks)
      Adults with ID with first health 
check during 1 January 2009 to 
31 December 2011 who were 
registered on 
1 January 2009 for at least 365 days
(n = 5583 health checks)
Description of what gets 
recorded during check,
and whether or not the 
check influences process 
measures before 
and after the check
Analysis among all adults 
with ID still registered 
on 31 December 2011
as to what predicts
who gets a health 
check during 2009–11
(n = 5026 checks)
FIGURE 3 Summary of health check analyses.
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admissions continued as long they remained resident in England. A total of 7487 adults with ID aged
18–84 years with a first health check between April 2009 and March 2013 were identified.
The distribution of month of first health check for the 7487 adults with ID is shown in Figure 4. As the
payments for the DES are made at the end of the financial year, there are notable spikes in activity each
February and March during the study. The early years (2009–10) were the most common years for a first
health check, reflecting that the majority of participating practices joined the scheme during its initial years.
The distribution of first health check date was used to assign a random index date to a group of 6922
adults with ID without health checks (see Figure 3). These patients formed a complementary group in our
analysis of hospital admissions to check whether or not any observed changes in admissions for adults with
ID were specific to those receiving health checks only.
For the descriptive analysis of health checks, we included a total of 5583 first health checks made during
2009–11 (see Figure 3). We no longer restricted to practices with linked HES data, so we could include
from a wider set. However, we did then restrict to 361 practices with some participation in the DES
(at least 20% of adults with ID with health checks) to try to capture regular procedures around the health
checks. As some of these analyses would focus on health processes in the year after the health check,
we included checks only up to the end of 2011. Finally, we also carried out an analysis that investigated
predictors of receiving a health check during 2009–11. We restricted to 7754 adults with ID registered
throughout 2009–11, in which 5026 received a first health check during that period.
Definition of severe health needs
Although there are specific Read codes that allow for the severity of a patient’s ID to be classified
(e.g. ‘Eu81500 – severe learning disability’), we found that fewer than half of our patients had such a
code recorded. For example, among the 14,751 adults with ID alive and registered on 1 January 2012,
only 45% had a code indicating the severity of their ID (Table 2). Among those with severity of ID
recorded, and using the highest level in their record, 38% had ID classed as mild, 35% had ID classed
as moderate, 24% had ID classed as severe and 3% had ID classed as profound.
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FIGURE 4 Distribution of month of first health check from April 2009 to March 2013.
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With severity missing in over half of the sample, we had to consider two options. The first would be to
only look at severity in the subgroup with it recorded. However, this approach is problematic, as the
existence of such Read codes probably do not occur at random in our study group, and this group with
severity recorded will not be representative of our total group. For example, patients in 2012 with recorded
severity were a mean of 2.6 years older than those with no severity recorded (see Table 2).
Therefore, we considered an alternative approach that used Read codes that identify severity when
available, and, when these codes were not present, used a selection of other codes in their record that
would indicate that the patient had severe or complex health needs. We identified six health areas that
encapsulated a wide range of support or severe health needs:
1. epilepsy – Read codes as per QOF definition, but excluding absence seizures
2. mobility – wheelchair use or greater problem; cerebral palsy
3. visual – blind or low vision
4. hearing – deafness, significant impairment, hearing aid use
5. continence – bowel or bladder (recorded after age of 12 years)
6. percutaneous endoscopic gastrostomy feeding.
We refined this list by cross-checking the prevalence of these codes and conditions in the patients with severe
or profound ID versus mild or moderate ID (the full list of codes used is provided in Appendix 2). All categories
were significantly associated with severe or profound ID, with the exception of hearing impairment. However,
we retained this category to enable our definition to be as complete as possible in terms of various health
needs. Finally, we improved precision by imposing a restriction that for a patient to have a high level of
support or severe health needs, he or she needed to fulfil two or more of these categories (Figure 5). This
ensured that we were not just creating, for example, a marker for age-related frailty. The only exception to
this rule was that if the patient already had Read codes indicating severe or profound ID.
TABLE 2 Summary of recorded ID severity in adults with ID on 1 January 2012
Severity of ID n % of all adults with ID
% of adults with
ID who are men Mean age in years (SD)
Severity recorded 6565 44.5 57.2 43.5 (15)
Severity not recorded 8186 55.5 58.4 40.9 (16)
Severity
Mild 2515 38.3 56.6 43.7 (15)
Moderate 2298 35.0 58.7 43.4 (16)
Severe 1567 23.9 56.6 43.6 (15)
Profound 185 2.8 53.5 40.7 (14)
SD, standard deviation.
Severe or profound ID
At least two of the following:
• Epilepsy
• Significant mobility problem
• Severe visual impairment
• Severe hearing impairment
• Continence problem
• PEG feeding
OR
FIGURE 5 Definition of severe health needs used as a proxy for severity of ID. PEG, percutaneous endoscopic
gastrostomy.
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In the cross-sectional analyses (see Chapter 3), this approach identified a total of 3527 patients with ID
with severe health needs (23.9% of all patients with ID). This group was made up of 1752 patients with
severe or profound ID who are automatically included, plus the inclusion of 686 patients with mild or
moderate ID and 1089 patients with no severity of ID recorded on their record. The proportion with severe
health needs (13.5%) among those without severity recorded on their GP record was very similar to that
estimated from those with mild or moderate ID recorded (14.3%). This suggests that those without
severity recorded, as well as being younger, have primarily mild or moderate ID.
Other subgroups of interest
In addition to adults with ID with severe health needs, we identified other ID subgroups of interest: living
arrangements, autism spectrum disorder and Down syndrome.
We wanted to describe the living arrangements of our patients with ID, but we were limited by the
inconsistent recording of information in relation to this (e.g. carer details, or whether or not they lived with
their family). The clearest distinction we could make was to identify patients who were living in dependent
settings, such as residential or nursing homes, and to compare these patients with the remainder who
were not classified in this way. We could primarily do this by the use of an address flag on the CPRD
database, which can identify clusters of patients living at the same address. We have used this flag
previously to identify elderly patients in care homes.52 Here we assumed that the presence of three or more
people with ID at the same address indicated communal or shared accommodation. The use of this
address flag can vary by practice, so in addition we used some specific Read codes for living arrangements
(see Appendix 3) to bolster our definition.
We also stratified analyses, when possible, by whether or not the adult with ID also had a record of autism
spectrum disorder and, separately, by whether or not they had Down syndrome. The Read codes for these
are provided in Appendix 3.
Definition of a consultation
We defined a consultation as a unique event during which the patient was seen or telephoned by a doctor
or nurse. However, identifying patient consultations is not always straightforward in CPRD, as many of the
administration entries on the computer system can confusingly resemble a consultation if they are not
accounted for. Although there is a specific variable for ‘consultation type’, this is not consistently used
across practices, and cannot solely be relied on to identify consultations.
To automate a definition of consultations in CPRD, we restricted it to events on the system for which the
consultation type (e.g. surgery consultation) and staff member (e.g. senior partner) met our definition,
excluding administrative events and repeat prescribing. For patients with ID, we also excluded consultations
on days when a health check was recorded. Within the consultations we identified, we could further
subdivide into whether the consultation had been doctor or nurse led, and whether it had been face to
face (at the GP surgery or a home visit) or by telephone. Further details of the definition used for
consultations are given in Appendix 4.
It is possible to ascertain the length of the patient consultation from within CPRD, using the recorded
duration on the system. For face-to-face consultations with a doctor, we classified consultation length into
standard (1–10 minutes) and long (> 10 minutes), excluding a small number of zero-length consultations.
As each clinician has a unique identifier on the system, we could estimate continuity of care by calculating
the highest proportion of doctor consultations with the same doctor. We used a cut-off point of > 50% to
summarise continuity, so if a patient had a total of five consultations, they would need at least three with
DOI: 10.3310/hsdr05250 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 25
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Carey et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
15
the same doctor to achieve this. Although other indices of continuity have been proposed,53 our summary
has the advantage of being largely independent of number of consultations.
Difficulties with Hospital Episodes Statistics linkage
Of the 451 practices initially extracted by the CPRD, 353 (78%) had linkage to HES data. When the linked
data set (adults with ID and controls) was provided by the CPRD in March 2014, the HES data were
available only to 31 March 2012 as a result of a national postponement in the linkage of all HES data
during 2014–15. As our analyses had been powered for follow-up into 2013, the uncertainty over
extended linkage presented a dilemma. While waiting for this issue to resolve, we were able to proceed
with analyses not involving HES data. When the HES linkage to 31 March 2013 was finally performed and
delivered to us in January 2015, we then had a further issue, that patients from practices that dropped out
from the CPRD during the linkage postponement could not have their follow-up extended. We made the
decision to keep these patients in the analyses, but terminated their follow-up for hospital admissions
outcome at 31 March 2012. This affected approximately 2.6% of all of the linked patients in the original
extracted data set.
Missing entity data in the Clinical Practice Research Datalink
During the initial data acquisition, we discovered a data extraction error that existed in the complete
database held by the CPRD. This had occurred between the extraction of data from the general practices
and the building of the CPRD database. Briefly, the Vision system (In Practice Systems Ltd, London, UK)
used by the practices allows for more complex data entries, which cannot be conveyed simply by
Read codes, to be held in additional data areas called ‘entities’. For example, the diastolic and systolic
measurements for blood pressure would be held this way. For three outcome measures we were interested
in (medication review, diabetic retinal screening and glomerular filtration rate), we discovered significantly
lower than expected recording in the CPRD, owing to an unspecified historical issue with the entity data
within some practices. After raising this with the CPRD in the summer of 2014, it took another year for a
potential data fix to be provided. However, the fix could be applied to current practices only, which meant
that practices no longer contributing to the CPRD were unable to be corrected. Thus, our reporting of
these outcomes, particularly medication review, is subject to under-recording. Sensitivity analyses, including
only those practices for which a fix was possible, suggested that this under-recording may be around
5–10%. However, even when the fix could be applied, the overall low recording of recent medication
reviews left us querying the data integrity for this outcome.
Economic costs
We included a descriptive analysis of NHS costs in our study. The intention was to use the CPRD and HES
data to best estimate, when possible, a before-and-after cost comparison to assess the impact of annual
health checks on NHS costs, and an estimate of NHS costs for care for adults with ID compared with the
general population. We did not, however, commit to a formal cost-effectiveness analysis, as our data
do not include some elements of NHS costs or social care costs that would be required for a robust
cost-effectiveness analysis.
We identified several sources of external data to guide us in estimating NHS costs. First, the Unit Costs
of Health and Social Care, produced by the Personal Social Services Research Unit,54 provided us with
many key primary costs, including of consultations. We used the costings produced for 2012, which,
for example, produce a guidance cost of £3.70 per minute of patient contact with a GP (including
qualification costs and direct care staff costs). Duration of consultation is generally available on the CPRD,
and so it is possible to estimate costs using this scaling.
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Second, prescribing costs were identified by the Prescription Cost Analysis documents produced by NHS
Digital.55 This allows a net ingredient cost to be identified by drug name, form and strength, which can be
linked to prescribing information on the CPRD. Again, we used 2012 costings to estimate prescribing costs.
Finally, for hospital admissions we relied on two sources of data. First, the National Schedule of Reference
Costs data for NHS trusts and NHS foundation trusts costings provided costings for all elective and
non-elective hospital stays.56 We generally relied on costings for 2011–12. These costing are coded by
Healthcare Resource Groups (HRGs), which are ‘standard groupings of clinically similar treatments which
use common levels of healthcare resource’ (contains public sector information licensed under the Open
Government Licence v3.0)57 (we used HRG4). We then used the International Classification of Diseases,
Tenth Edition (ICD-10)58 and OPCS Classification of Interventions and Procedures version 459 codes on the
HES data to translate these into HRGs using the HRG4 2011–12 reference costs Grouper software.60
A brief summary of the data sets and assumptions used in the economic cost estimation is given in
Appendix 5.
Statistical analysis
For the cross-sectional analyses (see Chapter 3), depending on the outcome being studied, we calculated
prevalence, odds or relative risk ratios between patients with ID and their matched controls using
conditional Poisson and logistic models (Stata Statistical Software: Release 13, 2013; StataCorp LP, College
Station, TX, USA). The models were conditioned on the adult with ID–control(s) match-sets; thus, all
comparisons are implicitly adjusted for matched factors: age, gender and practice (which will factor in
regional and urban–rural variations). For prevalence ratios (PRs), Poisson models were fitted with robust
error variances corrections to provide reliable estimates.61 When the outcome was based on a subgroup
defined not solely by age and gender (e.g. influenza vaccination among those with eligible comorbidity;
see Table 12), then only match-sets that included an adult with ID and at least one control could be used.
An exception to this was when we analysed attainment of QOF indicators (see Table 16), for which this
approach was not feasible. As patients could not be matched in this analyses, we fitted a (non-conditional)
log-binomial model adjusting for gender and age. Practice was included in the model, assuming an
exchangeable correlation structure. When the outcome was number of consultations over the previous
year (see Table 17), an offset for number of registered days was added to the Poisson model to allow
for patients who had been registered for < 1 year. In the consultation analyses, we further adjusted
for comorbidity using a weighted score of QOF conditions.62 For analyses on consultation length and
continuity, we also adjusted for total number of consultations. For cross-sectional analyses with economic
cost as the outcome (see Table 20), we fitted (conditional) fixed-effects negative binomial regressions to
account for overdispersion, with bias-corrected confidence intervals (CIs) produced from non-parametric
bootstrap estimation (1000 simulations).
For the analyses with mortality as the outcome (see Chapter 4), we estimated crude death rates and
hazard ratios (HRs) for comparisons between adults with ID and their matched controls. HRs were
calculated via Cox regression (SAS version 9.4; SAS Institute Inc., Cary, NC, USA), with further adjustment
for a weighted score of QOF conditions, which has been shown to predict mortality in the general
population,62 smoking and socioeconomic status using the IMD.46 For comparisons within subgroups
(defined by the adult with ID), we compared the HRs and CIs derived from each adult with ID versus
control comparison (e.g. adults with ID with Down syndrome vs. controls) and calculated p-values for
these between-group differences. We additionally carried out unmatched analyses focusing only on adults
with ID (see Chapter 4, All-cause mortality), fitting models that directly compared each subgroup category
(e.g. those with vs. those without Down syndrome), adjusting for age and gender differences, and
stratified according to practice.
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For the analyses on hospital admissions (see Chapter 5), we estimated crude admission rates for adults
with ID and their matched controls. Incidence rate ratios (IRRs) for emergency hospitalisation were
calculated using conditional Poisson models described previously, stratifying again on match-sets and
similarly adjusting for comorbidities, smoking and deprivation. For the examination of primary care
utilisation preceding admission, it was not possible to preserve the matching. Instead, we used logistic
regression to estimate an odds ratio (OR) for adults with ID versus controls, adjusting for differences in age
and gender.
The analyses that investigated the impact of health checks on hospital admissions (see Chapter 6) primarily
used the conditional Poisson model to compare the rate of change over time at a practice or individual level.
At practice level, these were conditioned on practice, and all admissions from registered adults with ID in
each period were counted, using an offset term to account for the total time registered. The effect of
practice participation on hospital admissions was estimated by the interaction between practice participation
(fully vs. none) and period (2011–12 vs. 2009–10). At individual level, we conditioned on individual as
opposed to match-set, as accounting for the matching variables is not paramount in matched cohort
analyses.63 This model was fitted to adults with ID and controls separately, estimating the individual change
in hospital admission rate after compared with before health check, with an offset accounting for the time
registered. A combined model of adults with ID and controls with a case–period interaction provides an
estimate of the effect of health checks on admission rates among adults with ID, adjusted for temporal
trends in admissions. All models used a sandwich estimator to obtain robust standard errors.
The analyses of hospital admissions in individuals with health checks also considered adults with ID without
health checks in two sets of sensitivity analyses to check the robustness of our findings. First, using the
assigned random index date (see Identification of health checks) instead of the health check date, we
simply repeated the analysis on this set of patients and their matched controls to see whether or not any
observed changes in the health check patients were also observed here. Second, we also considered a
direct comparison of adults with ID with and without health checks using Poisson and negative binomial
models, adjusting for age, gender and selected comorbidities (severe health needs, epilepsy, dementia and
Down syndrome).
The analyses of health process measures were largely descriptive (see Chapter 7), summarising the
recorded information on patient records before and after health checks. We calculated the change in
consultation and prescription rates in a period before (2006–8) and during the introduction of health
checks (2009–11) using conditional Poisson regression as described previously. We contrasted the change
between patients with ID with and without health checks, but did not attempt a formal statistical
comparison. Finally, we also carried out an analysis that investigated which factors predicted a health
check among a subset of patients with ID registered during 2009–11 in practices that were carrying out
health checks. Here a logistic model was fitted, with health check (yes/no) as the outcome and practice
included in the model as a random effect.
Patient and public involvement
Throughout the course of the study, a collaborative approach to patient and public involvement was
taken,64 and we engaged two groups through regular meetings every 8–12 weeks:
1. ResearchNet – a network of service user and staff members at St George’s, University of London, who
collaboratively undertake research to develop services and improve patient experience
2. Carers Support Merton – a local group of family carers of adults with an ID.
The focus of these meetings initially was to identify important outcomes for our study and concerns for
patients and carers. This involvement subsequently contributed to changes to the design of the study in
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terms of choice of outcomes, examination of potential modifying factors, and help in interpreting and
disseminating findings.
We have summarised some of the key issues that arose from these initial meetings with ResearchNet
(Table 3) and Carers Support Merton (Table 4). We tried, when possible, to explore many of these issues,
such as the addition of dysphagia, aspiration pneumonia, constipation and anxiety as potential outcomes
in our analysis. The focus on consultation length and continuity of care by health professionals as key
measures of health-care effectiveness were important additions to the study that ultimately strengthened
some of our published research findings.66 The groups stressed the importance of living arrangements for
adults with ID (e.g. living with their family) and, although the data could not adequately assess this, we
were able to identify a subgroup of patients with ID who were recorded as living in shared or communal
living arrangements (see Other subgroups of interest). However, not every issue raised by the groups could
be adequately explored, owing to limitations with our data.
TABLE 3 Factors identified by ResearchNet for investigation and analysis
Area Specific details
Prominent health issues Constipation
Depression (‘problems with feelings’), anxiety
Diabetes
Epilepsy
Podiatry (‘feet’)
Hearing and vision
Hydrocephalus
Lungs and breathing problems, aspiration pneumonia
Swallowing difficulties, dysphagia
Teeth
Other issues affecting health Living arrangements (such as whether they lived with their family, independently, in a
residential care home or in supported living) were mentioned as an explanation for the
variation in how many people had health checks and in accessing primary care generally
Health care for patient with ID Seeing the same doctor, the patient’s regular doctor
Having long enough appointments to discuss several things
Hard to make GP appointments for person with ID because they might rely on others to
make the appointment or take them to the GP
Health checks The group identified some checks that they thought could keep someone healthy in
future, and that should be part of health checks: BP checks, feet checks, heart checks,
kidney/urine checks, blood tests, memory tests, scans and X-rays, weight measurement,
smears, advice on self-examination
Some mentioned that the following had been particularly helpful to them from their
health checks: weight loss advice, help with pain, help with depression, including tablets,
regular medications for epilepsy or diabetes, calming tablets, help with addiction
Dislike of health check if it led to blood tests or injections but others recognised that
these could be valuable and it was possible to overcome those fears
There was particular interest in the group about being able to talk about mental health
issues with your doctor, particularly about being anxious or depressed. Some mentioned
that more time was needed to talk about these issues
BP, blood pressure.
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The discussion about health checks with both groups identified varied views on the effectiveness and
acceptability of health checks, and differing experiences of the delivery of the health check programme.
This highlighted the importance of describing process measures for the health checks, as well our main
focus on changes in hospital admissions.
A qualitative research paper65 has been published further detailing the views and experiences of the
members of the parent, carer and ResearchNet groups of their involvement in this research. Preliminary
findings suggest almost unanimous agreement from both groups that their involvement was meaningful to
them and that their participation felt genuine (see Appendix 6).
TABLE 4 Factors identified by Carers Support Merton for investigation and analysis
Area Specific details
Diagnosis and management Epilepsy diagnosis and management and quality of seizure control
Identification of depression
Hearing and vision problems
Vitamin D deficiency and osteoporosis diagnoses in older people
Later cancer diagnoses
Gout and osteoarthritis
Monitoring of therapy (e.g. having thyroid function tests if on thyroxine)
Medication Concern over number of medications prescribed
Risks of inappropriate prescribing
Overuse of antipsychotic medications for behavioural problems
Monitoring of epilepsy medication
Preventative care Importance of overweight and obesity
Smoking in those with less severe levels of disability
Screening for hypothyroidism in some conditions (e.g. Down syndrome)
Organisation of care Impact of place of residence (e.g. with family carer, in supported independent living,
in group home)
Being able to see the same GP, length of appointments
Organisation of health checks, variation in duration and place of delivery of health checks
(e.g. reports of some as short as 10 minutes, some as long as 2 hours, some done over
telephone, some as home visits)
What is actually covered in health checks? Content should be according to the Cardiff
health check, but is not always so, and there was marked variation in what was covered
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Chapter 3 Cross-sectional findings
Introduction
In presenting a summary of the health and health care of adults with ID in primary care in England,
we chose to carry out a series of cross-sectional analyses on a fixed date (1 January 2012) that would be
towards the end of our study period. It also had the benefit of maximising the number of CPRD practices
contributing data at that time, as some practices in our study stopped contributing data later in 2012.
This date allowed a total of 408 practices to be used in the cross-sectional analyses, from which a total of
14,751 patients with ID who were aged 18–84 years in 2012 were included. These patients were age,
gender and practice matched to 86,211 controls without ID (see Figure 2). All patients had been registered
with the practice for a minimum of 30 days.
Some of these results have already appeared in publication in Carey et al.66 © British Journal of General
Practice 2016. This is an Open Access article distributed under the terms of the Creative Commons
Attribution license (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse,
distribution and reproduction in any medium, provided the original work is properly cited. The text below
includes minor additions and formatting changes to the original text.
Prevalence of intellectual disability among adults in 2012
We were able to estimate the adult prevalence of recorded ID in primary care in 2012 by obtaining
denominators by gender and 5-year age groups for all registered patients in CPRD on 1 January 2012.
These totalled approximately 2.7 million patients aged 18–84 years from the eligible 408 practices. This
allowed us to estimate that the 14,751 adults with ID aged 18–84 years in 2012 represented 0.54% of
the total registered population for this age group. For comparative purposes, the published prevalence
from QOF for 2011–12 (effectively estimated at 31 March 2012) for all adults aged ≥ 18 years was 0.45%
(see Appendix 1), derived from all 8123 practices in England. Thus, our decision to include a wider set of
Read codes for ID, and not just those used for the QOF learning disability register (see Appendix 2),
increased our cohort of adults with ID by about 20%.
The estimated prevalence in the registered population of adults on 1 January 2012 differed by gender,
with a higher rate seen in men (0.63%) than in women (0.45%). When the prevalence was estimated by
age (in 2012), there were incremental reductions seen with increasing years of life. For those aged
18–34 years the prevalence was 0.72%, for those aged 35–54 years it was 0.59% and for those aged
55–84 years it fell to 0.34%.
There was considerable variation in the prevalence rate of ID when this was calculated in each of the 408
practices (Figure 6).
l Only 34 practices (8%) reported a prevalence of > 1 in 100 registered patients having ID recorded.
l There were two notable outliers in terms of prevalence (2.22% with 61 total patients with ID and
2.68% with 114 total patients with ID). More than two in three patients with ID in these practices
were estimated to be living in communal or shared accommodation, suggesting that these practices are
located near such residences.
l Although not outliers in terms of prevalence, five practices had > 120 patients with ID registered
(n = 173 with prevalence of 1.07%, n = 164 with prevalence of 1.51%, n = 139 with prevalence of
0.93%, n = 124 with prevalence of 1.08% and n = 122 with prevalence of 1.56%).
l Forty-seven practices (12%) had < 10 registered patients with ID; nine of these practices had fewer
than five registered patients with ID.
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Overall characteristics of adults with intellectual disability
The distribution of age (calculated in 2012) for the 14,751 adults with ID registered on 1 January 2012 is
shown in Figure 7. The resulting distribution is different from the pattern seen in the general UK population,67
which is indicated by the dotted line. There are two peaks (around 18–25 years and 45–50 years) that offset
the dearth in the older population with ID seen from the age of about 60 years onwards.
Further characteristics of our sample of adults with ID are shown in Table 5. The average age was 42.1 years,
and 58% were male. The percentage of men among adults with ID gradually fell with age, from 61% in
the youngest group (18–34 years) to 53% in the oldest group (55–84 years). Approximately three in four
patients had their ethnicity recorded on their primary care record, with > 90% being recorded as white.
Adults with ID with a non-white ethnicity recorded were much younger (mean 34.8 years) but were small in
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TABLE 5 Main characteristics of adults with ID
Characteristic n
% of all
adults with ID
% of adults with
ID who are men
Mean age in
years (SD)
All 14,751 100 57.9 42.1 (16)
Gender
Women 6216 42.1 0 43.3 (16)
Men 8535 57.9 100 41.2 (16)
Age (years) in 2012
18–34 5365 36.3 61.2 25.3 (5)
35–54 6041 41.0 57.5 44.8 (5)
55–84 3345 22.7 53.1 64.1 (7)
Ethnicity
White 10,192 69.1 56.7 43.1 (16)
Other 921 6.2 56.0 34.8 (13)
Not recorded 3638 24.7 61.4 41.0 (15)
ID subgroupa
On QOF learning disability register 12,862 87.2 58.1 42.1 (16)
Down syndrome 1571 10.7 53.9 40.4 (13)
Autistic spectrum disorder 1512 10.3 76.4 32.5 (13)
Has severe health needs 3527 23.9 52.6 44.2 (16)
In communal/shared accommodation 3138 21.3 55.8 49.3 (15)
Deprivationb
1 (least deprived fifth) 1563 10.6 58.8 41.2 (16)
2 2000 13.6 57.7 42.9 (16)
3 2232 15.1 59.5 41.9 (16)
4 2764 18.7 56.0 42.2 (16)
5 (most deprived fifth) 3056 20.7 57.8 42.4 (16)
Not available 3136 21.3 57.9 41.7 (15)
Time with practice (years)
< 1 1037 7.0 55.8 38.2 (16)
1–5 2945 20.0 56.8 40.2 (16)
≥ 5 10,769 73.0 58.3 43.0 (16)
Annual health check
None by 1 January 2012 7845 53.2 58.2 40.3 (16)
At least one by 1 January 2012 6906 46.8 57.4 44.1 (15)
SD, standard deviation.
a Subgroups are overlapping and only those with the characteristic are shown in the table.
b Deprivation was defined as IMD quintile.46
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patient numbers, and as a result we did not pursue ethnicity further as a subgroup of interest in this report.
Overall, 87% of our sample were on their practices’ QOF registers for learning disability.
About 1 in 10 of our adults with ID was recorded as having Down syndrome. Similarly, 1 in 10 had a
diagnosis of autistic spectrum disorder in addition to their ID; these patients were markedly younger (mean
32.5 years) and the majority were men (76%). About one-fifth of patients with ID (21%) were identified as
living in a communal setting, and this group was notably older (mean 49.3 years).
Socioeconomic status was approximated by IMD quintiles,46 linked at postcode level to the patient’s
residence (linked practices only). Although there was a trend towards more adults with ID being found in
increasing quintiles of IMD, representing higher deprivation, this mirrors the pattern seen in complete
population extracts of CPRD,68 and reflects a small geographical bias within CPRD whereby there are
comparatively fewer practices in the north of England.45 Almost three in four adults with ID (73%) had
been registered at their practice for at least 5 years. Just under half (46.8%) had received an annual health
check by 1 January 2012.
Disease prevalence among adults with intellectual disability
We chose to describe chronic disease prevalence by focusing on the range of conditions collated by the
QOF.69 For most of these conditions, we used version 26 of the business rules,70 which were in operation
circa 2012–13. These identify the set of Read codes used in definitions, and for the most part stay
consistent from year to year. For each condition, we searched for the presence of any Read code in the
medical record up to 1 January 2012 to allow the description of prevalence. For cancer and depression,
we first describe lifetime prevalence, but also include date-specific period prevalence in line with the
QOF definition. For asthma, epilepsy and hypothyroidism, in line with the QOF definitions, a recent
prescription was also required to give a measure of period prevalence. Severe mental illness was
subdivided into schizophrenia and affective disorder. We also included additional conditions of anxiety
and dysphagia.
Table 6 summarises the disease prevalences for adults with ID, compared with their controls, using PRs.
These were calculated using conditional Poisson models (see Chapter 2, Statistical analysis) that take into
account the matched design. Almost one in five adults with ID was recorded with epilepsy that is currently
managed (18.5%), compared with < 1 in 100 adults without ID (0.7%). This represents a prevalence
25 times higher than that in controls (PR 25.33, 95% CI 23.29 to 27.57). Other large relative differences in
prevalence were seen for severe mental illness (8.6% of adults with ID; PR 9.1, 95% CI 8.3 to 9.9) and
dementia (1.1% of adults with ID; PR 7.5, 95% CI 6.0 to 9.5). Adults with ID had a moderately increased
risk of dysphagia, hypothyroidism and heart failure (PR of between 2 and 3.5) compared with the general
population. In addition, significantly higher in adults with ID (PR of between 1.5 and 2) were osteoporosis,
stroke, diabetes and chronic kidney disease.
Not all recorded disease prevalence was higher in adults with ID. Recorded lifetime prevalences of both
ischaemic heart disease (IHD) (PR 0.65, 95% CI 0.57 to 0.74) and cancer (PR 0.70, 95% CI 0.61 to 0.80)
were significantly lower than those seen in the general population. Although a record of depression was
equally likely in adults with ID, when only diagnoses in the last year were considered, adults with ID were
20% less likely to have one recorded in their record (PR 0.80, 95% CI 0.70 to 0.92).
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Figure 8 displays a mean count of all QOF conditions from Table 6 (excluding anxiety and dysphagia,
which are not counted by QOF) in adults with ID and controls. The disparity between the groups is already
evident at the age of 18 years, when the mean count is approximately three times higher among adults
with ID (0.31 vs. 0.11). The higher burden of comorbidity persists through middle age, but after about
65 years of age the two lines in Figure 8 start to quickly converge. Comorbidity levels are then more similar
between adults with ID and matched controls in their seventies. Among the few adults with ID in their
eighties in our study (n = 116), levels of comorbidity were lower than among their matched controls.
TABLE 6 Prevalence of chronic disease in adults with ID vs. controls on 1 January 2012
Disease
Adults with ID
(N= 14,751), n (%)
Controls
(N= 86,221), n (%)
Adults with ID vs.
controls, PR (95% CI)
Anxiety 2398 (16.3) 12,580 (14.6) 1.13 (1.09 to 1.18)
Asthmaa 1208 (8.2) 5717 (6.6) 1.25 (1.18 to 1.33)
Atrial fibrillation 122 (0.8) 821 (1.0) 0.91 (0.75 to 1.09)
Cancerb 238 (1.6) 2090 (2.4) 0.70 (0.61 to 0.80)
Diagnosis since 1 April 2003 156 (1.1) 1490 (1.7) 0.65 (0.55 to 0.76)
Chronic kidney disease 468 (3.2) 1746 (2.1) 1.64 (1.49 to 1.82)
COPD 160 (1.1) 1184 (1.4) 0.84 (0.71 to 0.99)
Dementia 160 (1.1) 134 (0.2) 7.52 (5.95 to 9.49)
Depressionb 2609 (17.7) 15,179 (17.6) 1.03 (0.99 to 1.06)
Diagnosis since 1 April 2006 1626 (11.0) 9520 (11.0) 1.01 (0.96 to 1.06)
Diagnosis in last year 237 (1.6) 1723 (2.0) 0.80 (0.70 to 0.92)
Diabetes 1017 (6.9) 3786 (4.4) 1.64 (1.53 to 1.75)
Dysphagia 692 (4.7) 1263 (1.5) 3.30 (3.01 to 3.61)
Epilepsya 2731 (18.5) 633 (0.7) 25.33 (23.29 to 27.57)
Heart failure 121 (0.8) 324 (0.4) 2.26 (1.84 to 2.78)
Hypertension 1583 (10.7) 10,416 (12.1) 0.93 (0.89 to 0.98)
Hypothyroidisma 1169 (7.9) 2649 (3.1) 2.69 (2.52 to 2.87)
Ischaemic heart disease 244 (1.7) 2316 (2.7) 0.65 (0.57 to 0.74)
Osteoporosis 246 (1.7) 822 (1.0) 1.84 (1.60 to 2.12)
Peripheral vascular disease 61 (0.4) 423 (0.5) 0.90 (0.69 to 1.17)
Rheumatoid arthritis 73 (0.5) 550 (0.6) 0.82 (0.65 to 1.05)
Severe mental illness 1266 (8.6) 823 (1.0) 9.10 (8.34 to 9.92)
Schizophrenia 995 (6.7) 591 (0.7) 9.94 (8.99 to 10.99)
Affective disorder 371 (2.5) 333 (0.4) 6.66 (5.73 to 7.73)
Stroke and TIA 267 (1.8) 944 (1.1) 1.74 (1.52 to 1.98)
TIA, transient ischaemic attack.
a Also require recent medication as per QOF definition.69
b Cancer and depression were summarised as diagnoses ever. QOF definitions count diagnoses only from 2003 for cancer
and only from 2006 for depression.69
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Disease prevalence in subgroups
When the prevalence comparisons with the general population were made by age group (Table 7), there
were some interesting observations. Both cancer and IHD, which were lower overall in adults with ID, were
significantly higher (PR 1.98 for cancer and PR 2.68 for IHD) when only the youngest ages (18–34 years)
were directly compared. In general, most of the observed differences overall were much greater for the
youngest group, with epilepsy 40 times greater (PR 39.99). Heart failure (PR 12.05), osteoporosis (PR 10.07),
hypothyroidism (PR 7.56) and chronic kidney disease (PR 5.85) all also showed much greater disparities
within this age group. The exception to this trend with age was severe mental illness, for which the disparity
between adults with ID and the general population increased with age. Among the oldest age group
(55–84 years), only epilepsy (PR 17.97) and severe mental illness (PR 12.37) were more than three times as
prevalent in adults with ID as in controls.
Within adults with ID, there were some differences in disease prevalence by gender (Figure 9). Generally,
women had higher levels of recorded disease than men. For example, there were higher rates in women
for hypothyroidism (12.4% vs. 4.7%), chronic kidney disease (4.5% vs. 2.2%), cancer (2.2% vs. 1.2%)
and a recording of depression ever (22.0% vs. 14.6%). The only condition with a notably higher rate in
men was IHD (1.9% vs. 1.3%).
Disease prevalence by severity of ID, when this was recorded, is summarised in Figure 10 (for completeness,
patients without severity are also shown in the figures). More than one-third of adults with severe or
profound ID (36.2%) had epilepsy, compared with about one in six of adults with mild or moderate ID
(16.3%). Compared with their general population controls, adults with severe or profound ID were 50 times
more likely to have epilepsy (PR 50.4, 95% CI 39.9 to 63.8). Dysphagia was recorded in about one in nine
adults with severe or profound ID (11.0%). However, the prevalence of most other conditions was lower in
adults with severe or profound ID, such as anxiety (9.4%), depression (9.6%), diabetes (4.5%), hypertension
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FIGURE 8 Mean number of QOF conditions by age in adults with ID and controls.
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TABLE 7 Prevalence of chronic disease in adults with ID vs. controls by age
Disease
Age group (years)
18–34 35–54 55–84
Adults with
ID (%) PR (95% CI)
Adults with
ID (%) PR (95% CI)
Adults with
ID (%) PR (95% CI)
Anxiety 12.8 1.32
(1.23 to 1.44)
19.1 1.15
(1.09 to 1.21)
16.8 0.95
(0.87 to 1.03)
Asthmaa 8.2 1.50
(1.36 to 1.66)
8.4 1.24
(1.13 to 1.36)
7.8 1.00
(0.88 to 1.13)
Atrial fibrillation 0.1 3.40
(1.00 to 11.48)
0.5 1.33
(0.89 to 1.99)
2.7 0.80
(0.64 to 0.99)
Cancer 0.5 1.98
(1.29 to 3.03)
1.1 0.69
(0.54 to 0.89)
4.3 0.62
(0.53 to 0.74)
Chronic kidney
disease
0.3 5.85
(2.74 to 12.49)
2.1 3.55
(2.85 to 4.44)
9.8 1.32
(1.18 to 1.49)
COPD 0.02 2.61
(0.21 to 33.01)
0.8 1.48
(1.08 to 2.03)
3.3 0.70
(0.58 to 0.85)
Depression 11.6 1.05
(0.97 to 1.14)
20.9 1.01
(0.96 to 1.06)
21.7 1.04
(0.97 to 1.12)
Depression
(last year)
1.9 0.91
(0.73 to 1.12)
1.6 0.73
(0.59 to 0.90)
1.2 0.78
(0.56 to 1.08)
Diabetes 2.1 3.26
(2.58 to 4.10)
6.6 1.88
(1.68 to 2.10)
15.2 1.36
(1.24 to 1.48)
Dysphagia 2.8 5.85
(4.64 to 7.37)
4.4 3.28
(2.84 to 3.80)
8.3 2.70
(2.36 to 3.10)
Epilepsya 17.2 39.99
(33.26 to 48.06)
19.9 24.31
(21.48 to 27.52)
18.1 17.97
(15.44 to 20.92)
Heart failure 0.5 12.05
(5.86 to 24.81)
0.4 3.98
(2.38 to 6.65)
2.2 1.60
(1.24 to 2.07)
Hypertension 1.5 3.25
(2.46 to 4.29)
9.1 1.11
(1.02 to 1.21)
28.6 0.81
(0.77 to 0.86)
Hypothyroidisma 4.3 7.56
(6.18 to 9.25)
9.2 3.15
(2.86 to 3.47)
11.5 1.72
(1.55 to 1.91)
IHD 0.1 2.68
(0.91 to 7.89)
0.8 0.74
(0.55 to 0.99)
5.6 0.62
(0.54 to 0.72)
Osteoporosis 0.6 10.07
(5.57 to 18.22)
1.1 3.72
(2.77 to 5.01)
4.3 1.29
(1.08 to 1.54)
Rheumatoid
arthritis
0.2 2.23
(1.02 to 4.89)
0.5 1.02
(0.70 to 1.50)
1.0 0.62
(0.43 to 0.88)
Severe mental
illness
4.3 7.10
(5.84 to 8.64)
9.4 8.12
(7.18 to 9.19)
13.9 12.37
(10.61 to 14.41)
Stroke and TIA 3.2 4.47
(2.33 to 8.53)
7.6 2.42
(1.81 to 3.22)
10.9 1.50
(1.29 to 1.76)
TIA, transient ischaemic attack.
a Also require recent medication as per QOF definition. Note that dementia and peripheral vascular disease are dropped
from the analysis as there were too few cases in those aged < 55 years.
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(6.9%) and severe mental illness (5.9%). Compared with their general population controls, adults with
severe or profound ID were four times less likely to have a diagnosis of depression recorded in the last year
(PR 0.26, 95% CI 0.14 to 0.49).
Among adults with ID identified as living in communal settings, there were variations in disease prevalence
(Figure 11). Epilepsy (27.8%), severe mental illness (12.6%), hypothyroidism (11.5%), dysphagia (8.4%),
dementia (2.9%) and stroke (3.4%) were all higher. However, anxiety (13.2%), currently treated asthma
(5.3%) and depression diagnosed in the last year (0.7%) were all lower.
Among adults with ID with Down syndrome (Figure 12), the prevalences of hypothyroidism (31.9%),
dysphagia (6.1%), dementia (5.8%) and heart failure (1.6%) were all higher. However, for most recorded
chronic diseases the prevelance was lower, for example COPD (0.1%), diabetes (4.8%), epilepsy (6.8%),
depression ever (8.7%), hypertension (1.7%) and severe mental illness (1.9%).
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FIGURE 9 Prevalence of chronic disease in adults with ID by gender. TIA, transient ischaemic attack.
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Finally, for disease prevalence among adults with ID only, in Table 8 we present a series of PRs for each
condition, mutually adjusted for all the subgroups of interest (gender, severity, communal accommodation,
Down syndrome and autism) and age. Many of the patterns observed in Figures 9–12 persist here.
Women with ID were more likely to have many of these conditions recorded, with the greatest relative
disparities observed for rheumatoid arthritis (PR 2.79), hypothyroidism (PR 2.35), osteoporosis (PR 1.86),
chronic kidney disease (PR 1.72) and cancer (PR 1.59). Men, on the other hand, were only significantly
more likely to have IHD and atrial fibrillation recorded (both PR 0.54).
The prevalence of recording of many conditions was lower for adults with severe or profound ID than for
those with mild or moderate ID. For example, both IHD (PR 0.56) and severe mental illness (PR 0.49) were
approximately half as likely to be recorded in patients with severe or profound ID. Notable exceptions to
this trend were dysphagia (PR 2.32) and epilepsy (PR 2.08), which were much higher in patients with
severe or profound ID.
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FIGURE 10 Prevalence of chronic disease in adults with ID by recorded severity. TIA, transient ischaemic attack.
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The prevalence of recording of several conditions was much higher for adults with ID living in communal
or shared accommodation, even after adjustment for age and severity. These conditions included stroke
and transient ischaemic attack (TIA) (PR 2.53), dementia (PR 2.10) and severe mental illness (PR 1.81).
However, for some conditions (e.g. IHD) this was, surprisingly, lower (PR 0.44).
As expected, the large disparities seen for dementia (PR 19.25), hypothyroidism (PR 6.50) and heart failure
(PR 2.87) for patients with Down syndrome, compared with patients with ID without Down syndrome,
remained after adjustment.
For patients with ID and autism spectrum disorder, the rate of recording of all conditions was generally
lower than for patients with ID without autism, the lone exception (see Table 8) being anxiety (PR 1.39).
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FIGURE 11 Prevalence of chronic disease in adults with ID by living arrangements. TIA, transient ischaemic attack.
CROSS-SECTIONAL FINDINGS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
30
Comorbidity: Quality and Outcomes Framework conditions versus
the Charlson index
To further investigate the burden of chronic disease among adults with ID, and to compare this with that
of the general population, we compared three different approaches (Table 9). First, we took a frequency
count of the conditions from Table 6 that are in the QOF (this excludes anxiety and dysphagia). We
compared this with a comorbidity score based on QOF conditions, which was developed using UK primary
care data and uses nine conditions in total.62 Finally, we used the Charlson index, a well-known and widely
used predictor of mortality, which was developed in the USA in the 1980s and incorporates 17 common
chronic conditions.71
Adults with ID had more multimorbidity (two or more recorded QOF conditions from Table 6), at 22.9%,
than the control group, at 13.3% (PR 1.80, 95% CI 1.74 to 1.86). When the Charlson index and the QOF
comorbidity score were compared, there was a difference in how the two populations (adults with and
adults without ID) were categorised. Adults with ID were more than three times as likely to have a QOF
Anxiety
0 5 10 15
Prevalence (%)
302520 35
8.4
17.2
Asthma 6.58.4
Atrial fibrillation 0.30.9
Cancer 0.91.7
Chronic kidney disease 4.03.1
COPD 0.11.2
Dementia 5.80.5
Depression (ever) 8.7 18.9
Depression (last year) 0.51.7
Diabetes 4.8 7.2
Dysphagia
C
h
ro
n
ic
 d
is
ea
se
6.1
4.5
Epilepsy 6.8 19.9
Heart failure 1.60.7
Hypertension 1.7 11.8
Hypothyroidism 31.95.1
IHD 0.71.8
Osteoporosis 1.31.7
Peripheral vascular disease 0.40.4
Rheumatoid arthritis 0.60.5
Severe mental illness 1.9 9.4
Stroke and TIA 1.01.9
Down syndrome
Not Down syndrome
FIGURE 12 Prevalence of chronic disease in adults with ID by presence or absence of Down syndrome.
TIA, transient ischaemic attack.
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TABLE 8 Adjusted chronic disease PRs by subgroup in adults with ID
Disease
Subgroup, PRa (95% CI)
Female vs.
male
Severe/profound
ID vs. mild/
moderate ID
Communal
accommodation
vs. not
Down
syndrome
vs. not
Autism
spectrum
disorder vs. not
Anxiety 1.31
(1.22 to 1.40)
0.51
(0.43 to 0.60)
0.74
(0.65 to 0.86)
0.53
(0.44 to 0.62)
1.39
(1.23 to 1.58)
Asthmab 1.36
(1.22 to 1.52)
0.78
(0.64 to 0.96)
0.62
(0.52 to 0.73)
0.76
(0.62 to 0.93)
0.64
(0.49 to 0.84)
Atrial fibrillation 0.54
(0.37 to 0.79)
1.02
(0.51 to 2.07)
0.71
(0.45 to 1.12)
0.59
(0.24 to 1.41)
0.55
(0.19 to 1.60)
Cancer 1.59
(1.24 to 2.04)
1.11
(0.75 to 1.64)
0.86
(0.65 to 1.16)
0.65
(0.38 to 1.11)
0.94
(0.51 to 1.74)
Chronic kidney
disease
1.72
(1.45 to 2.04)
0.73
(0.53 to 1.00)
0.91
(0.75 to 1.09)
1.83
(1.40 to 2.39)
0.51
(0.26 to 1.00)
COPD 0.73
(0.53 to 1.00)
0.24
(0.10 to 0.59)
0.48
(0.33 to 0.70)
0.18
(0.04 to 0.70)
0.62
(0.24 to 1.61)
Dementia 1.21
(0.89 to 1.63)
1.16
(0.68 to 1.98)
2.10
(1.50 to 2.96)
19.25
(13.64 to 27.15)
0.30
(0.04 to 2.13)
Depression 1.49
(1.38 to 1.59)
0.50
(0.43 to 0.59)
0.73
(0.64 to 0.83)
0.49
(0.42 to 0.58)
1.07
(0.93 to 1.22)
Diabetes 1.09
(0.97 to 1.23)
0.64
(0.50 to 0.82)
0.69
(0.59 to 0.81)
0.81
(0.65 to 1.02)
0.68
(0.50 to 0.92)
Dysphagia 1.15
(0.98 to 1.34)
2.32
(1.68 to 3.20)
1.54
(1.20 to 1.98)
1.32
(1.06 to 1.64)
0.79
(0.58 to 1.09)
Epilepsyb 1.09
(1.02 to 1.16)
2.08
(1.89 to 2.30)
1.60
(1.46 to 1.75)
0.32
(0.26 to 0.39)
0.84
(0.74 to 0.95)
Heart failure 0.78
(0.54 to 1.12)
0.82
(0.46 to 1.48)
0.80
(0.53 to 1.21)
2.87
(1.92 to 4.30)
0.83
(0.33 to 2.11)
Hypertension 1.10
(1.00 to 1.21)
0.60
(0.50 to 0.72)
0.75
(0.66 to 0.84)
0.19
(0.13 to 0.27)
0.55
(0.42 to 0.73)
Hypothyroidismb 2.35
(2.10 to 2.62)
0.93
(0.78 to 1.11)
1.18
(1.04 to 1.34)
6.50
(5.81 to 7.25)
0.81
(0.59 to 1.10)
IHD 0.54
(0.43 to 0.69)
0.56
(0.33 to 0.97)
0.44
(0.31 to 0.62)
0.70
(0.39 to 1.26)
0.41
(0.15 to 1.11)
Osteoporosis 1.86
(1.44 to 2.39)
1.22
(0.84 to 1.76)
1.39
(1.05 to 1.83)
0.82
(0.53 to 1.26)
0.46
(0.22 to 0.95)
Peripheral vascular
disease
0.79
(0.47 to 1.33)
0.45
(0.14 to 1.42)
1.85
(1.06 to 3.24)
0.85
(0.38 to 1.90)
0.44
(0.14 to 1.38)
Rheumatoid arthritis 2.79
(1.75 to 4.45)
0.60
(0.26 to 1.40)
0.87
(0.55 to 1.39)
1.31
(0.66 to 2.59)
0.27
(0.03 to 2.05)
Severe mental Illness 1.02
(0.92 to 1.13)
0.49
(0.39 to 0.61)
1.81
(1.56 to 2.10)
0.19
(0.13 to 0.28)
1.06
(0.89 to 1.26)
Stroke and TIA 1.15
(0.88 to 1.50)
0.98
(0.66 to 1.45)
2.53
(1.98 to 3.24)
0.47
(0.29 to 0.76)
0.27
(0.14 to 0.52)
TIA, transient ischaemic attack.
a All characteristics mutually adjusted for each other, and adjusted for age.
b Also require recent medication as per QOF definition.
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score of ≥ 1 (34.6% vs. 10.6%; PR 3.35, 95% CI 3.25 to 3.45), whereas the proportions with an
estimated Charlson index of ≥ 1 were much more similar between the groups (30.0% vs. 26.3%; PR 1.16,
95% 1.12 to 1.19). The difference between the performance of the two scores is primarily due to the
inclusion of epilepsy and severe mental illness within the QOF score, but not within the Charlson index.
This suggests that the Charlson index may not be a comprehensive summary of comorbidity within the
population with ID and, as a result, may be a poorer predictor of mortality for this subgroup.
The mean QOF comorbidity score among adults with ID was 0.76 [standard deviation (SD) 1.18], compared
with 0.21 (SD 0.71) for the control group. Figure 13 further summarises the mean QOF comorbidity scores
by selected subgroups. The greatest relative disparity between adults with ID and controls was seen
among the youngest age group (0.48 vs. 0.04), primarily attributable to epilepsy. Adults with ID with
Down syndrome had less comorbidity than adults with ID without Down syndrome, but this may be partly
explained by the younger overall age of these adults in our sample (see Table 5). Adults with ID living in
communal establishments, or with severe health needs, had mean scores roughly twice as high as adults
with ID not designated as such. Although there was a small trend of more comorbidity with deprivation in
the control population, no such trend existed in the population of adults with ID. This suggests that our
socioeconomic status (the IMD based on residential postcode) behaves differently in the population with
ID, and may not predict morbidity and mortality in the same way as it does in the general population.
TABLE 9 Charlson index, QOF conditions and score in adults with ID vs. controls
Item
Adults with ID
(N= 14,751), n (%)
Controls
(N= 86,221), n (%)
Adults with ID vs.
controls, PR (95% CI)
Number of QOF diseasesa
0 6320 (42.8) 53,856 (62.5)
1 5056 (34.3) 20,901 (24.2)
2 2138 (14.5) 7174 (8.3)
≥ 3 1237 (8.4) 4290 (5.0)
≥ 2 vs. 0–1 1.80 (1.74 to 1.86)
QOF scoreb
0 9643 (65.4) 77,050 (89.4)
1–2 4131 (28.0) 6384 (7.4)
≥ 3 977 (6.6) 2787 (3.2)
Mean score of ≥ 1 vs. 0 3.35 (3.25 to 3.45)
Charlson indexc
0 10,323 (70.0) 63,561 (73.7)
1–2 3803 (25.8) 20,090 (23.3)
≥ 3 625 (4.2) 2570 (3.0)
Mean score of ≥ 1 vs. 0 1.16 (1.12 to 1.19)
a Frequency count of all the QOF diseases listed in Table 6 except anxiety and dysphagia.
b Scoring system: atrial fibrillation (1), diabetes (1), stroke and TIA (1), epilepsy (2), heart failure (2), psychosis,
schizophrenia + bipolar affective disorder (2), COPD (2), cancer (3) and dementia (3).
c Scoring system: COPD (1), dementia (1), diabetes without complications (1), heart failure (1), mild liver disease (1),
myocardial infarction (1), peptic ulcer disease (1), peripheral vascular disease (1), rheumatological disease (1), stroke and
TIA (1), non-metastatic cancer (2), diabetes with complications (2), hemiplegia (2), renal disease (2), moderate liver
disease (3), acquired immunodeficiency syndrome (6) and metastatic cancer (6).
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Recording of disability and other problems
We investigated the recording of selected disability (mobility problems, vision loss and hearing impairment)
and other problems (continence, constipation and behavioural) in the patient record for adults with ID
compared with the control group, summarised by PRs (Table 10). Further adjustment of these ratios for
differences in comorbidity between the groups made little difference and did not explain the findings (data
not shown), so in Table 10 we present only the unadjusted PRs.
About 4 in 10 adults with ID (41.4%) had some recording of mobility status in their record, with about
1 in 10 overall (11.4%) reporting some form of difficulty recorded, including the use of an aid or a
wheelchair. By comparison, a record of mobility (0.9%) or a mobility problem (0.5%) was rare in the
matched control group. Thus, compared with adults of the same age and gender, those with ID were
24 times more likely (PR 24.02, 95% CI 21.53 to 26.79) to have a recorded mobility disability or problem.
A recording of low or loss of vision was found for 1 in 20 adults with ID (4.7%), almost eight times as
likely (PR 7.86, 95% CI 7.01 to 8.82) as for those the control group (0.6%). A hearing impairment was
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FIGURE 13 Mean QOF comorbidity score in adults with ID and controls by subgroup.
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recorded for about one in five adults with ID (18.7%), which was twice as likely (PR 2.28, 95% CI 2.19 to
2.37) as for the controls (8.3%).
An incontinence problem (beyond the age of 12 years) was recorded in about one in five adults with ID
(20.5%), over five times more often (PR 5.68, 95% CI 5.41 to 5.96) than in controls (3.7%). When the
incontinence was specified in the adult with ID, it was more likely to be recorded as a urinary problem
(11.9%) than as a bowel problem (3.9%). However, when compared with the control group, bowel
problems (PR 14.43, 95% CI 12.39 to 16.80) were relatively more likely than urinary problems to be
recorded for adults with ID (PR 4.00, 95% CI 3.77 to 4.23). A record of constipation ever was about
three times more likely among adults with ID (22.9% vs. 8.3%; PR 2.78, 95% CI 2.68 to 2.88).
Behavioural problems were far more commonly recorded for adults with ID, with 14.1% having one
recorded in the last 5 years and 3.8% having one recorded in the last year. Less than 1% of controls had a
behavioural problem recorded in the last 5 years.
There were some differences by gender in the recording of disability and other problems among adults
with ID (Figure 14). Mobility problems were more common in women than in men (14.1% vs. 9.4%).
Among women, a record of a continence problem (24.7%), particularly urinary (16.1%), was also higher,
as was a record of constipation (27.5%). Hearing problems, visual loss and behavioural problems were
much more similar between men and women with ID.
TABLE 10 Prevalence of disability and other problems in adults with ID vs. controls
Recorded disability/problem
Adults with ID
(N= 14,751), n (%)
Controls
(N= 86,221), n (%)
Adults with ID vs.
controls, PR (95% CI)
Mobility
Recorded ever 6111 (41.4) 753 (0.9) 47.58 (43.63 to 51.88)
Some difficulty 1677 (11.4) 418 (0.5) 24.02 (21.53 to 26.79)
Vision
Bilateral visual loss or low vision 687 (4.7) 510 (0.6) 7.86 (7.01 to 8.82)
Continence (aged ≥ 12 years)
Recorded ever 3017 (20.5) 3199 (3.7) 5.68 (5.41 to 5.96)
Bowel problem 579 (3.9) 240 (0.3) 14.43 (12.39 to 16.80)
Urinary problem 1755 (11.9) 2663 (3.1) 4.00 (3.77 to 4.23)
Hearing
Recorded ever 7361 (49.9) 9403 (10.9) 4.58 (4.47 to 4.71)
Impairment 2752 (18.7) 7111 (8.3) 2.28 (2.19 to 2.37)
Deaf 1220 (8.3) 2784 (3.2) 2.59 (2.42 to 2.76)
Behavioural problems
Last year 564 (3.8) 155 (0.2) 21.34 (17.86 to 25.50)
Last 5 years 2072 (14.1) 742 (0.9) 16.28 (14.97 to 17.71)
Constipation
Ever 3370 (22.9) 7135 (8.3) 2.78 (2.68 to 2.88)
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The recording of disability and other problems was more marked among adults with ID living in communal
or shared accommodation (Figure 15). More than one in five adults identified as living communally had a
mobility problem recorded (21.4%), whereas approximately one in three adults had a continence problem
recorded (31.1%) and, similarly, one in three had a record of constipation ever (34.6%). Behavioural
problems were also much more likely to be recorded among this subgroup, with one in four (24.4%)
adults with ID having one recorded in the last 5 years.
Among adults with Down syndrome, there were fewer differences in the recording of disability and other
problems (Figure 16). The main difference was much higher recording of hearing, with more than one in
three adults with Down syndrome being recorded as having an impairment (37.4%), and about one in six
being recorded as having deafness (16.1%).
Recording of smoking, body mass index, alcohol consumption
and blood pressure
Table 11 summarises the recording of smoking, BMI, alcohol consumption and blood pressure in adults
with ID and their matched control group as of 1 January 2012.
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FIGURE 14 Prevalence of disability and other problems in adults with ID by gender.
CROSS-SECTIONAL FINDINGS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
36
0 10 20 30
Prevalence (%)
40 6050 70
D
is
ab
ili
ty
 o
r 
o
th
er
 p
ro
b
le
m
Constipation (ever) 34.619.7
Behavioural problems (last 5 years) 24.411.3
Behavioural problems (last year) 5.83.3
Hearing (deafness) 9.18.1
Hearing (impairment) 18.318.8
Hearing (ever) 62.946.4
Continence (urinary) 19.99.8
Continence (bowel) 7.43.0
Continence (ever, aged > 12 years) 31.117.6
Vision (bilateral loss or low) 6.64.1
Mobility (difficulty) 21.48.7
Mobility (recorded) 62.835.7
Lives in communal/
shared accommodation
Does not/not recorded
FIGURE 15 Prevalence of disability and other problems in adults with ID by living arrangements.
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FIGURE 16 Prevalence of disability and other problems in adults with ID by Down syndrome.
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TABLE 11 Recording of smoking, BMI, alcohol consumption and blood pressure in adults with ID vs. controls
Disease
Adults with ID
(N= 14,751), n (%)
Controls
(N= 86,221), n (%)
Adults with ID vs.
controls PRa (95% CI)
Smoking recorded
Last 5 years 13,629 (92.4) 72,284 (83.8) 1.10 (1.10 to 1.11)
Smoking status (most recent)
Never smoked 10,591 (71.8) 41,512 (48.2)
Current smoker 2236 (15.2) 20,411 (23.7)
Ex-smoker 1648 (11.2) 20,314 (23.6)
Missing 276 (1.9) 3984 (4.6)
Current smoking vs. not 0.64 (0.61 to 0.66)
BMI recorded
Last year 7771 (52.7) 21,061 (24.4) 2.19 (2.14 to 2.23)
Last 5 years 11,352 (77.0) 49,987 (57.9) 1.34 (1.32 to 1.35)
BMI value (kg/m2) (last 5 years only)
10–19.99 1083 (9.5) 3239 (6.5)
20–24.99 2969 (26.2) 15,518 (31.1)
25–29.99 3170 (27.9) 16,941 (34.0)
30–39.99 3363 (29.6) 12,328 (24.7)
≥ 40 767 (6.8) 1871 (3.8)
Obesity (≥ 30 kg/m2) vs. non-obese 1.33 (1.29 to 1.37)
Alcohol status recorded
Last year 6903 (46.8) 13,571 (15.7) 3.05 (2.97 to 3.12)
Last 5 years 10,925 (74.1) 39,404 (45.7) 1.64 (1.62 to 1.66)
Alcohol status (last 5 years only)
Non-drinker 3980 (36.4) 4553 (11.6)
Current drinker 4918 (45.0) 30,795 (78.2)
Ex-drinker 1861 (17.0) 3744 (9.5)
Unknown 166 (1.5) 312 (0.8)
Current drinker vs. not 0.58 (0.57 to 0.59)
Blood pressure recorded
Last year 9073 (61.5) 33,492 (38.8) 1.61 (1.58 to 1.63)
Last 5 years 12,473 (84.6) 62,608 (72.6) 1.17 (1.16 to 1.18)
Blood pressure (last 5 years only)
< 150/90 mmHg vs. not 11,196 (89.8) 54,404 (86.9) 1.03 (1.02 to 1.04)
a PRs derived from conditional Poisson models. When the analysis was based on a subgroup that required a measurement
in the last 5 years only match-sets that included an adult with ID and at least one control could be used. The number of
match-sets (m) and matched controls (n) used for these analyses were BMI (m = 10,756; n = 40,387), alcohol status
(m = 9861; n= 31,740) and blood pressure (m = 12,197; n= 55,052).
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More than 9 in 10 adults with ID (92.4%) had a smoking status recorded in the last 5 years, which was
about 10% higher (PR 1.10) than that seen in the control group. Among those with a status recorded,
about 7 in 10 adults with ID were recorded as having never smoked (71.8%), compared with
approximately half the control group (48.2%). Adults with ID were 36% less likely to be recorded as a
current smoker (PR 0.64, 95% CI 0.61 to 0.66).
For BMI, adults with ID were twice as likely as controls to have a valid recording made in the last year
(PR 2.19, 95% CI 2.14 to 2.23). Approximately three-quarters of adults with ID (77.0%) had a BMI
recorded in the last 5 years. Among those with a BMI recorded in the last 5 years, more than one in
three adults (36.4%) with ID were classed as obese (BMI of ≥ 30 kg/m2), and adults with ID were more
likely to be obese (PR 1.33, 95% CI 1.29 to 1.37) than the general population. About 1 in 10 adults
with ID (9.5%) was classed as being underweight (BMI of < 20 kg/m2), compared with 6.5% of controls
(PR 1.48, 95% CI 1.40 to 1.57).
A record of alcohol consumption some time in the last 5 years was found in approximately three-quarters
of adults with ID (74.1%), which was much higher than in the control group (45.7%). Among those with
a record in the last 5 years, adults with ID were 42% less likely than those in the control group to be
reported as a current drinker (PR 0.58, 95% CI 0.57 to 0.59).
Blood pressure was also more likely to be recorded among adults with ID, with 6 in 10 (61.5%) having a
measurement during the last year. However, there was little difference in levels between the groups, with
89.8% of adults with ID with a measurement of < 150/90 mmHg compared with 86.9% of all controls.
Among subgroups, some of the biggest disparities were seen for smoking status among adults with ID and
severe health needs or Down syndrome (Figure 17). Only 6.7% with severe health needs were classed as
current smokers, compared with 17.8% among those not reporting severe health needs. Very few adults
with Down syndrome (1.9%) were recorded as current smokers. Among those with a BMI recorded, there
were also differences among adults with ID and severe health needs or Down syndrome (data not shown).
Adults with ID with Down syndrome were more likely to be classed as obese (46.8%) than those with ID
without Down syndrome (35.1%), whereas being underweight (BMI of < 20 kg/m2) was more common
among those with severe health needs than among those without (13.6% vs. 9.2%).
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FIGURE 17 Smoking status by severe health needs and Down syndrome.
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Recording of health promotion
A summary of some health promotion measures, such as vaccination and screening, is shown in Table 12.
About 4 in 10 adults had a vaccination for influenza in the last year (41.5%). When restricted to a subgroup
with relevant comorbidity (CHD, stroke, diabetes mellitus or COPD), this rose to 76.9% for adults with ID.
This was marginally higher than the rate (73.1%) found across all (matched and unmatched) controls with
similar comorbidity (CHD, stroke, diabetes mellitus or COPD). A similar difference was observed when the
TABLE 12 Recording of health promotion interventions in adults with ID vs. controls
Health promotion measure
Adults with ID
(N= 14,751), n (%)
Controls
(N= 86,221), n (%)
Adults with ID vs.
controls, PRa (95% CI)
Influenza vaccination
Last year 6128 (41.5) 14,115 (16.4) 2.61 (2.55 to 2.68)
CHD, stroke, diabetes mellitus or COPD only 1493b 7039b
Last year 1148 (76.9) 5144 (73.1) 1.03 (0.98 to 1.07)
Cervical screening
Women aged 25–64 years only 4618b 27,481b
Smear ever 2062 (44.7) 25,088 (91.3) 0.49 (0.48 to 0.51)
Hysterectomy ever 195 (4.2) 2218 (8.1) 0.56 (0.48 to 0.64)
Excepted ever 2206 (47.8) 2593 (9.4) 5.06 (4.80 to 5.34)
No hysterectomy and not excepted 2242b 22,771b
Smear in last 5 years 1176 (52.5) 19,304 (84.8) 0.64 (0.61 to 0.66)
Mammogram
Women aged 50–69 years only 1846b 11,709b
Last 3 years 861 (46.6) 7310 (62.4) 0.75 (0.72 to 0.78)
Urinalysis
Last year 433 (27.6) 1095 (11.9) 2.15 (2.09 to 2.22)
Thyroid function
Last year 4958 (33.6) 15,765 (18.3) 1.88 (1.83 to 1.93)
Down syndrome match-sets only 1571b 9178b
Last year (Down syndrome only) 974 (62.0) 1604 (17.5) 3.64 (3.41 to 3.88)
Contraception use/advice
Women aged 18–54 years only 4646b 26,652b
Last year 1586 (34.1) 8450 (31.7) 1.04 (0.99 to 1.08)
Medication review
Last year 5467 (37.1) 17,690 (20.5) 1.84 (1.80 to 1.88)
Prescribed medication in 2011 12,649b 57,493b
Last year 5412 (42.8) 17,351 (30.2) 1.46 (1.43 to 1.50)
a PRs derived from conditional Poisson models. When the analysis was based on a subgroup not solely defined by age
and gender, only match-sets that included an adult with ID and at least one control could be used. The number of
match-sets (m) and matched controls (n) used for these analyses were influenza (m = 803; n= 1,589), cervical screening
(m = 2237; n= 11,398) and medication review (m = 12,417; n= 50,629).
b Number of patients listed here are totals for the subgroup. The n–s and percentage listed directly below are derived from
this subtotal.
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statistical analysis included only controls with at least one of these comorbidities who were matched to
these cases (PR 1.03, 95% CI 0.98 to 1.07).
Cervical smear coverage in adults with ID was much lower than in controls. Among women with ID aged
25–64 years, fewer than half had a smear ever (44.7%). Almost half (47.8%) had a code in their record
of being ‘excepted’ from a smear in the past, a much higher rate than that seen in the controls. These
exceptions are based on QOF rules47 that cover Read codes indicating that the screen was ‘not wanted’,
‘refused’ or ‘not indicated’ or that the GP was in receipt of a disclaimer on the patient’s record. When
the comparison of cervical smears was restricted to the last 5 years among those with no record of a
hysterectomy or an exception ever, adults with ID were still 36% less likely than adults without ID to have
had a smear (PR 0.64, 95% CI 0.61 to 0.66) during this period. Severity of ID influenced the likelihood of a
recent smear, with women with ID and severe health needs having lower coverage (31.5%) than those
without severe health needs (57.1%).
Mammograms were less likely among adults with ID than among the general population, with fewer than
half women aged 50–69 years having a record of one during the last 3 years (46.6%). Other investigative
tests, however, were more common among adults with ID, with higher recorded rates of urinalysis
(27.6%) and thyroid function (33.6%) tests in the last year. Contraceptive advice or recorded use among
18–54 year olds was similar between adults with ID (34.1%) and adults without ID (31.7%).
Medication reviews during the last year were more commonly recorded among adults with ID than among
controls, both among all patients (37.1% vs. 20.5%) and among those prescribed medication during the
year (42.8% vs. 30.8%). However, these figures are likely to be underestimating the true scale as we
have some reservations about the completeness of medications reviews during this period on the CPRD
database (see Chapter 2, Missing entity data in the Clinical Practice Research Datalink).
Overall prescribing trends
We first summarised prescribing by collating whether or not each patient had been receiving a prescription
in 2011 (Table 13). We further summarised by dividing the drugs into common groupings using British
National Formulary (BNF) chapter headings.72 We then summarised different drug classes by using BNF
subchapters to identify and count different drugs. Thus, for example, BNF 2.6.1 (nitrates) is counted as a
different drug from BNF 2.6.2 (calcium channel blockers).
Adults with ID were 29% more likely than their matched population controls to have received a prescription
during the year, with almost all receiving one (85.8%). When only repeat prescriptions were considered, the
disparity increased, and adults with ID were nearly twice as likely (PR 1.8) to be on repeat medication during
2011. Approximately one in five adults with ID (20.5%) was prescribed at least six different drug classes as
repeat medication during the year, a much higher rate than seen for controls (7.2%).
When the prescribing was summarised by different BNF chapter headings (1–13 only), some further
patterns emerged. Adults with ID were more likely to be prescribed from all drug classes, except the small
number of drugs prescribed for malignant disease and immunosuppression. Adults with ID were more than
twice as likely to be prescribed drugs from the following groups: nutrition and blood, skin diseases and
central nervous system. Six in 10 adults with ID were prescribed a drug from the central nervous system
group, with carbamazepine (10%), sodium valproate (9%) and risperidone (7%) being the most frequent
drug substances prescribed. Within controls, the pattern in the central nervous system chapter was
completely different, with paracetamol or codeine phosphate (17%) and citalopram (10%) being the
most prescribed.
An alternative summary measure of prescribing was to calculate the total volume of drugs prescribed in
2011. We calculated the mean number of prescriptions per patient, and then summarised this as a rate per
DOI: 10.3310/hsdr05250 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 25
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Carey et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
41
1000 patients (Figure 18). This revealed larger relative differences for adults with ID, suggesting that they
were not only more likely to receive a drug from a particular class, but also more likely to be prescribed
more drugs from that class over the year. For example, the prescribing volume of drugs for central nervous
system, nutrition and blood, and skin diseases all showed rates five to six times higher for adults with ID
than for matched controls. The mean volume of central nervous system drugs (13,387 per 1000 patients)
signifies that, on average, an adult with ID was receiving a drug from this class every month during 2011.
Prescribing of psychotropic drugs
We wanted to further summarise prescribing by analysing patterns of psychotropic medication (BNF
chapters 4.1–4.4) between adults with ID and matched controls. Within psychotropic prescribing, we
identified the following subgroups of interest: hypnotics/anxiolytics (BNF 4.1.1–4.1.2), antipsychotics (BNF
4.2.1–4.2.2), antimanic drugs (BNF 4.2.3) and antidepressants (BNF 4.3). We excluded from antidepressants
any prescriptions for low-dose tricyclic and related antidepressants used at smaller doses than the minimum
effective for depression treatment (specifically amitriptyline and nortriptyline at doses of < 50 mg), in line
with previous analyses of primary care databases that we have carried out,73 as these doses may be
prescribed for reasons other than depression, such as chronic neuropathic pain. We chose not to include
the specific chapter of antiepileptic drugs (BNF 4.8) in our definition of psychotropic drugs, but to include a
TABLE 13 Prescribing summary during 2011 in adults with ID vs. controls
Prescribing group
Adults with ID
(N= 14,751), n (%)
Controls
(N= 86,221), n (%)
Adults with ID vs.
controls, PR (95% CI)
Overall
Any prescription 12,649 (85.8) 57,493 (66.7) 1.29 (1.28 to 1.30)
BNF chapter headings (1 to 13)
(1) Gastrointestinal system 5086 (34.5) 17,347 (20.1) 1.75 (1.71 to 1.80)
(2) Cardiovascular system 3519 (23.9) 17,509 (20.3) 1.23 (1.19 to 1.26)
(3) Respiratory system 3314 (22.5) 11,810 (13.7) 1.66 (1.61 to 1.72)
(4) Central nervous system 8847 (60.0) 24,916 (28.9) 2.11 (2.07 to 2.14)
(5) Infections 5583 (37.9) 24,165 (28.0) 1.36 (1.33 to 1.39)
(6) Endocrine system 2610 (17.7) 9417 (10.9) 1.69 (1.62 to 1.75)
(7) Obstetrics, gynaecology and
urinary tract disorders
1985 (13.5) 10,609 (12.3) 1.06 (1.02 to 1.10)
(8) Malignant disease and
immunosuppression
63 (0.4) 460 (0.5) 0.81 (0.63 to 1.06)
(9) Nutrition and blood 2721 (18.5) 5606 (6.5) 2.88 (2.76 to 3.01)
(10) Musculoskeletal and joint diseases 2388 (16.2) 10,461 (12.1) 1.36 (1.31 to 1.42)
(11) Eye 1630 (11.1) 4944 (5.7) 1.96 (1.86 to 2.07)
(12) Ear, nose and oropharynx 2285 (15.5) 7040 (8.2) 1.92 (1.84 to 2.01)
(13) Skin 5651 (38.3) 13,950 (16.2) 2.39 (2.32 to 2.45)
Repeat prescribing only
Any repeat prescription 10,507 (71.2) 34,421 (39.9) 1.82 (1.79 to 1.84)
1–2 drug classes 3730 (25.3) 18,404 (21.4) –
3–5 drug classes 3758 (25.5) 9810 (11.4) –
6–10 drug classes 2463 (16.7) 5052 (5.9) –
≥ 11 drug classes 556 (3.8) 1155 (1.3) –
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separate category for this instead. We also include a category of drugs classed as benzodiazepines
(which are selected hypnotics/anxiolytics and antiepileptic drugs).
Table 14 summarises the pattern of psychotropic prescribing in 2011. Adults with ID were almost three
times more likely to be prescribed a psychotropic drug than controls (PR 2.73, 95% CI 2.66 to 2.81),
with almost 4 in 10 (38.2%) receiving at least one prescription during the year. Of these, only 51.1%
(n = 2874) of adults with ID prescribed a psychotropic drug in 2011 had a recorded medication review
during the year.
The disparity in psychotropic prescribing was being driven by large differences in antipsychotic prescribing,
whereby adults with ID were nine times more likely to receive this class of drug (PR 9.19, 95% CI 8.69
to 9.73), and by antimanic drugs, which were 16 times more likely to be prescribed to adults with ID
(PR 16.05, 95% CI 13.89 to 18.55). Smaller differences between adults with ID and controls were seen for
hypnotics/anxiolytics (PR 2.70, 95% CI 2.57 to 2.83), and antidepressants (PR 1.99, 95% CI 1.92 to 2.07).
Although adults with ID had higher overall prescribing for psychotropic drugs, they were less likely (PR 0.73,
95% CI 0.65 to 0.82) than controls to receive low-dose amitriptyline or nortriptyline (which were excluded
from our antidepressants category). The prescribing of benzodiazepines was approximately four times
higher among adults with ID than among controls (PR 4.03, 95% CI 3.82 to 4.26).
The higher prevalence of epilepsy in adults with ID compared with controls (25 times higher; see Table 6) is
reflected in the similarly higher prescribing of antiepileptic drugs among adults with ID (PR 19.60, 95% CI
18.26 to 21.03). However, the higher prevalence of epilepsy among adults with ID explained only some of
the observed difference in psychotropic prescribing in Table 14. Although more than half of adults with ID
and epilepsy (n = 2731) were prescribed a psychotropic drug in 2011 (n = 1450, 53.1%), one-third of
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DOI: 10.3310/hsdr05250 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 25
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Carey et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
43
adults with ID without epilepsy (34.8%) were still being prescribed a psychotropic drug in 2011, which
represented a rate two and half times higher (PR 2.54, 95% CI 2.47 to 2.62) than that seen in the
matched control group (see Table 14). By contrast, the prescribing of antimanic drugs (BNF 4.2.3) was
much more common among adults with ID with epilepsy (15.9% vs. 2.0%). This was primarily due to the
prescribing of carbamazepine, which is listed as both an antimanic and an antiepileptic drug (BNF 4.8),
and is presumably being prescribed mainly to treat seizures among adults with ID as opposed to bipolar
disorder. However, excluding adults with ID with epilepsy from the comparison still resulted a large
relative increase compared with the matched controls (PR 11.87, 95% CI 9.56 to 14.76). Benzodiazepine
prescribing was also far more common among adults with ID with epilepsy (37.4% vs. 8.7%), and the
relative difference between adults with ID and controls fell from a PR of 4.03 to a PR of 2.67 when we
excluded adults with ID and epilepsy (and their controls) from the comparison.
Figure 19 displays the top 20 psychotropic drug substances prescribed to adults with ID during 2011,
compiled from all prescriptions issued under BNF chapters 4.1–4.4. These are summarised as a rate per
1000 adults (counting a maximum of one prescription per day for each drug class), with the corresponding
rates seen in the matched controls also shown in the figure.
The most commonly prescribed item was the antipsychotic risperidone (1032 prescriptions per 1000 adults),
which was rarely prescribed across the control group (13 per 1000). Other large relative disparities were
seen for zuclopenthixol (113 per 1000 adults with ID compared with 1.4 per 1000 controls), haloperidol
(193 per 1000 adults with ID compared with 3 per 1000 controls) and carbamazepine (421 per 1000 adults
with ID compared with 11 per 1000 controls). The most commonly prescribed antidepressants among
adults with ID (e.g. citalopram, fluoxetine and sertraline) were prescribed at rates approximately three to
TABLE 14 Prescribing of psychotropic drugs during 2011 in adults with ID vs. controls
Drug class
Adults with ID
(N= 14,751), n (%)
Controls
(N= 86,221), n (%)
Adults with ID vs.
controls, PR (95% CI)
All psychotropic drugs
Any (BNF 4.1, 4.2, 4.3, 4.4) 5629 (38.2) 12,226 (14.2) 2.73 (2.66 to 2.81)
Hypnotics and anxiolytics (BNF 4.1.1, 4.1.2) 2020 (13.7) 4457 (5.2) 2.70 (2.57 to 2.83)
Antipsychotics (BNF 4.2.1, 4.2.2) 2887 (19.6) 1875 (2.2) 9.19 (8.69 to 9.73)
Antimanic (BNF 4.2.3) 678 (4.6) 250 (0.3) 16.05 (13.89 to 18.55)
Antidepressants (BNF 4.3), excluding low-dose
amitriptyline
2905 (19.7) 8706 (10.1) 1.99 (1.92 to 2.07)
Other selected groupings
Benzodiazepinesa 2037 (13.8) 2998 (3.5) 4.03 (3.82 to 4.26)
Antiepileptic (BNF 4.8) 3138 (21.3) 943 (1.1) 19.60 (18.26 to 21.03)
Low-dose amitriptyline (< 50mg) 334 (2.3) 2774 (3.2) 0.73 (0.65 to 0.82)
Among patients with ID without epilepsy onlyb 12,020 69,722
Any psychotropic drug 4179 (34.8) 9698 (13.9) 2.54 (2.47 to 2.62)
Antimanic (BNF 4.2.3) 245 (2.0) 123 (0.2) 11.87 (9.56 to 14.76)
Benzodiazepinesa 1050 (8.7) 2337 (3.4) 2.67 (2.48 to 2.86)
a Selected from BNF chapters 4.1.1, 4.1.2 and 4.8.
b This analysis excludes 2731 adults with ID and epilepsy, and is restricted to 12,020 adults with ID without epilepsy and
their matched controls (n= 69,722 after removing n= 506 with epilepsy).
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four times higher among adults with ID than among controls. Although the most prescribed
benzodiazepine among the psychotropic drugs in adults with ID was diazepam (378 per 1000 adults), this
was also prescribed frequently among controls (94 per 1000 adults). By contrast, lorazepam, another
benzodiazepine, was frequently prescribed among adults with ID (196 per 1000 adults) but rarely
prescribed among controls (9 per 1000 adults).
We summarised overall psychotropic prescribing in adults with ID and controls by subgroups of interest
(Figure 20). Although women with ID were marginally more likely than men with ID to have received a
psychotropic drug in 2011 (41.1% vs. 36.0%), this contrasted with the matched control group, in which
women were twice as likely (19.9% vs. 10.0%). Prescribing increased with age, for both adults with
ID and controls, but the largest relative disparity was seen among the youngest ages (18–34 years).
Approximately 3 in 10 younger adults (28.7%) with ID received a psychotropic drug in 2011, compared
with 1 in 10 (9.2%) among the control group.
Prescribing of psychotropic drugs by socioeconomic status (using the IMD) showed contrasting patterns
between adults with ID and controls. Although controls in more deprived areas were more likely to be
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FIGURE 19 Top 20 psychotropic drugs prescribed by volume in 2011 among adults with ID, with rates among
controls shown for comparison.
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prescribed a psychotropic drug during the year (18.2% in most deprived quintile vs. 11.6% in least deprived),
no such pattern existed among adults with ID. Those living in the most deprived areas (IMD = 5) had similar
psychotropic prescribing levels in 2011 (38.3%) to those in the least deprived areas (38.1%). However, when
we restricted the analysis to adults with ID not recorded as living in communal or shared accommodation,
there was a weak trend, whereby those living in the most deprived area had higher levels of psychotropic
prescribing (34.8%) than those in the living in the least deprived category of IMD (31.7%).
Among subgroups with ID there were some key differences in psychotropic prescribing. Much higher rates
were seen among the following: those living in communal or shared accommodation (56.2%), those with
autism spectrum disorder (55.6%) and those with severe health needs (47.8%). Adults with ID and Down
syndrome, however, were much less likely to be prescribed a psychotropic drug in 2011 (21.5% vs. 40.2%).
Finally, we looked further back in the patient record to summarise longer-term prescribing of psychotropic
drugs. Among patients who were continuously registered with their practice for the last 5 years, 36.6%
(3940 out of 10,769) of adults with ID averaged more than one prescription per year, compared with
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FIGURE 20 Psychotropic drug prescribing in 2011 in adults with ID and controls by subgroup.
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14.4% of controls (10,765 out of 74,784), which compares closely with what we found from the analyses
based on a single year (2011). The average number of psychotropic prescriptions per year during the last
5 years was 7.6 for adults with ID, compared with 1.3 per year for controls.
Attainment of Quality and Outcomes Framework indicators
We wanted to compare the achievement for a number of QOF indicators47 between adults with ID and
their matched controls. The indicators are generally disease specific and calculated only on patients who
are on that particular QOF disease register, making any matched analysis here infeasible.
A summary of the age and gender characteristics of adults with ID and controls on selected QOF disease
registers (chronic kidney disease, diabetes, epilepsy, hypertension, hypothyroidism, IHD and stroke) is
shown in Table 15. The prevalence of these diseases has previously been described in Table 6.
There were some notable differences in the age–gender structure between adults with ID and controls on
the QOF disease registers. Generally, adults with ID were about 5 years younger on average. For diabetes,
a greater proportion of adults with ID were women (47.1% vs. 38.5%), whereas for hypothyroidism adults
with ID were more likely to be men (34.3% vs. 19.6%). Thus, any (unmatched) analysis of QOF indicators
must account for age and gender differences.
Table 15 also reports on QOF exception reporting within the selected disease registers. Exception reporting
is when GPs are allowed to specifically exclude patients from indicators owing to patient-specific clinical
circumstances.47 For example, this may arise when an indicator includes medication that cannot be
prescribed because of a recorded contraindication or side effect. For all selected disease registers, adults
with ID were more likely to be excepted from QOF indicators. For example, for stroke (and TIA), 8.6% of
adults with ID were excepted, compared with 2.3% of controls.
The selected QOF indicators that we chose to compare from the seven disease registers are shown in
Table 16. These were calculated for attainment in the last 12 months on our chosen cross-sectional date
(1 January 2012). This differs from QOF, which makes its annual calculations at the end of March each
year.47 We also chose to not to apply the disease exceptions from Table 15 for this comparison. As patients
were no longer matched in this analyses, we fitted a log-binomial model here to obtain ratios adjusted for
age and gender (see Chapter 2, Statistical analysis).
TABLE 15 Summary of adults with ID and controls on selected QOF disease registers
QOF register
Adults with ID Controls
n Men (%)
Mean age
(SD)
Number
excepteda
(%) n Men (%)
Mean age
(SD)
Number
excepteda
(%)
Chronic kidney disease 468 39.7 60.1 (11.9) 9 (1.9) 1746 44.2 67.0 (10.9) 24 (1.4)
Diabetes 1017 52.9 53.6 (14.3) 70 (6.9) 3786 61.5 57.5 (13.0) 187 (4.9)
Epilepsy 2731 55.4 42.4 (14.7) 141 (5.2) 633 55.5 47.4 (14.7) 35 (5.5)
Hypertension 1583 52.0 57.1 (12.7) 29 (1.8) 10,416 54.8 60.4 (11.2) 150 (1.4)
Hypothyroidism 1169 34.3 48.3 (14.7) 8 (0.7) 2649 19.6 55.5 (13.2) 8 (0.3)
IHD 244 67.2 62.5 (12.0) 14 (5.7) 2316 69.5 64.2 (10.3) 72 (3.1)
Stroke and TIA 267 52.4 60.2 (13.6) 23 (8.6) 944 56.6 64.2 (12.0) 22 (2.3)
a Exceptions refer to disease-wide specific exceptions recorded during the last year (2011) that exempt patients from all
indicators related to that disease.
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TABLE 16 Attainment of selected QOF indicators during 2011 in adults with ID vs. controls
QOF indicator
Adults with ID,
n (%)
Controls,
n (%)
Adults with ID
vs. controls PRa
(95% CI)
Chronic kidney disease
Last BP is ≤ 150/90 mmHg (CKD3) 340 (72.7) 1151 (65.9) 1.11 (1.03 to 1.19)
Diabetes mellitus
Last BP is ≤ 150/90 mmHg (DM30) 861 (84.7) 3119 (82.4) 1.03 (1.00 to 1.06)
Last cholesterol is ≤ 5mmol/l (DM17) 679 (66.8) 2617 (69.1) 1.00 (0.95 to 1.04)
Last IFCC HbA1c/HbA1c is ≤ 59/7.5% (DM26) 535 (52.6) 2011 (53.1) 1.01 (0.94 to 1.08)
Retinal screening (DM21) 496 (48.8) 2137 (56.4) 0.89 (0.84 to 0.95)
Foot examination and classification (DM29b) 658 (65.0) 2573 (68.1) 0.97 (0.92 to 1.02)
Micro-albuminuria testing (DM13b) 544 (56.4) 2145 (60.0) 0.95 (0.89 to 1.01)
Estimated glomerular filtration rate or serum creatinine testing
(DM22)
903 (88.8) 3409 (90.0) 0.99 (0.97 to 1.01)
Epilepsy
Record of seizure frequency (EPIL6) 2202 (80.6) 501 (79.2) 1.03 (0.98 to 1.08)
Record of seizure free (EPIL8) 1281 (46.9) 340 (53.7) 0.91 (0.83 to 1.00)
Hypertension
Last BP is ≤ 150/90 mmHg (BP5) 1249 (78.9) 7927 (76.1) 1.04 (1.01 to 1.07)
Hypothyroidism
Thyroid function test (THY2) 1027 (87.9) 2355 (88.9) 0.99 (0.97 to 1.02)
IHD
Last BP is ≤ 150/90 mmHg (CHD06) 211 (86.5) 1934 (83.5) 1.02 (0.97 to 1.09)
Last cholesterol is ≤ 5mmol/l (CHD08) 144 (59.0) 1508 (65.1) 0.92 (0.83 to 1.03)
Aspirin, an alternative antiplatelet therapy or an anticoagulant
(CHD09)
199 (81.6) 1917 (82.8) 0.99 (0.93 to 1.05)
Stroke and TIA
Last BP is ≤ 150/90 mmHg (STR6) 209 (78.3) 746 (79.0) 1.00 (0.92 to 1.07)
Last cholesterol is ≤ 5mmol/l (STR8) 149 (55.8) 566 (60.0) 0.96 (0.96 to 1.08)
Aspirin, an alternative antiplatelet therapy or an anticoagulant
(STR12c)
132 (75.0) 555 (82.8) 0.96 (0.89 to 1.03)
BP, blood pressure; HbA1c, glycated haemoglobin; IFCC, International Federation of Clinical Chemistry and Laboratory
Medicine.
a PRs derived from log-binomial model that adjusts for gender and age. Practice was included in the model, assuming an
exchangeable correlation structure.
b DM29 applied to non-double amputees only (adults with ID, n = 1013; controls, n= 3781). DM13 applied only to those
without proteinuria (adults with ID, n= 964; controls, n= 3575).
c STR12 is based on strokes shown to be non-haemorrhagic only, or a history of TIA (adults with ID, n= 176;
controls, n= 670).
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Generally, there was little evidence of differences in the attainment of these QOF indicators between
adults with ID and controls in our study sample. Indicators for which adults with ID performed relatively
poorer were retinal screening among those with diabetes mellitus (48.8% vs. 56.4%; PR 0.89, 95% CI
0.84 to 0.95) and being seizure free for 12 months those with epilepsy (46.9% vs. 53.7%; PR 0.91, 95%
CI 0.83 to 1.00).
Primary care consultations in 2011
The total number of primary care doctor and nurse consultations during 2011 was collated for all adults
with ID and their matched controls who were registered on 1 January 2012. The resulting distribution is
shown in Figure 21; 86.9% of adults with ID consulted at least once in the year, compared with 72.6% of
controls. Approximately one in seven adults with ID (14.9%) averaged at least one consultation per month,
more than double the rate seen in controls.
The average number of consultations in 2011 for adults with ID was 6.29 compared with 3.89 in controls
(Table 17), an overall rate that was 70% higher. Accounting for greater levels of comorbidity among
adults with ID did not explain all of this difference [adjusted rate ratio (RR) 1.49, 95% CI 1.47 to 1.53].
The differences in consultation levels between adults with ID and controls were slightly greater for nurse
or telephone consultations and less marked for face-to-face doctor consultations.
The characteristics of all consultations recorded in 2011 are further presented in Figure 22. As a proportion
of all consultations, face-to-face consultations were marginally lower among adults with ID (84.9% vs.
88.7%), as telephone consultations were more common (15.1% vs. 11.3%). Similarly, the proportion of all
consultations with a doctor was lower in adults with ID (70.8% vs. 73.9%), as nurse consultations were
more common (29.2% vs. 26.1%).
Consultation length was estimated for all consultation during 2011. This was non-zero for approximately
95% of consultations, and was grouped into standard (1–10 minutes) and long length (> 10 minutes).
Although adults with ID were more likely to have had a longer doctor consultation at any time during 2011
(51.3% vs. 45.1% for controls; data not shown), the proportion of their consultations that were > 10 minutes
was lower (34.7% vs. 42.2%; see Figure 22). Thus, in a logistic regression model (adjusted for comorbidity)
that estimates the odds of a long consultation for adults with ID versus controls and takes account of total
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FIGURE 21 Number of primary care consultations in 2011 in adults with ID and controls.
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number of consultations in the year, adults with ID were estimated to be less likely to receive a longer
consultation (OR 0.73, 95% CI 0.69 to 0.77).
The mean number of primary care consultations in 2011 was further summarised by subgroup (Figure 23).
Women with ID had a greater consultation rate than men with ID, although this trend was similar to that seen
in the matched control group. Although consultations increased with deprivation in the general population,
this trend was not seen within adults with ID, as those living in the most and least deprived areas had similar
consultation rates. Adults with ID living in communal settings had a higher mean level of total consultations
during 2011 (7.51), as did those patients with severe health needs (7.46). Lower consultation rates were seen
among adults with ID with autism spectrum disorder (4.98) and Down syndrome (5.87).
To further assess to what extent the variation in consultations during 2011 by subgroup (see Figure 23)
were explained by different underlying characteristics within these groups, a series of Poisson regressions
TABLE 17 Mean number of consultations in 2011 in adults with ID vs. controls
Consultation type
Adults with ID
(n= 14,751),
mean (SD)
Controls
(n= 86,221),
mean (SD)
Adults with ID vs. control, RR (95% CI)
RR1a RR2b
All consultations 6.29 (8.33) 3.89 (5.20) 1.70 (1.66 to 1.74) 1.49 (1.47 to 1.53)
Telephone 0.95 (2.56) 0.44 (1.32) 2.26 (2.16 to 2.37) 1.87 (1.78 to 1.97)
Doctor 4.45 (5.81) 2.88 (3.91) 1.63 (1.59 to 1.67) 1.45 (1.41 to 1.48)
Doctor (face to face) 3.65 (4.51) 2.52 (3.30) 1.53 (1.50 to 1.56) 1.37 (1.34 to 1.40)
Nurse 1.84 (4.64) 1.01 (2.42) 1.91 (1.83 to 2.00) 1.64 (1.56 to 1.71)
a Unadjusted.
b Adjusted for comorbidity score that used the following weights: atrial fibrillation (1), diabetes (1), stroke and TIA (1),
epilepsy (2), heart failure (2), psychosis, schizophrenia and bipolar affective disorder (2), COPD (2), cancer (3) and
dementia (3).
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FIGURE 22 Characteristics of primary care consultations in 2011 in adults with ID and controls.
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were carried out on adults with ID only (Table 18). These revealed that the higher consultation rate among
women was not explained by recorded health needs or other characteristics. However, the higher rate
among patients with ID living in communal or shared accommodation was largely attributable to these
patients being older and having more severe health needs. The lower consultation rates among patients
with ID with autism was explained by them being considerably younger (see Table 5).
Continuity of care among doctor consultations
To assess continuity of care, we restricted analyses to patients who had at least two face-to-face consultations
with a doctor during 2011. For each patient we calculated a continuity of care summary measure, defined by
whether or not more than half of their consultations had been with the same doctor (see Chapter 2, Definition
of a consultation). Table 19 summarises the continuity of care for face-to-face doctor consultations
during 2011.
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Among the 9167 adults with ID with at least two face-to-face consultations, 43.2% had more than half of
their total consultations recorded with the same GP. Although this was higher among the control group
(49.1%), the 20,611 controls identified here are strictly no longer a matched set with the 9167 adults with ID.
A matched analysis, based on 8677 match-sets in which there was at least one adult with ID and a matched
control (n = 27,905) who both had at least two face-to-face doctor consultations, still suggested, however,
that adults with ID were less likely to see the same doctor more than half the time in 2011 (adjusted OR 0.77,
95% CI 0.73 to 0.82). This difference was consistent across different total numbers of consultations. For
example, among those with at least 12 face-to-face doctor consultations during 2011, 40.8% of adults with
ID saw the same doctor for more than half of their consultations compared with 52.1% of controls. This
difference was confirmed in adjusted matched regressions, but these were based on very small match-sets as
it became increasingly difficult to have the match-sets balanced on total number of consultations.
TABLE 19 Continuity of care for face-to-face doctor consultations in 2011 in adults with ID vs. controls
Consultation type
Adults with ID
(N= 14,751),
n (%)
Controls
(N= 86,221),
n (%)
Adults with ID vs. control, OR (95% CI)
OR1a OR2a
All adults with ≥ 2 doctor consultations 9167 42,135
Number with > 50% with same doctorb 3962 (43.2) 20,611 (49.1) 0.77 (0.73 to 0.81) 0.77 (0.73 to 0.82)
Adults with 2–5 total doctor consultations
only
5906 30,332
Number with > 50% with same doctorb 2690 (45.6) 14,851 (49.0) 0.87 (0.81 to 0.93) 0.86 (0.80 to 0.93)
Adults with 6–11 total doctor consultations
only
2473 9675
Number with > 50% with same doctorb 975 (39.4) 4713 (48.7) 0.64 (0.55 to 0.75) 0.64 (0.54 to 0.75)
Adults with ≥ 12 total doctor consultations
only
788 2128
Number with > 50% with same doctorb 297 (40.8) 1109 (52.1) 0.54 (0.33 to 0.90) 0.62 (0.36 to 1.06)
a OR1: unadjusted. OR2: adjusted for total number of doctor (face-to-face) consultations and comorbidity score that used
the following weights: atrial fibrillation (1), diabetes (1), stroke and TIA (1), epilepsy (2), heart failure (2), psychosis,
schizophrenia plus bipolar affective disorder (2), COPD (2), cancer (3) and dementia (3).
b Regressions restricted to match-sets (m) when there was at least one adult with ID and matched control (n). These
totals were all with ≥ 2 consultations (m = 8677, n= 27,905), 2–5 consultations (m = 5289, n= 12,411), 6–11
consultations (m = 1305, n= 2023) and ≥ 12 consultations (m = 175, n= 208).
TABLE 18 Adjusted consultation RRs in 2011 by characteristic of adults with ID
Characteristic of adult with ID RR1a (95% CI) RR2b (95% CI) RR3c (95% CI)
Men vs. women 0.66 (0.63 to 0.69) 0.68 (0.66 to 0.71) 0.69 (0.67 to 0.72)
Down syndrome vs. not 0.92 (0.86 to 0.99) 0.94 (0.88 to 1.01) 0.94 (0.87 to 1.01)
Severe health needs vs. not 1.25 (1.19 to 1.32) 1.17 (1.11 to 1.23) 1.15 (1.09 to 1.22)
Lives in communal accommodation vs. not 1.26 (1.16 to 1.36) 1.09 (1.01 to 1.18) 1.06 (0.97 to 1.14)
Autism spectrum disorder vs. not 0.79 (0.74 to 0.85) 1.01 (0.94 to 1.09) 0.98 (0.91 to 1.06)
a Unadjusted.
b Adjusted for age and gender.
c Further adjusted for all other characteristics listed in table.
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Economic costings in 2011
Using all available data on the CPRD and HES data sets, we estimated annual NHS costings in 2011 for
adults with ID and their matched controls when feasible (see Appendix 5 for more details). As we wanted
to factor hospital admissions into the costings, this analysis was based on a subset of the 14,751 adults
registered on 1 January 2012 with linked HES data and suitable matched controls. This resulted in a subset
of 11,776 adults with ID and 68,428 matched controls.
Table 20 summarises the estimated costs per patient, overall and broken into the individual components in
the calculation. An estimated ratio for the costs of adults with ID compared with their matched controls
was obtained by conditional negative binomial regressions (see Chapter 2, Statistical analysis). Owing to
the non-symmetrical distribution of all of the costing summaries (positively skewed), the model sometimes
produced more conservative estimates than the relative mean differences. The estimated mean annual cost
for adults with ID in 2011 (£1445.4 per patient) was more than double (RR 2.05, 95% CI 2.01 to 2.10) the
estimated costs for the control group (£640.1 per patient). The largest relative discrepancy was seen for
primary care prescribing costs (£494.2 per adult with ID vs. £126.6 per control; RR 2.48 95% CI 2.40 to
2.53). Most of the difference in estimated costs for hospital admissions was driven by non-elective
(emergency) admissions, for which adults with ID had a more than double estimated cost (£456.4 vs.
£186.5 per patient).
Annual economic costs were also estimated by subgroup (Figure 24). Although costs were higher for
women with ID (£1682.1 vs. £1272.7 per patient), this gender difference was similar in relative terms in
the control group. The costs estimated for the youngest (age 18–34 years) group of adults with ID
(£1178.8 per patient) still exceeded those estimated for the oldest (age 55–84 years) patients in the control
group (£1137.9 per patient). Adults with ID with severe health needs had double the estimated annual
costs of those without (£2331.8 vs. £1159.1 per patient).
The association between annual NHS costs and deprivation was different between adults with ID and
controls. In the general population, costs steadily increased with each quintile of IMD (from £513.7 to
£783.1 per patient). However, within adults with ID the trend was not repeated, such that the most
deprived group (£1394.9 per patient) had lower costs than the least deprived group (£1507.3 per patient).
TABLE 20 Mean annual estimated NHS costs (£ per patient) in 2011 in adults with ID and controls
Costed source
Adults with ID
(n= 11,776), mean (IQR)
Controls (n= 68,428),
mean (IQR)
Adults with ID vs.
controls, RRa (95% CI)
GP consultations 193.0 (37.0–255.3) 115.2 (0–155.4) 1.71 (1.67 to 1.75)
Nurse consultations 22.6 (0–26.5) 10.9 (0–12.4) 1.95 (1.90 to 2.01)
Primary care prescribing 494.2 (15.8–617.3) 126.6 (0–79.4) 2.48 (2.42 to 2.55)
Other primary care initiated 5.7 (0–0) 3.0 (0–0) 1.98 (1.84 to 2.13)
A&E/casualty 37.4 (0–0) 17.6 (0–0) 1.48 (1.40 to 1.55)
Elective hospital admissions 236.1 (0–0) 180.4 (0–0) 1.14 (1.07 to 1.22)
Non-elective hospital admissions 456.4 (0–0) 186.5 (0–0) 1.98 (1.86 to 2.10)
Total estimated mean cost 1445.4 (130.0–1360.5) 640.1 (18.5–418.5) 2.05 (2.01 to 2.10)
A&E, accident and emergency; IQR, interquartile range.
a Ratios obtained from (conditional) fixed-effects negative binomial regressions with bias-corrected CIs produced from
non-parametric bootstrap estimation (1000 simulations).
Note that costs are estimated as mean £ per patient. For more details on how these were estimated, please see Appendix 5.
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The association with deprivation was further explored by stratifying by the accommodation status of the
adult with ID (Figure 25). The absence of the trend seen with IMD in the general population was still
apparent among adults with ID estimated to be living in the community. However, a much clearer trend
towards higher costs with lower levels of deprivation was now seen among adults with ID living in
communal accommodation.
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FIGURE 24 Mean annual estimated NHS cost per patient in 2011 in adults with ID and controls by subgroup.
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FIGURE 25 Mean annual estimated NHS costs in 2011 in adults with ID and controls by IMD and accommodation
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Chapter 4 Mortality
Introduction
As the CPRD data set had been linked to ONS death registration data, it provided an opportunity to
describe mortality differences between adults with ID and the age- and gender-matched controls in our
study. Although the date of death can be reasonably inferred from CPRD data, cause of death cannot be
consistently identified. Therefore, we restricted mortality analyses to the 343 practices with linked data to
ONS (see Figure 2). From these practices, a total of 16,666 adults with ID who were aged 18–84 years at
the beginning of their follow-up are included (see Figure 2), in addition to the 113,352 age-, gender- and
practice-matched controls without ID who were also registered at this point in time.
Some of these results have already appeared in the publication by Hosking et al.,74 and are reproduced
here under the terms of the Open Access licence for non-commercial use with the publisher, the American
Public Health Association. Hosking FJ, Carey IM, Shah SM, Harris T, DeWilde S, Beighton C, Cook DG.
Mortality among adults with intellectual disability in England: comparisons with the general population.
Am J Public Health 2016;106:1483–90. Available at: http://ajph.aphapublications.org/doi/pdf/10.2105/
AJPH.2016.303240
Longitudinal design
More details of the longitudinal design for the analysis we devised are shown in Figure 26. All patients had
to be registered for at least 30 days before they were eligible for follow-up. We define follow-up to run
from 1 January 2009 to 31 March 2013. Of the 16,666 adults with ID included, the majority (n = 11,973)
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(n = 3666)Adults with ID registered by 
1 January 2009 for 
30 days aged 14–17 years 
in 2009
(n = 1027)
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Follow-up time 
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Control must be 
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start of follow-up
Deaths
(n = 656) 
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(n = 1358) 
Censored at earliest of 
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stops providing data or 
(iii) 31 March 2013
Matched controls registered 
at point of entry for adult 
with ID
(n = 113,562)
Adults with ID eligible for 
longitudinal follow-up
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FIGURE 26 Summary of how the longitudinal cohort was constructed.
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were already registered by 1 January 2009 and were aged ≥ 18 years. To this core group we made two
additions to the analysis cohort. First, patients with ID registered by 1 January 2009 but who were not
aged 18 years by then (n = 1027) were allowed entry into the cohort on 1 January of the year that they
turned 18 (assuming they were still registered at the practice). Second, adults with ID (n = 3666) who were
not registered with their practice on 1 January 2009 but subsequently registered some time during the
study follow-up (2009–12) were included from the point at which they had been registered with the study
practice for 30 days. Matched controls (n = 113,562) were included only if they had been registered at the
defined entry point of the cohort for the adult with ID.
All adults in the longitudinal cohort were followed to the earliest recorded event representing (1) date of
death, (2) date of deregistration from the practice, (3) date when their practice stopped providing data
to CPRD or (4) 31 March 2013 (see Figure 26). Controls within a match-set were still followed to their
end-point date even if their matched adult with ID had exited the cohort earlier. The average length of
follow-up for all individuals was approximately 3 years (1097 days).
Primarily, the date of death recorded on the ONS record was used for the majority of deaths. However, we
used the date derived from the CPRD record if it was clear that a patient had received no further primary
care contact after this date. This inconsistency was often only a matter of a few days, but for a small
number of deaths it was approximately 1 year as it appeared that the year of death had been incorrectly
recorded on the ONS record and was wrong by one digit (e.g. 2011 rather than 2010).
Cause of death and avoidable mortality
Underlying cause of death was derived from the ONS death registration data for patients who died during
the study (656 adults with ID and 1358 controls). For 38 (2%) of these deaths, we were unable to obtain
cause of death from the ONS record. A full list of the ICD-10 codes used to group cause of death is in
Appendix 7. When examining how often ID is recorded on death certificates, we searched all recorded
main and contributory causes of death for ID-associated codes, including an extended range of conditions
weakly associated with ID, such as cerebral palsy.75
Using the recorded cause of death, we further classified deaths as being potentially avoidable. We
followed ONS guidelines that have used underlying cause of death to identify where scope exists for
intervention to reduce mortality.76 Potentially avoidable deaths have been further classified as being either
(1) amenable to good-quality health care (treatable) or (2) preventable through public health action, or
both. These definitions primarily include deaths aged < 75 years except for accidental deaths. For example,
deaths due to asthma are identified as amenable to health care through effective long-term treatment,
whereas deaths due to lung cancer are identified as preventable through tobacco control. As some causes
of death are defined as both amenable and preventable (e.g. IHD), potentially avoidable mortality is smaller
than the sum of amenable and preventable mortality.
Characteristics of adults with intellectual disability in longitudinal
analyses
Table 21 summarises the characteristics of the 16,666 adults with ID who are included in the longitudinal
analyses. Fifty-eight per cent were men, an identical figure to that seen in the cross-sectional analyses
(see Table 5). What differed slightly in these analyses was how we defined a patient’s age. We classified
age here by the recorded age in the year of entry to the cohort, which was primarily 2009. Therefore, the
average age of the longitudinal cohort is summarised as 39.9 years, whereas in the cross-sectional analysis,
based on a 1 January 2012 date, it was 42.1 years.
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All-cause mortality
During follow-up from 1 January 2009 to 31 March 2013, a total of 656 (3.94%) adults with ID died
compared with 1358 (1.20%) of the matched controls (Table 22). The crude mortality rate was 132.4 per
10,000 persons per year for adults with ID, compared with 39.7 per 10,000 persons per year for controls.
Among adults with ID, there were elevated death rates among those with Down syndrome (6.58%, 220.0
per 10,000 persons per year), those with high support needs (5.94%, 190.2 per 10,000 persons per year),
those with epilepsy (5.79%, 188.0 per 10,000 persons per year) and those living in communal/shared
accommodation (7.8%, 254.7 per 10,000 persons per year). There were fewer deaths among the primarily
younger subgroup with autism (0.98%, 36.3 per 10,000 persons per year).
Hazard ratios (unadjusted and adjusted for comorbidity, smoking and deprivation) for all-cause mortality
are shown in Table 23. The overall HR of 3.62 (95% CI 3.33 to 3.93) for adults with ID versus controls was
only partially explained by observed differences in comorbidity between the groups (adjusted HR 3.05,
95% CI 2.73 to 3.41). Although the HR for all-cause mortality was higher for men than for women, this
difference was not statistically significant after adjustment (p = 0.07). The higher mortality risk among
adults with ID was seen at all ages. Prior to adjustment, the largest disparity between adults with ID and
TABLE 21 Characteristics of adults with ID eligible for longitudinal analyses
Characteristic
Adults with ID Controls
n Men (%) Mean age in years (SD) n
All 16,666 58.1 39.9 (16.2) 113,562
Gender
Women 6989 0 41.3 (16.4) 47,587
Men 9677 100 38.8 (15.9) 65,975
Age (years) (at baseline)
18–34 6981 61.2 24.2 (5.1) 46,939
35–54 6283 57.4 44.2 (5.4) 43,123
55–84 3402 52.9 64.0 (7.1) 23,500
Down syndromea
Yes 1793 55.0 39.1 (14.4) 12,226
No 14,873 58.4 40.0 (16.4) 101,336
Severe health needsa
Yes 3263 54.4 41.4 (16.4) 22,298
No 13,403 59.0 39.5 (16.1) 91,264
Communal accommodationa
Yes 3392 57.2 47.2 (15.7) 23,117
No 13,274 58.3 38.0 (15.8) 90,445
Autism spectrum disordera
Yes 1532 73.2 30.5 (13.3) 10,387
No 15,134 56.5 40.8 (16.1) 103,188
Epilepsya
Yes 2884 55.4 41.0 (15.3) 19,705
No 13,782 58.6 39.6 (16.3) 93,857
a Characteristic of adult with ID only. For definition of severe health needs, see Chapter 2, Definition of severe health
needs, and Figure 5 for further details. For definition of communal accommodation, see Chapter 2, Other subgroups of
interest, for further details.
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controls was among the youngest ages (18–34 years), but the opposite was true after adjusting for
comorbidity and other factors. However, these age differences were not significant in either comparison.
Among adults with ID, those with Down syndrome had a very high relative risk of death compared with
controls (HR 9.21, 95% CI 7.22 to 11.76), which was significantly different from the risk of death seen in
adults with ID without Down syndrome (p < 0.001) and was not explained by further adjustment. Similarly,
adults with ID with severe support needs had a death rate nearly five times higher than that of their
controls (HR 4.77, 95% CI 4.08 to 5.59), which was significantly different from that of adults with ID
without severe health needs both before and after adjustment (p ≤ 0.001). The same was true for adults
with ID recorded living in communal/shared living who had a similarly elevated death rate to their controls
(HR 4.99, 95% CI 4.36 to 5.73). Within the population with ID, epilepsy was a strong determinant of
mortality risk, relative both to the controls (HR 6.04, 95% CI 5.04 to 7.24) and to other adults with ID
without epilepsy (p < 0.001).
TABLE 22 Number of deaths and crude death rates (per 10,000 persons per year) 2009–13 among adults with ID
and controls
Characteristic
Adults with ID (N= 16,666) Controls (N= 113,562)
n (%) Rate per 10,000 n (%) Rate per 10,000
All 656 (3.94) 132.4 1358 (1.20) 39.7
Gender
Women 291 (4.16) 139.5 538 (1.13) 37.5
Men 365 (3.77) 127.3 820 (1.20) 41.5
Age (years) (at baseline)
18–34 48 (0.69) 25.3 69 (0.15) 5.6
35–54 167 (2.66) 83.1 276 (0.64) 19.6
55–84 441 (12.69) 420.0 1013 (4.31) 129.6
Down syndromea
Yes 118 (6.58) 220.0 92 (0.75) 24.9
No 538 (3.62) 121.8 1266 (1.25) 41.6
Severe health needsa
Yes 194 (5.94) 190.2 302 (1.35) 43.9
No 462 (3.45) 117.4 1056 (1.16) 38.7
Communal accommodationa
Yes 265 (7.81) 254.7 416 (1.80) 56.5
No 391 (2.90) 99.9 942 (1.04) 35.1
Autism spectrum disordera
Yes 15 (0.98) 36.3 44 (0.42) 16.0
No 641 (4.24) 141.2 1314 (1.27) 41.8
Epilepsya
Yes 167 (5.79) 188.0 205 (1.04) 33.7
No 498 (3.55) 120.3 1153 (1.23) 41.0
a Characteristic of adults with ID only. For definition of severe health needs, see Chapter 2, Definition of severe health
needs, and Figure 5 for further details. For definition of communal accommodation, see Chapter 2, Other subgroups of
interest, for further details.
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The differences in mortality between subgroups was further investigated in additional (unmatched)
analyses that directly compared adults with ID in each subgroup (Table 24) and adjusted for age, gender
and other confounders. These confirmed the earlier findings in Table 23. For example, an adult with ID
with Down syndrome had a risk of death nearly three times as high (HR 2.91, 95% CI 2.31 to 3.66) as
that for an adult with ID without Down syndrome. Adults with ID living in communal accommodation,
with severe health needs or with epilepsy had risks of death that were, respectively, 44%, 52% and 73%
higher than that for adults with ID without each of those criteria. Adults with ID with autism were at lower
risk of death (HR 0.56, 95% CI 0.34 to 0.94) than adults with ID without autism.
TABLE 23 Hazard ratios for all-cause mortality 2009–13 for adults with ID vs. controls
Characteristic
Base (unadjusted) model Adjusted modela
HR (95% CI) p-valueb HR (95% CI) p-valueb
All 3.62 (3.33 to 3.93) – 3.05 (2.73 to 3.41) –
Gender
Women 4.10 (3.61 to 4.66) 0.01 3.50 (2.94 to 4.16) 0.07
Men 3.30 (2.96 to 3.68) 2.81 (2.43 to 3.24)
Age (years) (at baseline)
18–34 4.29 (3.13 to 5.88) – 2.43 (1.56 to 3.77) –
35–54 4.17 (3.52 to 4.92) 0.88 3.22 (2.53 to 4.08) 0.25
55–84 3.39 (3.07 to 3.75) 0.21 3.03 (2.65 to 3.46) 0.32
Down syndromec
Yes 9.21 (7.22 to 11.76) < 0.001 10.39 (7.13 to 15.13) < 0.001
No 3.19 (2.92 to 3.49) 2.66 (2.36 to 3.00)
Severe health needsc
Yes 4.77 (4.08 to 5.59) < 0.001 4.95 (4.03 to 6.07) 0.001
No 3.28 (2.98 to 3.62) 3.15 (2.79 to 3.55)
Communal accommodationc
Yes 4.99 (4.36 to 5.73) < 0.001 4.30 (3.52 to 5.26) < 0.001
No 3.05 (2.74 to 3.39) 2.64 (2.30 to 3.02)
Autism spectrum disorderc
Yes 2.39 (1.45 to 3.96) 0.05 2.22 (1.01 to 4.86) 0.40
No 3.66 (3.37 to 3.98) 3.07 (2.74 to 3.43)
Epilepsyc
Yes 6.04 (5.04 to 7.24) < 0.001 7.76 (6.10 to 9.86) < 0.001
No 3.18 (2.90 to 3.50) 2.91 (2.60 to 3.27)
a Adjusted for nine comorbidities (atrial fibrillation, cancer, COPD, dementia, diabetes mellitus, epilepsy, heart failure,
severe mental illness and stroke), deprivation and smoking status, except for subgroup analysis for epilepsy and severe
health needs in which epilepsy is not included in the adjustment.
b p-value for differences between subgroups (for age: 18–34 years is taken as baseline group).
c Characteristic of adults with ID only. For definition of severe health needs see Chapter 2, Definition of severe health
needs, and Figure 5 for further details. For definition of communal accommodation see Chapter 2, Other subgroups of
interest, for further details.
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Cause-specific mortality
The higher mortality risk in adults with ID produced different patterns of cause-specific mortality when
compared with the matched controls (Figure 27). In adults with ID, the most common causes of mortality
were circulatory diseases (22%), respiratory diseases (19%), neoplasms (15%) and nervous system diseases
(12%). This is different from the pattern in controls, in whom neoplasms (37%), circulatory (27%),
respiratory (10%) and external causes (8%) were the most common causes.
Cause of death is explored in more detail in Table 25, which shows the number and rate (per 10,000
persons per year) of deaths for adults with ID and controls for main causes, and for specific subgroups
of these when numbers allow. Notable specific contributions to mortality among people with ID, in
comparison with controls, were dementia (n = 27; rate = 5.5 vs. 0.5 per 10,000 persons per year), epilepsy
(n = 29; rate = 5.9 vs. 0.1 per 10,000 persons per year), pneumonia (n = 67; rate = 13.5 vs. 1.1 per 10,000
persons per year) and aspiration pneumonitis (n = 21; rate = 4.2 vs. 0.2 per 10,000 persons per year). On
the other hand, transport accidents (n = 1) and intentional self-harm (n = 0) were rarely or non-existent
recorded causes of death among adults with ID.
Although cancer (neoplasms) as a cause of death represented a lower proportion of all deaths among
adults with ID (see Figure 27), the death rate from cancer overall was marginally higher for adults with ID
(19.8 vs. 14.9 per 10,000 per year) (Table 25). There was, however, some variation in types of cancer
recorded as the cause of death. Colorectal cancer (n = 17) was the most commonly recorded cause among
adults with ID, whereas among the matched controls lung cancer (n = 117) was far more frequent. Urinary
tract cancers (n = 2), prostate cancer (n = 2) and oesophageal cancer (n = 0) were rarely recorded causes of
death among adults with ID.
TABLE 24 Hazard ratios for all-cause mortality 2009–13 among adults with ID subgroups only
Characteristic Adults with ID, n Base model,a HR (95% CI) Adjusted model,b HR (95% CI)
Down syndrome
Yes 1793 2.92 (2.37 to 3.59) 2.91 (2.31 to 3.66)
No 14,873 1 1
Severe health needsc
Yes 3263 1.48 (1.23 to 1.77) 1.52 (1.27 to 1.83)
No 13,403 1 1
Communal accommodationc
Yes 3392 1.60 (1.33 to 1.92) 1.44 (1.19 to 1.74)
No 13,274 1 1
Autism spectrum disorder
Yes 1532 0.55 (0.34 to 0.90) 0.56 (0.34 to 0.94)
No 15,134 1 1
Epilepsy
Yes 2884 1.64 (1.37 to 1.97) 1.73 (1.43 to 2.09)
No 13,782 1 1
a Adjusted for age and gender only.
b Adjusted for age, gender, nine comorbidities (atrial fibrillation, cancer, COPD, dementia, diabetes mellitus, epilepsy,
heart failure, severe mental illness and stroke), deprivation and smoking status, except for subgroup analysis for epilepsy
and severe health needs in which epilepsy is not included in the adjustment.
c For definition of severe health needs see Chapter 2, Definition of severe health needs, and Figure 5 for further details.
For definition of communal accommodation see Chapter 2, Other subgroups of interest, for further details.
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FIGURE 27 Recorded causes of death during 2009–13 in (a) adults with ID and (b) controls.
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TABLE 25 Number of deaths and crude death rates (per 10,000 persons per year) by cause of death 2009–13
among adults with ID and controls
Cause of death
Adults with ID (N= 16,666) Controls (N= 113,562)
n Rate per 10,000 n Rate per 10,000
Infectious and parasitic disorders 3 0.6 14 0.4
Neoplasms 98 19.8 508 14.9
Oesophageal 0 0.0 16 0.5
Colorectal 17 3.4 44 1.3
Pancreatic 6 1.2 22 0.6
Lung 10 2.0 117 3.4
Breast 7 1.4 36 1.1
Prostate 2 0.4 28 0.8
Urinary tract 2 0.4 30 0.9
Lymphoma 10 2.0 40 1.2
Endocrine, nutritional and metabolic diseases 13 2.6 16 0.5
Mental and behavioural disorders 35 7.1 31 0.9
Dementia 27 5.5 17 0.5
Diseases of the nervous system 76 15.3 39 1.1
Epilepsy 29 5.9 3 0.1
Diseases of the circulatory system 142 28.7 360 10.5
IHD 62 12.5 188 5.5
Cerebrovascular disease 34 6.9 57 1.7
Diseases of the respiratory system 123 24.8 135 3.9
Pneumonia 67 13.5 39 1.1
COPD 19 3.8 59 1.7
Aspiration pneumonitis 21 4.2 6 0.2
Diseases of the digestive system 46 9.3 87 2.5
Liver disease 8 1.6 44 1.3
Diseases of the musculoskeletal system 6 1.2 8 0.2
Diseases of the genitourinary system 23 4.6 15 0.4
Congenital/chromosomal abnormalities 45 9.1 2 0.06
External causes of morbidity 27 5.5 101 3.0
Transport accidents 1 0.2 20 0.6
Other external causes of accidental injury 20 4.0 31 0.9
Intentional self-harm 0 0.0 35 1.0
Other (skin, blood diseases, residual codes) 10 2.0 13 0.4
Not available 9 1.8 29 0.8
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The most common underlying cause of death in adults with ID with Down syndrome (n = 118) was
respiratory diseases (n = 24, 20%). For an additional 30 adults with ID who died (25%), Down syndrome
or other chromosomal abnormalities was given as the underlying cause. Almost all of these adults (n = 26)
had respiratory disease listed as a secondary cause of death. If these 26 deaths were assumed to be due to
respiratory disease, then the percentage of deaths of adults with Down syndrome caused by respiratory
diseases would rise to 42%.
Hazard ratios for selected grouped causes of death are shown in Table 26. These are presented for the
unadjusted model only, which accounts for age and gender differences via the matching. These were
calculated for both the main groupings (e.g. neoplasms) and, when possible, the subgroups (e.g. colorectal
cancer). It was not possible to calculate a HR for deaths from congenital or chromosomal abnormalities
owing to the small number of control deaths.
The largest (estimable) relative difference in risk of death between adults with ID and adults without ID,
for the main groups, was seen for nervous system disorders, primarily epilepsy (HR 13.79, 95% CI 9.70 to
19.62), followed by diseases of the genitourinary system, including UTIs (HR 10.89, 95% CI 6.09 to 19.47).
Other notable disparities were seen for diseases of the respiratory system (HR 6.68, 95% CI 5.38 to 8.29),
with aspiration pneumonitis (HR 27.73) and pneumonia deaths (HR 13.09) being key contributors, and
mental and behaviour disorders (HR 7.99, 95% CI 5.19 to 12.31), which were influenced by the higher
risk of dementia-related deaths (HR 12.18).
Although deaths from cancer represented a smaller proportion of deaths among adults with ID than
among the general population, the overall risk of death from neoplasms was still marginally higher
(HR 1.44, 95% CI 1.18 to 1.76). Cancer-specific estimates were imprecise owing to the small number of
deaths with each type, but deaths from colorectal cancer were notably higher for adults with ID (HR 2.82,
95% CI 1.71 to 4.63). Deaths from lung and prostate cancer both produced a HR of < 0.7, but the CIs
were wide.
Potentially avoidable mortality
The proportion of all deaths classified as potentially avoidable (amenable and/or preventable) was similar in
adults with ID (n = 304, 46.3%) and controls (n = 645, 47.5%). However, individually, the proportion of
amenable and preventable deaths differed between the two groups (Figure 28). Within adults with ID,
the percentage of amenable deaths (n = 243, 37.0%) was notably higher than that seen in controls
(n = 305, 22.5%). This difference is reflected in a large estimated HR (5.86, 95% CI 5.06 to 6.80) for deaths
amenable to health care among adults with ID versus controls. This may be an underestimate, as standard
ONS definitions do not include a number of causes of deaths in people with ID that may be considered
amenable, such as deaths from UTI (n = 12, 1.7%) and aspiration pneumonitis (n = 21, 3.1%).
The pattern in preventable deaths was different, with the proportion being smaller among adults with ID
(n = 127, 19.4%) than among controls (n = 543, 40.0%). However, preventable deaths were still marginally
more likely overall among adults with ID (HR 1.69, 95% CI 1.42 to 2.02).
Recording of intellectual disability on death certificates
Finally, we electronically searched the linked ONS death certification data for any mention of ID or a
related condition, as either a main or a contributory cause of death. Only 200 (30.9%) of the linked
647 deaths had any such mention. Therefore, for 7 in 10 deaths among adults with ID there was no
mention of their ID on their death certificate. For those with a recorded cause associated with ID, the most
commonly listed were Down syndrome (n = 88), cerebral palsy (n = 39) and developmental disorder of
scholastic skills (n = 50).
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TABLE 26 Hazard ratios for cause-specific mortality 2009–13 for adults with ID vs. controls
Cause of death Base (unadjusted) model, HR (95% CI)
Infectious and parasitic disorders 2.30 (0.70 to 7.48)
Neoplasms 1.44 (1.18 to 1.76)
Oesophageal a
Colorectal 2.82 (1.71 to 4.63)
Pancreatic 1.92 (0.89 to 4.14)
Lung 0.69 (0.37 to 1.28)
Breast 1.42 (0.69 to 2.94)
Prostate 0.54 (0.13 to 2.19)
Urinary tract 0.90 (0.15 to 2.37)
Lymphoma 1.72 (0.91 to 3.26)
Endocrine, nutritional and metabolic diseases 5.38 (2.79 to 10.07)
Mental and behavioural disorders 7.99 (5.19 to 12.31)
Dementia 12.18 (6.84 to 21.69)
Diseases of the nervous system 13.79 (9.70 to 19.62)
Epilepsy 180.6 (24.9 to 1308.2)
Diseases of the circulatory system 3.05 (2.56 to 3.64)
IHD 2.50 (1.93 to 3.23)
Cerebrovascular disease 4.88 (3.34 to 7.12)
Diseases of the respiratory system 6.68 (5.38 to 8.29)
Pneumonia 13.09 (9.09 to 18.87)
COPD 2.43 (1.52 to 3.87)
Aspiration pneumonitis 27.73 (11.48 to 66.95)
Diseases of the digestive system 4.02 (2.92 to 5.54)
Liver disease 1.31 (0.65 to 2.66)
Diseases of the musculoskeletal system 5.50 (2.22 to 13.61)
Diseases of the genitourinary system 10.89 (6.09 to 9.47)
Congenital/chromosomal abnormalities a
External causes of morbidity 1.85 (1.26 to 2.71)
Transport accidents 0.32 (0.05 to 2.26)
Other external causes of accidental injury 4.94 (3.02 to 8.07)
Intentional self-harm a
Other (skin, blood diseases, residual codes) 5.03 (2.40 to 10.54)
Not available 2.27 (1.19 to 4.43)
a Not estimable owing to insufficient numbers.
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Adults with ID
All mortality (100%, rate = 132.4)
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(37%, rate = 49.1)
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FIGURE 28 Amenable and preventable mortality during 2009–13 among adults with ID and controls. Note that total areas inside the squares are proportional to the mortality
rates for each subgroup; rates given are per 10,000 people per year. The overall subgroup of avoidable mortality is the total area covered by amenable and/or preventable
[ID rate= 61.4 (46.3% of all mortality) and control rate = 18.9 (47.5%); HR 3.44, 95% CI 3.05 to 3.89]. Figure redrawn from Hosking et al.74 Hosking FJ, Carey IM, Shah SM,
Harris T, DeWilde S, Beighton C, Cook DG. Mortality among adults with intellectual disability in England: comparisons with the general population. Am J Public Health
2016;106:1483–90. Available at: http://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.2016.303240
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Chapter 5 Hospital admissions
Introduction
In this section, we use the linked hospital admissions data from the HES data set to provide a summary of
hospitalisations during our study for adults with ID, and to compare the volume and type of admissions
with those of the matched controls. We also take advantage of the linkage by comparing the primary care
record prior to admission for two infections, UTIs and LRTIs, which we suspected would be common in
both adults with ID and the general population.41
Analyses are, again, based on 343 practices with linked data (see Figure 2). We used the same longitudinal
design that was introduced for mortality analyses in Chapter 4, involving a total of 16,666 adults with ID
and 113,562 age-, gender- and practice-matched controls without ID (see Figure 26). Follow-up was from
1 January 2009 to a maximum date of 31 March 2013, with the average length of follow-up for all
individuals being approximately 3 years (1097 days). The characteristics of the adults with ID and controls
used in the analysis have been described in Table 21.
Some of these results have already appeared in the publication by Hosking et al.77 Reproduced with
permission from Preventable Emergency Hospital Admissions Among Adults with Intellectual Disability in
England, September/October 2017, Vol. 15, No. 5, Annals of Family Medicine © 2017 Annals of Family
Medicine, Inc.
Categorising admissions
The HES data set contains information on every admission to a NHS hospital in England.78 This includes
information on the date, duration and type (e.g. elective) of admission and the primary reason for
admission (coded using ICD-1058). Although multiple episodes can sometimes occur within a continuous
period of hospitalisation (such as when a patient is transferred to a different consultant), we decided to
focus solely on the initial episode as we were interested in the reason for admission that this represented.41
We categorised admissions, using the method of admission variable ADMIMETH,79 into the following
groups: emergency, elective, maternity and other (such as transfers from other hospital providers). Within
emergency admissions, we further identified a subgroup of admissions for ACSCs,41 which represent a
group thought to be potentially preventable with better clinical management. We included 20 widely used
ACSCs, but also considered an additional five conditions relevant to the population with ID.13,80 These were
constipation, aspiration, gastro-oesophageal reflux disease, osteoporosis and schizophrenia. We chose not
to use osteoporosis, as it was rarely recorded as the primary reason for admission, or schizophrenia, owing
to the idiosyncratic recording of elective versus emergency for many English psychiatric admissions.12 This
resulted in a total of 23 ACSCs (see Appendix 8).
For elective admissions, a small number of patients were receiving regular elective hospital procedures
(e.g. dialysis) during the study and their inclusion was potentially problematic for calculating an overall
rate. We made the pragmatic choice to exclude patients in our analyses of elective admission rates who
averaged more than six elective admissions per year. This represented about 0.20% of the cohort
(adults with ID, n = 32; controls, n = 233).
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Summary of overall admissions
Admission rates (per 1000 persons per year) by type are shown in Figure 29. The overall rate for adults
with ID was 351.6 per 1000 persons per year, compared with 246.4 per 1000 persons per year for
controls. This difference was essentially due to the higher rate among emergency admissions (182.2 vs.
67.7 per 1000 persons per year), as elective rates were similar between groups.
Of the 16,666 adults with ID, 5924 (35.5%) had an emergency or elective admission during follow-up. By
comparison, among the age-, gender-, practice-matched controls (n = 113,562), 30,676 (27.0%) had at
least one emergency or elective admission during follow-up. For emergency admissions only, 3847 (23.1%)
adults with ID had at least one admission, compared with 13,496 (11.9%) of the controls. Only 2525
(66%) of these adults with ID had any corresponding mention of ID on their hospital record. A total of
1809 (10.9%) adults with ID had multiple emergency admissions, compared with 4326 (3.8%) of the
controls.
Emergency admissions by subgroups
A summary of emergency hospitalisation rates among subgroups within adults with ID and matched
controls is shown in Table 27. A statistical comparison of the rates is shown in Table 28, which estimates
the IRRs for hospitalisation for adults with ID versus controls using conditional Poisson regression (see
Chapter 2, Statistical analysis). These are presented unadjusted (accounting only for the matching factors)
and then adjusted for comorbidities (atrial fibrillation, cancer, COPD, dementia, diabetes mellitus, epilepsy,
heart failure, severe mental illness and stroke), smoking and deprivation. Subgroup comparisons used IRRs
and CIs derived from ID versus control comparisons to calculate p-values for differences between them.
The overall rate for emergency hospitalisation in adults with ID (182.2 per 1000 persons per year)
represented a nearly three times increase (IRR 2.82, 95% CI 2.66 to 2.98) compared with their matched
controls. This remained more than double (HR 2.16, 95% CI 2.02 to 2.30) when adjusting for
comorbidities, smoking and deprivation. Although admission rates appeared higher for women with ID
than for men with ID (203.8 vs. 166.5 per 1000 persons per year), this difference was not significantly
different (p = 0.36). The disparity for emergency admissions between adults with ID and controls was more
marked with increasing age.
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5.9
7.5
Maternity
20.8
6.9
Elective
Ty
p
e 
o
f 
ad
m
is
si
o
n
152.0
155.0
Emergency
67.7
182.2
All
246.4
351.6
0 100 200
Rate of admissions per 1000 persons per year
300 400
Adults with ID
Controls
FIGURE 29 Hospital admissions rates during 2009–13 for adults with ID and controls.
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Higher rates of emergency admission were seen in adults with ID with severe health needs (243.9 per 1000
persons per year) than in adults with ID without severe health needs (166.2 per 1000 persons per year).
Compared with their matched controls, adults with ID with severe health needs were at nearly four times the
risk of emergency hospitalisation (adjusted IRR 3.83, 95% CI 3.42 to 4.28). This disparity was significantly
different from the increased risk seen in adults with ID without severe health needs (p < 0.001).
Rates of emergency admission did not significantly vary by communal accomodation or by Down syndrome
when the RR between adults with ID and matched controls was compared (see Table 28). However, there
TABLE 27 Number of emergency admissions during 2009–13 and rate (per 1000 persons per year) among adults
with ID and controls
Characteristic
Adults with ID (N= 16,666) Controls (N= 113,562)
Number of people Admissions
Rate per
1000 Number of people Admissions
Rate per
1000
All 16,666 9026 182.2 113,562 23,148 67.7
Gender
Women 6989 4250 203.8 47,587 10,613 73.5
Men 9677 4776 166.5 65,975 12,535 63.4
Age (years) (at baseline)
18–34 6981 2374 125.3 46,939 6217 50.5
35–54 6283 3201 159.3 43,123 7812 55.6
55–84 3402 3451 328.7 23,500 9119 116.7
Down syndromea
Yes 1793 804 150.0 12,226 2326 62.9
No 14,873 8222 186.1 101,336 20,822 68.2
Severe health needsa
Yes 3263 2487 243.9 22,298 4826 70.2
No 13,403 6539 166.2 91,264 18,322 67.1
Communal accommodationa
Yes 3392 2141 205.7 23,117 5523 75.0
No 13,274 6885 175.9 90,445 17,625 65.7
Autism spectrum disordera
Yes 1532 339 82.1 10,374 1459 53.2
No 15,134 8687 191.3 103,188 21,689 69.0
Epilepsya
Yes 2884 2725 306.8 19,705 4108 67.5
No 13,782 6301 155.0 93,587 19,040 67.7
a Characteristic of adults with ID only. For definition of severe health needs see Chapter 2, Definition of severe health
needs, and Figure 5 for further details. For definition of communal accommodation see Chapter 2, Other subgroups of
interest, for further details.
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were significant variations in rates of emergency admission by whether the adult with ID had epilepsy or
autism. Adults with ID and epilepsy had an emergency hospitalisation rate approximately double that of
adults with ID without epilepsy (306.8 vs. 155.0 per 1000 persons per year). Adults with ID and autism
had an emergency hospitalisation rate less than half that of adults with ID without autism (82.1 vs. 191.3
per 1000 persons per year).
A direct comparison between subgroups among adults with ID is shown in Table 29, with IRRs adjusted for
age, gender and comorbidity. This confirmed the doubling of emergency hospitalisations among those
with epilepsy (adjusted HR 2.14), as well as the higher rate among adults with severe health needs
(HR 1.54) and lower rates among those with autism (HR 0.61).
TABLE 28 Incidence rate ratios for emergency hospital admissions during 2009–13 for adults with ID vs. controls
Characteristic
Base (unadjusted) model Adjusted modela
IRR (95% CI) p-valueb IRR (95% CI) p-valueb
All 2.82 (2.66 to 2.98) – 2.16 (2.02 to 2.30) –
Gender
Women 2.90 (2.66 to 3.15) 0.36 2.09 (1.89 to 2.30) 0.45
Men 2.75 (2.55 to 2.96) – 2.20 (2.01 to 2.41) –
Age at baseline (years)
18–34 2.54 (2.31 to 2.80) – 1.81 (1.61 to 2.04) –
35–54 2.96 (2.69 to 3.25) 0.03 2.10 (1.87 to 2.37) 0.09
55–84 2.90 (2.63 to 3.19) 0.06 2.43 (2.19 to 2.70) < 0.001
Down syndromec
Yes 2.61 (2.23 to 3.05) 0.31 2.37 (1.97 to 2.84) 0.27
No 2.84 (2.68 to 3.01) – 2.11 (1.96 to 2.26) –
Severe health needsc
Yes 3.67 (3.32 to 4.05) < 0.001 3.83 (3.42 to 4.28) < 0.001
No 2.59 (2.42 to 2.77) – 2.32 (2.16 to 2.49) –
Communal accommodationc
Yes 2.91 (2.63 to 3.22) 0.50 2.15 (1.88 to 2.47) 0.95
No 2.79 (2.61 to 2.98) – 2.16 (2.00 to 2.33) –
Autism spectrum disorderc
Yes 1.60 (1.32 to 1.94) < 0.001 1.24 (0.98 to 1.57) < 0.001
No 2.90 (2.74 to 3.07) – 2.21 (2.07 to 2.37) –
Epilepsyc
Yes 4.80 (4.32 to 5.33) < 0.001 4.98 (4.44 to 5.59) < 0.001
No 2.39 (2.24 to 2.56) – 2.15 (2.00 to 2.30) –
a Adjusted for nine comorbidities (atrial fibrillation, cancer, COPD, dementia, diabetes mellitus, epilepsy, heart failure,
severe mental illness and stroke), deprivation and smoking status, except for subgroup analysis for epilepsy and severe
health needs in which epilepsy is not included in the adjustment.
b p-value for differences between subgroups (for age: 18–34 years is taken as baseline group).
c Characteristic of adults with ID only. For definition of severe health needs see Chapter 2, Definition of severe health
needs, and Figure 5 for further details. For definition of communal accommodation see Chapter 2, Other subgroups of
interest, for further details.
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Emergency admissions for ambulatory care-sensitive conditions
Emergency admissions for ACSCs were much higher among adults with ID than among controls (61.3 vs.
11.7 per 1000 persons per year). Additionally, the proportion of emergency admissions for ACSCs among
adults with ID was much higher (33.7% vs. 17.3% for controls). When this relationship with ACSCs was
further explored by age (Figure 30), the proportion of emergency admissions that were ACSCs (dark green
shading) remained constant across age for adults with ID. Within the controls, however, this proportion
increased from 12% in the youngest age group to 24% in the oldest age group.
Emergency admissions for ACSCs are summarised in adults with ID and controls by subgroup in Table 30
(rates per 1000 persons per year) and in Table 31 (unadjusted and adjusted IRRs). The relative difference in
admission rate was over five times higher for adults with ID (IRR 5.62, 95% CI 5.14 to 6.13). Adjusting for
comorbidity explained some of this difference, but adults with ID were still over three times more likely to
have an admission for an ACSC (IRR 3.60, 95% CI 3.25 to 3.99).
The relationship of admissions for ACSCs in adults with ID varied by age, with the youngest group
(18–34 years) over seven times more likely than their controls to have an admission (IRR 7.12, 95% CI 5.96
to 8.51). However, once comorbidity was adjusted for, the trend by age group reversed and older adults
with ID (55–84 years) were now the most likely to have an admission for an ACSC relative to their controls
(IRR 4.09, 95% CI 3.52 to 4.76). Even after adjustment for comorbidity, adults with ID with severe health
needs were almost 12 times more likely than their controls to have an admission for an ACSC (IRR 11.78,
95% CI 9.78 to 14.19). This difference was significantly different from that estimated between adults with
ID without severe health needs and their controls (p < 0.001). A similar observation was seen when the
comparison was made between adults with ID with epilepsy and their controls (IRR 16.77) versus adults
with ID without epilepsy (IRR 3.46).
TABLE 29 Incidence rate ratios for emergency admissions during 2009–13 among adults with ID subgroups only
Characteristic Adults with ID, n Base model,a IRR (95% CI) Adjusted model,b IRR (95% CI)
Down syndrome
Yes 1793 0.86 (0.74 to 1.00) 1.10 (0.95 to 1.25)
No 14,873 1 1
Severe health needsc
Yes 3263 1.40 (1.24 to 1.58) 1.54 (1.37 to 1.74)
No 13,403 1 1
Communal accommodationc
Yes 3392 1.03 (0.89 to 1.20) 1.00 (0.87 to 1.16)
No 13,274 1 1
Autism spectrum disorder
Yes 1532 0.58 (0.47 to 0.71) 0.61 (0.49 to 0.75)
No 15,134 1 1
Epilepsy
Yes 2884 1.95 (1.76 to 2.17) 2.14 (1.91 to 2.39)
No 13,782 1 1
a Adjusted for age and gender only.
b Adjusted for age, gender, nine comorbidities (atrial fibrillation, cancer, COPD, dementia, diabetes mellitus, epilepsy,
heart failure, severe mental illness and stroke), deprivation and smoking status, except for subgroup analysis for epilepsy
and severe health needs in which epilepsy is not included in the adjustment.
c For definition of severe health needs see Chapter 2, Definition of severe health needs, and Figure 5 for further details.
For definition of communal accommodation see Chapter 2, Other subgroups of interest, for further details.
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For adults with ID with Down syndrome, almost half of emergency admissions were for ACSCs (48.8%). As a
result, adults with ID with Down syndrome were estimated to be a higher risk of ACSC admission versus their
controls (IRR 8.28) than adults with ID without Down syndrome versus their controls (IRR 3.21), and this was
significantly different (p = 0.002). Similarly, adults with ID recorded as living in communal accommodation
were at a higher risk of emergency admission for an ACSC than those not recorded as such (p = 0.006).
Among all emergency admissions for ACSCs, the contribution of common conditions within adults with ID
and controls separately is summarised in Figure 31. For adults with ID, the most common ACSCs resulting
in admission were convulsions/epilepsy (36%), pneumonia/LRTI (19%) and UTI (11%). For matched
controls, although pneumonia/LRTI (19%) and UTI (13%) admissions accounted for similar proportions,
admissions for convulsions/epilepsy (6%) were much rarer.
The rates of emergency admissions for each of the 23 ACSCs, and the associated IRRs for adults with ID
versus controls (when estimable), are shown in Table 32. The largest relative disparities between adults
with ID and controls were seen for aspiration (IRR 85.9, 95% CI 45.3 to 162.9) and convulsions/epilepsy
(IRR 31.2, 95% CI 24.6 to 39.5). Among emergency admissions with sufficient occurrence in both groups,
only angina did not show any evidence of a higher admission rate among adults with ID (IRR 1.00, 95% CI
0.60 to 1.68).
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FIGURE 30 Emergency admissions, overall and for ACSCs, during 2009–13 by age group in adults with ID and controls.
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Primary care utilisation before admission
We sought to use the linked CPRD and HES databases to describe the primary care utilisation and
management prior to admission for ACSCs. We decided to choose two infections (UTIs and LRTIs) as
exemplar ACSCs as they are common in both adults with ID and adults without ID. Although epilepsy is a
much larger contributor to ACSC admissions in adults with ID owing to its high prevalence (see Table 6),
the corresponding low prevalence in adults without ID makes any comparison potentially difficult.
We identified all recorded UTI and LRTI admissions during our study follow-up (see Table 31), and then
included the first admission when there was no evidence of a prior admission for UTI or LRTI at any time
previously in the patient’s record. This resulted in 727 UTI admissions and 1128 LRTI admissions. For each
of these we electronically searched in the primary care record 2 weeks before admission to investigate
TABLE 30 Number and rate (per 1000 persons per year) of emergency admissions for ACSCs during 2009–13 among
adults with ID and controls
Characteristic
Adults with ID (n= 16,666) Controls (n= 113,562)
Admissions Rate per 1000
% of all
emergency Admissions Rate per 1000
% of all
emergency
All 3038 61.3 33.7 4008 11.7 17.3
Gender
Women 1428 68.5 33.6 1885 13.1 17.8
Men 1610 56.1 33.7 2123 10.7 16.9
Age (years) (at baseline)
18–34 805 42.5 33.9 759 6.2 12.2
35–54 1041 51.8 32.5 1204 8.6 15.4
55–84 1192 113.5 34.5 2045 26.2 22.4
Down syndromea
Yes 392 73.1 48.8 345 9.3 14.8
No 2646 59.9 32.2 3663 12.0 17.6
Severe health needsa
Yes 1154 113.2 46.4 830 12.1 17.2
No 1884 47.9 28.8 3178 11.6 17.3
Communal accommodationa
Yes 915 87.9 42.7 1032 14.0 18.7
No 2123 54.2 30.8 2976 11.1 16.9
Autism spectrum disordera
Yes 116 28.1 34.2 192 7.0 13.2
No 2922 64.3 33.6 3816 12.1 17.6
Epilepsya
Yes 1413 159.1 51.9 723 11.9 17.6
No 1625 40.0 28.8 3285 11.7 17.3
a Characteristic of adults with ID only. For definition of severe health needs see Chapter 2, Definition of severe health
needs, and Figure 5 for further details. For definition of communal accommodation see Chapter 2, Other subgroups of
interest, for further details.
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whether or not there were any differences in primary care utilisation between adults with ID and adults
without ID. Specifically, we sought whether or not these patients had consulted their GP during normal
operating hours or if they had an emergency encounter during this time. We included all Read codes that
indicated that the patient had been seen in the following locations: walk-in centre, out-of-hours service
and accident and emergency department. For those who consulted their GP during the 2-week period,
we then searched for the following: (1) any relevant diagnosis or suspected diagnosis, (2) an antibiotic
prescription (first-line antibiotics for UTI were defined as nitrofurantoin or trimethoprim, and for LRTI were
amoxicillin, clarithromycin, doxycycline or erythromycin) and (3) whether or not a urine test had been
performed (for UTI admissions only).
TABLE 31 Incidence rate ratios for emergency admissions for ACSCs during 2009–13 for adults with ID vs. controls
Characteristic
Base (unadjusted) model Adjusted modela
IRR (95% CI) p-valueb IRR (95% CI) p-valueb
All 5.62 (5.14 to 6.13) – 3.60 (3.25 to 3.99) –
Gender
Women 5.68 (5.03 to 6.42) 0.81 3.35 (2.87 to 3.91) 0.16
Men 5.56 (4.91 to 6.30) – 3.89 (3.39 to 4.46) –
Age (years) (at baseline)
18–34 7.12 (5.96 to 8.51) – 3.06 (2.47 to 3.79) –
35–54 6.34 (5.43 to 7.39) 0.34 3.25 (2.74 to 3.87) 0.67
55–84 4.56 (4.00 to 5.20) < 0.001 4.09 (3.52 to 4.76) 0.03
Down syndromec
Yes 10.00 (7.54 to 13.28) 0.001 8.28 (5.73 to 11.98) 0.002
No 5.26 (4.79 to 5.77) – 3.21 (2.88 to 3.58) –
Severe health needsc
Yes 10.31 (8.81 to 12.07) < 0.001 11.78 (9.78 to 14.19) < 0.001
No 4.40 (3.95 to 4.90) – 4.28 (3.80 to 4.81) –
Communal accommodationc
Yes 6.86 (5.78 to 8.14) 0.01 4.98 (4.01 to 6.20) 0.006
No 5.20 (4.70 to 5.76) – 3.35 (2.98 to 3.77) –
Autism spectrum disorderc
Yes 4.14 (2.94 to 5.83) 0.05 2.42 (1.54 to 3.81) 0.04
No 5.69 (5.20 to 6.23) – 3.69 (3.33 to 4.10) –
Epilepsyc
Yes 14.84 (12.59 to 17.49) < 0.001 16.77 (13.83 to 20.34) < 0.001
No 3.64 (3.29 to 4.03) – 3.46 (3.10 to 3.87) –
a Adjusted for nine comorbidities (atrial fibrillation, cancer, COPD, dementia, diabetes mellitus, epilepsy, heart failure,
severe mental illness and stroke), deprivation and smoking status, except for subgroup analysis for epilepsy and severe
health needs in which epilepsy is not included in the adjustment.
b p-value for differences between subgroups (for age: 18–34 years is taken as baseline group).
c Characteristic of adults with ID only. For definition of severe health needs see Chapter 2, Definition of severe health
needs, and Figure 5 for further details. For definition of communal accommodation see Chapter 2, Other subgroups of
interest, for further details.
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FIGURE 31 Emergency admissions for individual ACSCs during 2009–13 in (a) adults with ID and (b) controls.
GE, gastroenteritis.
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It was no longer possible to preserve any age, gender or practice matching in the comparison between
adults and controls with UTI (Table 33) and LRTI (Table 34) admissions. Therefore, in the logistic regressions,
which estimated separate ORs for consultation, diagnosis or antibiotic prior to admission, we directly
adjusted for age and gender differences between the two groups.
The pattern of primary care utilisation in the 2 weeks before a UTI admission is shown for 276 adults with ID
and 451 adults without ID (see Table 33). Adults with ID were more likely to be men (48.6% vs. 33.3%),
older (55.6% vs. 47.2% aged > 55.6 years) and at a high risk of a UTI (50.4% vs. 25.9%). However, both
groups had a similar proportion with a primary care consultation (about 56%) or an emergency encounter
(about 7%) in the 2-week period. The adjusted odds of a primary care consultation for adults with ID were
not significantly different (OR 1.04, 95% CI 0.77 to 1.40). For patients who did consult with their GP, adults
with ID were slightly less likely to receive a UTI diagnosis (14.1% vs. 17.9%), although this was not statistically
TABLE 32 Number and rate (per 1000 persons per year) of emergency admissions for individual ACSCs during
2009–13 among adults with ID and controls
ACSC
Adults with ID
(N= 16,666) Controls (N= 113,562)
Base (unadjusted)
model, IRR (95% CI)n
Rate per
1000 n
Rate per
1000
Angina 47 1.0 329 1.0 1.00 (0.60 to 1.68)
Aspiration 152 3.1 25 0.07 85.9 (45.3 to 162.9)
Asthma 91 1.8 233 0.7 2.84 (1.99 to 4.06)
Cellulitis 156 3.1 331 1.0 3.31 (2.56 to 4.28)
COPD 105 2.1 454 1.3 1.68 (1.04 to 2.70)
Congestive heart failure 44 0.9 156 0.5 2.21 (1.44 to 3.38)
Constipation 128 2.6 142 0.4 6.79 (5.17 to 8.91)
Convulsions/epilepsy 1081 21.8 256 0.8 31.2 (24.6 to 39.5)
Dehydration and gastroenteritis 141 2.9 224 0.7 4.71 (3.60 to 6.17)
Dental conditions 22 0.4 52 0.2 2.80 (1.67 to 4.71)
Diabetes complications 61 1.2 140 0.4 3.26 (1.90 to 5.58)
Ear, nose and throat 28 0.6 132 0.4 1.42 (0.93 to 2.17)
Gangrene 1 0.02 10 0.03 a
Gastro-oesophageal reflux disease 22 0.4 74 0.2 2.22 (1.35 to 3.67)
Hypertension 3 0.06 32 0.1 a
Influenza 8 0.2 18 0.05 a
Iron deficiency anaemia 21 0.4 40 0.1 3.97 (2.18 to 7.20)
Nutritional deficiencies 0 0 2 0.01 a
Pelvic inflammatory disease 5 0.1 26 0.08 a
Perforated/bleeding ulcer 10 0.2 20 0.06 3.78 (1.63 to 8.75)
Pneumonia and other LRTIs 566 11.4 772 2.3 5.59 (4.85 to 6.45)
Tuberculosis and other vaccine preventable 1 0.02 11 0.03 a
UTIs 345 7.0 528 1.5 4.76 (3.99 to 5.68)
a Not estimable owing to insufficient numbers.
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TABLE 33 Summary of health-care use in the 2 weeks prior to hospitalisation for all patients with a first emergency
admission for UTI during 2009–13
Characteristics
Adults with ID
(N= 276), n (%) Controls (N= 451), n (%)
Age (years)
18–34 43 (15.6) 123 (27.3)
35–54 77 (27.9) 115 (25.5)
55–84 156 (55.6) 213 (47.2)
Gender
Men 134 (48.6) 150 (33.3)
At high risk of UTIa
Yes 139 (50.4) 117 (25.9)
Category of health-care use
Consulted at general practice 156 (56.5) 251 (55.7)
Had emergency encounterb 19 (6.9) 32 (7.1)
Other recordc 70 (25.4) 85 (18.8)
No record 31 (11.2) 83 (18.4)
Details of GP consultation
All 156 251
Diagnosis recorded 22 (14.1) 45 (17.9)
Urine testedd 44 (28.2) 75 (29.9)
Antibiotics prescribed 62 (39.7) 115 (45.8)
None of the above 76 (48.7) 118 (47.0)
Type of antibiotics
All 62 115
First linee only 29 (46.8) 57 (49.6)
Other only 28 (45.2) 52 (45.2)
Front linee and other 5 (8.1) 6 (5.2)
Number of antibiotics
One antibiotic 55 (88.7) 94 (81.7)
More than one 7 (11.3) 21 (18.3)
a High-risk UTI patients had a history of specific kidney operations, UTIs, catheter or incontinence.
b Includes accident and emergency and out-of-hours visits.
c Other records are repeat prescriptions, administrative entries or routine specialist appointments.
d Urine tests include both immediate dipstick and non-immediate urine microscopy. Thirty-seven (84%) adults with ID and
62 (83%) adults without ID have urine microscopy.
e Nitrofurantoin and trimethoprim.
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TABLE 34 Summary of health-care use in the 2 weeks prior to hospitalisation for all patients with a first emergency
admission for pneumonia/LRTI during 2009–13
Characteristics
Adults with ID
(N= 457), n (%) Controls (N= 671), n (%)
Age (years)
18–34 84 (18.4) 81 (12.1)
35–54 145 (31.7) 194 (28.9)
55–84 228 (49.9) 396 (59.0)
Gender
Men 260 (56.9) 384 (57.2)
At high risk of admissiona
Yes 108 (23.6) 23 (3.4)
Category of health-care use
Consulted at general practice 277 (60.6) 368 (54.8)
Had emergency encounterb 27 (5.9) 39 (5.8)
Other recordc 97 (21.2) 131 (19.5)
No record 56 (12.3) 133 (19.8)
Details of GP consultation
All 277 368
Diagnosis recorded 60 (21.7) 80 (21.7)
Antibiotics prescribed 111 (40.1) 163 (44.3)
None of the above 151 (54.5) 187 (50.8)
Type of antibiotics 0.0 0.0
All 111 163
First lined only 65 (58.6) 113 (69.3)
Other only 32 (28.8) 34 (20.9)
First lined and other 14 (12.6) 16 (9.8)
Number of antibiotics
One antibiotic 88 (79.3) 130 (79.8)
More than one 23 (20.7) 33 (20.2)
a High-risk pneumonia/LRTI patients had a history or recurrent chest infections, pneumonitis, percutaneous endoscopic
gastrostomy feeding, prescriptions for food thickeners or having two or more chest infections in the preceding year.
b Includes accident and emergency and out-of-hours visits.
c Other records are repeat prescriptions, administrative entries or routine specialist appointments.
d Amoxicillin, clarithromycin, doxycycline and erythromycin.
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significant (OR 0.78, 95% CI 0.52 to 1.17). Similarly, adults with ID were less likely to be prescribed an
antibiotic (39.7% vs. 45.8%), but a statistical comparison of this difference was imprecise (OR 0.75, 95% CI
0.43 to 1.31).
For LRTI, 457 adults with ID with an admission were compared with 671 adults without ID (see Table 34).
Although both groups had a similar proportion of men, adults with ID were more likely to be younger
(18.4% vs. 12.1% aged 18–34 years) and far more likely to be at a high risk for a LRTI (23.6% vs. 3.4%).
The percentage of adults with ID consulting with their GP in the 2 weeks before admission was marginally
higher than among adults without ID (60.6% vs. 54.8%), although this difference was not formally
statistically significant (OR 1.26, 95% CI 0.99 to 1.60). Both groups had a similar proportion (about 6%)
with an emergency consultation in the 2-week period. Among patients with a consultation, an associated
LRTI diagnosis during this period was similar between the groups (both 21.7%; OR 0.99, 95% CI 0.68 to
1.45). Prescribing of an antibiotic was marginally lower for adults with ID (40.1% vs. 44.3%), but not
significantly different from that for controls (OR 0.84, 95% CI 0.61 to 1.15).
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Chapter 6 Health checks and hospital admissions
Introduction
In this chapter we present a robust observational methodology, using practice- and individual-level designs, to
assess whether or not the introduction of health checks in 2009 reduced emergency hospitalisation for adults
with ID. First, we compare practices with high participation in the DES with practices with low participation
in the DES, evaluating change in admission rates for all adults with ID, controlling for underlying differences
between practices. However, the possibility remains that practices participating in the DES improved the care
of their patients with ID independent of introducing the health checks. Therefore, we also present a matched
cohort study (Figure 32) comparing the change in admission rates of 7487 individual adults with ID who had
health checks with the change seen in the matched population controls without ID. This will account for any
secular trends in practice care or hospital admissions that may have taken place.
However, there is also a possibility that during our study there might have been underlying trends in
admissions specific to all patients with ID in England. Therefore, a second matched cohort study for adults
with ID not receiving health checks is used to confirm the specificity of findings to those having a health
check only. In Figure 32 the date of health check is replaced with a random index date based on the
known distribution of health check dates (see Figure 4).
Some of these results have already appeared in Carey et al.81 Published by the BMJ Publishing Group
Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/
company/products-services/rights-and-licensing/. This is an Open Access article distributed in accordance
with the terms of the Creative Commons Attribution (CC-BY 4.0) license, which permits others to distribute,
remix, adapt and build upon this work, for commercial use, provided the original work is properly cited.
See: http://creativecommons.org/licenses/by/4.0/. The text below includes minor additions and formatting
changes to the original text.
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FIGURE 32 Matched cohort design for individual health check analyses.
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Classification of practices
For the analysis carried out at practice level, we restricted to 289 practices with complete data from
1 January 2009 to 31 December 2012 (Figure 33). We then classified practice participation in the DES by
calculating the percentage of patients registered on 1 January 2009 on the QOF learning disability register
who subsequently received a health check by the end of 2010 or 2012. We defined full practice participation
as practices with ≥ 50% of their adults with ID having a health check by the end of 2010. A total of 126
out of 289 (43.6%) practices were classed as fully participating. Non-participating practices were defined as
practices with < 25% of their adults with ID having a health check by 2012, and 68 (23.5%) practices
satisfied this criterion. Finally, 95 practices satisfied neither criterion and were classed as partially participating,
having participation rates of ≥ 25% and < 50%. Of the 289 practices, 72 had zero participation by 2010,
which fell to 35 by 2012.
We were able to compare some practice characteristics of fully participating practices with those of non- or
partially participating ones. Practices located in the north or midlands of England were marginally more
likely to be classified as fully participating in health checks (48/102, 47.1%) than those located in the south
(78/187, 41.7%). Practices located in the most deprived fifth of IMD were similarly more likely to be fully
participating (25/60, 41.7%) than practices located in the least deprived fifth (15/44, 34.1%).
Participating practices with 
≥ 50% of adults with ID 
with health check by end of 2010
(n = 126)
Non-participating practices with 
< 25% of adults with ID with 
health check by end of 2012
(n = 68)
Practice-level analyses
(see Practice participation
in health checks and
hospital admissions)
Only practices with
complete data 
1 January 2009 to 
31 December 2012a
(n = 289)
Health check patients
adults with IDc with first health 
check during 2009–13 and
 46,408 matched controlsd
(n = 7487)
Non-health check patients adults 
with IDe with no health
check during 2009–13 and
47,662 matched controlsd
(n = 6922)
Individual-level analyses
(see Individual analyses of
health checks and hospital
admissions)
CPRD practices with 
HES data active on 
1 January 2009
(n = 343)
Partially participating practicesb
(n = 95)
FIGURE 33 Summary of health check analyses. a, 14,080 total adults with ID with ≥ 1 registered day in these
practices during 2009–12; b, practices with ≥ 25% and < 50% of adults with ID with health check by end of 2010,
or only achieves ≥ 50% during 2011–12; c, adults with ID must have been registered for 90 days prior to the health
check and have been alive from at least 90 days after it; d, controls subject to same criteria as above using their
case’s health check date as the index date; e, adults with ID without health checks were assigned an index date
using the distribution of known health check dates.
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We then compared the patient characteristics of practices fully participating in health checks with the patient
characteristics of those not participating, by first calculating the mean for a summary measure in each practice,
and then calculating the median value across all practices in each participation group (Table 35). For example,
for mean percentage of adults with ID registered on 1 January 2009 who had a health check by the end of
2010, among the median practice in the fully participating group, 69.5% of adults with ID had a health
check by that point. This compared with 0.0% of adults with ID in the median practice for non-participating
practices and 22.2% of adults with ID in in the median practice among partially participating practices. As the
percentage rose to 58.6% for the median practice among partially participating practices for health checks by
the end of 2012, we chose to keep these practices separate from the fully participating ones, as we wanted to
assess any effect from the early adoption of the scheme.
The median of the mean number of adults with ID registered on 1 January 2009 was higher among all
participating practices (38.0 patients) than among non-participating ones (26.5 patients). This may be
attributed to the former having a higher mean percentage of patients recorded living in shared or
communal establishments (median 15.8 vs. 5.9%). Practices fully participating in health checks tended to
have more patients with ID with severe health needs than those non-participating (median 22.2 vs.
15.2%). However, it may be that each of these measures reflects higher recording levels on the general
practice systems by more engaged staff in these participating practices.
TABLE 35 Summary of each practice’s population of adults with ID by overall practice-level participation in health
checks 2009–12
Characteristics of adults with ID
summarised at practice levela
Level of practice participation, median (IQR)
All (n= 289)
Non-
participatingb
(n= 68)
Partially
participatingb
(n= 95)
Fully
participatingb
(n= 126)
Total patients registered at any time during
2009–12,c n
43.0 (25.0–64.0) 36.0 (16.0–50.0) 46.0 (31.0–64.0) 45.0 (24.0–79.0)
Number of patients registered on 1 January
2009 only, n
34.0 (19.0–52.0) 26.5 (12.5–39.5) 34.0 (31.0–64.0) 38.0 (19.0–61.0)
With health check by end of 2010 (%) 43.1 (1.6–65.8) 0.0 (0.0–0.0) 22.2 (4.3–41.7) 69.5 (60.0–80.0)
With health check by end of 2012 (%) 66.7 (28.6–81.8) 0.0 (0.0–0.0) 58.6 (41.0–68.8) 81.8 (74.2–87.9)
Men (%) 57.6 (50.0–64.3) 55.6 (50.0–64.5) 58.3 (50.0–63.2) 57.5 (50.0–65.0)
Age (in 2009), mean 41.6 (38.7–44.8) 41.9 (38.9–45.8) 40.5 (37.5–43.8) 42.6 (39.4–45.0)
With severe health needsd (%) 18.8 (10.5–27.0) 15.2 (8.2–21.6) 17.4 (10.2–27.8) 22.2 (14.0–30.0)
Living in communal establishment
residenced (%)
9.7 (0.0–26.4) 5.9 (0.0–23.1) 8.6 (0.0–21.4) 15.8 (2.3–34.2)
With epilepsy (%) 17.1 (12.2–22.1) 16.3 (9.4–24.4) 16.7 (11.1–21.1) 18.3 (13.5–22.2)
IQR, interquartile range.
a Medians calculated among all adults with ID registered on 1 January 2009, except for ‘total registered during 2009–12’.
First, a mean is calculated at practice level, and then a median of the practice means is calculated.
b Fully participating practices had ≥ 50% of their adults with ID with a health check by the end of 2010. Non-participating
practices had < 25% of their adults with ID with a health check by the end of 2012. Ninety-five partially participating
practices did not meet either criterion.
c Patients who spent at least 1 day registered during 2009–12 (n = 14,080).
d For definition of severe health needs, see Chapter 2, Definition of severe health needs, and Figure 5 for further details.
For definition of communal accommodation, see Chapter 2, Other subgroups of interest, for further details.
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Practice participation in health checks and hospital admissions
A summary of hospital admissions (all emergency, emergency ACSCs and elective) among adults with ID
during 2009–12 is shown in Figure 34. In each plot the admission rate per quarter has been calculated by
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FIGURE 34 Hospital admissions in each quarter during 2009–12 by practice level of participation in health checks.
(a) All emergency admissions; (b) emergency ACSCs admissions only; and (c) elective admissions.
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dividing the total admissions during that quarter by the total registration time from those patients. Unlike
analyses presented elsewhere in this report, these plots include patients with no minimum registration
period, and include a total of 14,080 adults with ID who were registered at any time during 2009–12
irrespective of whether or not they received a health check. For elective admissions, we excluded the small
number of patients who had abnormally high elective admissions rates in any period (see Chapter 5,
Categorising admissions). The data are then analysed in Table 36, in which two periods are now considered,
2009–10 and 2011–12, and annual rates have been calculated. The effect of practice participation on
hospital admissions has been estimated by the interaction IRR between practice participation (fully vs. none)
and period (2011–12 vs. 2009–10) in a conditional Poisson model (see Chapter 2, Statistical analysis).
Emergency admission rates calculated in each quarter (see Figure 34) tended to fall over time in all practice
participation categories. This is summarised annually in Table 36 as a fall from 191.1 per 1000 adults per
year in 2009–10 to 176.7 in 2011–12. Non-participating health-check practices had consistently higher
emergency admission rates throughout than practices that were fully participating (see Figure 34), with
both groups of practices experiencing a similar fall over time (IRR 0.97, 95% CI 0.78 to 1.19).
When emergency admissions for only ACSCs were considered, the pattern was different (see Figure 34
and Table 36). Although these admissions had fallen among those practices fully participating in health
checks (69.2 in 2009–10 to 56.3 in 2011–12 per 1000 adults), this was not replicated in practices not
participating in health checks (70.1 in 2009–10 to 77.1 in 2011–12 per 1000 adults). A statistical
comparison of the difference in this change showed an overall benefit of greater practice participation
(IRR 0.74, 95% CI 0.58 to 0.95). There was no evidence of any difference in the change over time in
elective admissions between fully and non-participating practices (IRR 1.02, 95% CI 0.84 to 1.25).
TABLE 36 Hospital admissions in 2011–12 vs. 2009–10 by practice level of participation in health checks
Level of practice
participation
2009–10 admissions,
rate per 1000
person-years
2011–12 admissions,
rate per 1000
person-years
Period change,
IRRa (95% CI)
Fully vs. non-
participating
period change,
IRRb (95% CI)
All (n= 289)
All emergency
admissions
191.1 176.7 0.92 (0.86 to 0.99) –
Emergency ACSCs only 64.9 58.6 0.91 (0.82 to 1.00) –
All elective admissionsc 117.1 119.2 1.02 (0.95 to 1.09) –
Fully participating (n= 126)
All emergency
admissions
183.6 160.6 0.88 (0.80 to 0.96) 0.97 (0.78 to 1.19)
Emergency ACSCs only 69.2 56.3 0.82 (0.72 to 0.92) 0.74 (0.58 to 0.95)
All elective admissionsc 112.4 114.0 1.02 (0.92 to 1.14) 1.02 (0.84 to 1.25)
Non-participating (n = 68)
All emergency
admissions
226.9 205.3 0.90 (0.75 to 1.09) 1.00 (Baseline)
Emergency ACSCs only 70.1 77.1 1.10 (0.89 to 1.36) 1.00 (Baseline)
All elective admissionsc 125.9 127.3 1.00 (0.85 to 1.19) 1.00 (Baseline)
a This represents the within-practice change in admission post health check compared with pre health check estimated
from conditional Poisson model.
b This represents the within-practice post health check change in admissions between the fully participating practices and
the non-participating practices estimated from conditional Poisson model.
c Patients with abnormally high elective rates were excluded (average > 6 per year).
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Alternative modelling approaches provided similar findings. For example, a fixed-effects (conditional)
negative binomial showed no trend with all emergency ACSCs (IRR 0.98, 95% CI 0.82 to 1.18), but
reduced change with emergency ACSCs (IRR 0.76, 95% CI 0.59 to 0.98).
Assigning an index date to adults with intellectual disability
without health checks
We now consider analyses based on 7487 individuals with a first health check between 1 April 2009 and
31 March 2013. As explained previously in Chapter 2 (see Identification of health checks), we also include
in our analyses 6922 adults with ID who did not receive a health check during this period but were
assigned a random index date. We could then analyse this group in a complementary analysis to ensure
that any findings from our study are specific to adults with ID with health checks and not due to
underlying trends in hospital admissions in the population of adults with ID that might have taken place
during our study period.
Briefly, this matching involved assigning a random date based on the known distribution of health checks
between 1 April 2009 and 31 March 2013 in our data (Figure 35). For this, we used the dates from 7831
individuals with health checks we originally identified (344 of these individuals had subsequently been
Patients with health checks
All adults with ID with first
health check 1 April 2009 
to 31 March 2013
(n = 7831)
Health check patients
(n = 7487) 
Aged 18–84 years at time
of check and registered 
for 90 days prior to health
check and alive at least 
90 days after it
Patients without health checks
Randomly assign 
date of health check
Non-health check patients
(n = 6922) 
Adults with ID with no 
health check during 
2009–13 and still registered 
on index date of 
health check
All adults with ID aged 
18–84 years without first 
health check 1 April 2009
to 31 March 2013
(n = 7751)
Matched
(n = 7050)
Assigned an 
index date
Excluded
(n = 344)
Fails data, age or
registration criteria
Non-matches
(n = 701)
All possible date
matches exhausted
Excluded
(n = 128)
Fails data, age or
registration criteria
FIGURE 35 Summary of date matching between adults with ID with and without health checks.
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excluded owing to age, registration or data criteria). These dates were then randomly assigned to the 7751
adults without health checks, who we had identified as being potentially eligible for our analyses. This was
achieved by iteratively sampling (without replacement) from the pool of 7831 dates. For a date match to
be successful, the adult without the health check had to be alive and registered for at least 90 days on the
potential index date. Unsuccessful date matches were returned to the pool of matching dates, until no
more matches were possible.
At the end of this process, 7050 (91%) successful date matches were assigned. Among this group,
58% of index dates were in 2009 or 2010, compared with 59% among the 7487 individuals with health
checks. Most rejections were due to the patient only being registered for a short period, or only being age
eligible (i.e. 18 years old) in 2013. A further 128 patients were rejected after the date assignment, mainly
as a result of insufficient follow-up of 90 days that we required. This left 6922 adults without a health
check with an assigned index date that we could use in the complementary analyses of health checks,
which also used their 47,622 matched population controls.
Individual analyses of health checks and hospital admissions
A comparison of adults with ID with (n = 7487) and without (n = 6922) health checks is summarised in
Table 37. Although the two groups had a similar gender distribution (58% men), adults with ID with
health checks were notably older (mean age 42.6 vs. 39.0 years). More than one in four adults with ID
with a health check were classed as having severe health needs (27.2%) or living in a communal
establishment (25.6%). These proportions were much higher than those recorded in those without health
checks (12.9% and 11.7%, respectively). The mean follow-up time was similar in both groups [adults with
ID with health check, 560 days (pre) and 1081 days (post); adults with ID without health check, 521 days
(pre) and 1059 days (post)].
Hospital admission rates (all emergency, emergency ACSCs and elective) before and after the health check
are summarised in Table 38. Four groups are shown: adults with ID with and without health checks (using
their random index date), and the matched controls for each of these two groups. Conditional Poisson
models were used to estimate the IRR for period and interaction effects (see Chapter 2, Statistical analysis).
This model was first fitted to adults with ID with a health check and their controls separately, estimating
the individual change in hospital admission rate after as compared with before health check (or index
date). A combined model of adults with ID and controls with a case–period interaction then provided an
estimate for the effect of health checks (or index dates) on admission rates among adults with ID, adjusted
for any temporal trends in admissions. The process was then repeated using the adults with ID without
health checks and their controls.
For the 7487 adults with a health check, all emergency admissions rose by 22% from 145.7 to 173.2
annually per 1000 persons (IRR 1.22, 95% CI 1.11 to 1.34). By contrast, in their 46,408 matched controls
the rate for all emergency admissions increased by 27%, from 58.6 to 70.1 (IRR 1.27, 95% CI 1.20 to 1.34).
Therefore, in the combined Poisson model, the interaction for the impact of health checks on adults with ID
is estimated to be < 1 (IRR 0.96, 95% CI 0.87 to 1.07). Adults with ID without health checks had higher
overall admission rates for emergency admission (e.g. 186.0 vs. 145.7 annually per 1000 persons pre index
date) and a slight subsequent increase in admission rate post index date relative to their controls (IRR 1.05,
95% CI 0.94 to 1.17).
Although emergency admissions for ACSCs among adults with ID with health checks also showed a rise
post health check (52.4 to 59.3 per 1000 persons per year), this change was smaller than that seen in the
control group (11% vs. 35%). The combined Poisson model produced a statistically significant interaction
(IRR 0.82, 95% CI 0.69 to 0.99), which represents the change in admission rate post health check
compared with controls. This interaction effect and trend was not replicated in adults with ID without a
health check (IRR 1.11, 95% CI 0.92 to 1.36).
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For elective hospital admissions, the estimated post health check was similar between adults with ID with
health checks and controls (IRR 0.96, 95% CI 0.87 to 1.06). There was some evidence that elective
admissions among adults with ID without health check had shown a reduced change compared with their
controls (IRR 0.90, 95% CI 0.81 to 1.00) after their assigned index date.
We carried out sensitivity analyses using a different statistical modelling approach that directly compared
the change in admissions between adults with ID with health checks and those without health checks
(see Chapter 2, Statistical analysis). The models accounted for underlying differences between the two
unmatched groups by adjusting for age, gender and comorbidity. The Poisson and negative binomial
models produced similar findings to our previous approach. For example, for the negative binomial models
the interaction IRRs were all emergency admissions (IRR 1.04, 95% CI 0.90 to 1.19), emergency ACSCs
(IRR 0.80, 95% CI 0.66 to 0.99) and elective admissions (IRR 1.03, 95% CI 0.90 to 1.17).
TABLE 37 Characteristics of adults with ID with and without health checks between April 2009 and March 2013
used in hospital admissions analysis
Characteristic
Adults with ID with health
check (N= 7487), n (%)
Adults with ID without health
check (N= 6922), n (%)
Gender
Women 3183 (42.5) 2889 (41.7)
Men 4304 (57.5) 4033 (58.3)
Age (years) (at health check)
18–34 2579 (34.5) 3159 (45.6)
35–54 3136 (41.9) 2432 (35.1)
55–84 1772 (23.7) 1331 (19.2)
Down syndrome
Yes 914 (12.2) 639 (9.2)
No 6573 (87.8) 6283 (90.8)
Severe health needsa
Yes 2035 (27.2) 891 (12.9)
No 5452 (72.8) 6031 (87.1)
Communal accommodationa
Yes 1913 (25.6) 811 (11.7)
No 5574 (74.5) 6111 (88.3)
Autism spectrum disorder
Yes 743 (9.9) 499 (7.2)
No 6744 (90.1) 6423 (92.8)
Epilepsy
Yes 1552 (20.7) 975 (14.1)
No 5935 (79.3) 5947 (85.9)
a For definition of severe health needs, see Chapter 2, Definition of severe health needs, and Figure 5 for further details.
For definition of communal accommodation, see Chapter 2, Other subgroups of interest, for further details.
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Table 39 summarises the estimate of the impact of health checks on emergency hospital admissions,
stratified by individual characteristics for both adults with ID with and adults with ID without health checks.
These are the case–period interaction IRRs from the conditional Poisson models fitted to each group
separately. A significant rise in admissions was seen among adults with Down syndrome with health
checks compared with their population controls (IRR 1.55, 95% CI 1.15 to 2.08). However, this increase
was replicated among adults with Down syndrome without health checks (IRR 1.55) compared with their
controls, suggesting a trend specific to adults with Down syndrome. By contrast, although health checks
were associated with a smaller change in emergency admissions among adults with ID with severe health
needs compared with their controls (IRR 0.80, 95% CI 0.67 to 0.95), this trend was not replicated in adults
with ID without health checks with severe health needs compared with their controls (IRR 1.07, 95% CI
0.85 to 1.35). A further analysis of adults with ID with severe health needs receiving health checks also
suggested a decrease in their emergency admissions for ACSCs compared with controls (IRR 0.76, 95% CI
0.56 to 1.01).
TABLE 38 Comparison of hospital admission rates during 2009–13 in adults with ID and controls pre and post
health check, or index date for those without health checks
Patient group and health
check status
Pre health check,
rate per 1000
person-years
Post health check,
rate per 1000
person-years
Period change, IRRa
(95% CI)
Fully vs. non-
participating
period change,
IRRb (95% CI)
Adults with ID with health check (n= 7487)
All emergency admissions 145.7 173.2 1.22 (1.11 to 1.34) 0.96 (0.87 to 1.07)
Emergency ACSCs only 52.4 59.3 1.11 (0.95 to 1.29) 0.82 (0.69 to 0.99)
All elective admissionsc 115.9 122.4 1.11 (1.01 to 1.21) 0.96 (0.87 to 1.06)
Adults with ID without health check (n= 6922)
All emergency admissions 186.0 212.2 1.20 (1.09 to 1.32) 1.05 (0.94 to 1.17)
Emergency ACSCs only 52.7 66.7 1.35 (1.14 to 1.60) 1.11 (0.92 to 1.36)
All elective admissionsc 119.1 128.4 1.02 (0.93 to 1.12) 0.90 (0.81 to 1.00)
Controls for ID with health check (n = 46,408)
All emergency admissions 58.6 70.1 1.27 (1.20 to 1.34) –
Emergency ACSCs only 9.5 12.9 1.40 (1.24 to 1.58) –
All elective admissionsc 102.4 121.3 1.15 (1.11 to 1.20) –
Controls for ID without health check (n = 47,662)
All emergency admissions 56.9 66.1 1.15 (1.09 to 1.21) –
Emergency ACSCs only 8.5 11.0 1.28 (1.14 to 1.44) –
All elective admissionsc 88.4 106.2 1.13 (1.09 to 1.18) –
a This represents the within-person change in admission post health check compared with pre health check estimated
from conditional Poisson model.
b This represents the within-person post-health-check change in admissions between the patients with ID and their
respective controls estimated from conditional Poisson model.
c Patients with abnormally high elective rates were excluded (average > 6 per year).
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TABLE 39 Interaction IRRs comparing the change in emergency hospital admission rates during 2009–13 post
health check between adults with ID and matched controls stratified by individual characteristics
Characteristic
Adults with ID with health
check (n= 7487), IRR (95% CI)
Adults with ID without health
check (n= 6922), IRR (95% CI)
Gender
Women 1.07 (0.92 to 1.25) 1.13 (0.95 to 1.34)
Men 0.88 (0.76 to 1.01) 0.98 (0.85 to 1.13)
Age (years) (at health check)
18–34 1.01 (0.81 to 1.25) 0.97 (0.80 to 1.16)
35–54 0.95 (0.80 to 1.13) 1.12 (0.92 to 1.34)
55–84 0.96 (0.81 to 1.14) 0.96 (0.78 to 1.18)
Down syndrome
Yes 1.55 (1.15 to 2.08) 1.55 (1.08 to 2.22)
No 0.91 (0.82 to 1.02) 1.01 (0.90 to 1.14)
Severe health needsa
Yes 0.80 (0.67 to 0.95) 1.07 (0.85 to 1.35)
No 1.06 (0.93 to 1.22) 1.03 (0.90 to 1.17)
Communal accommodationa
Yes 1.13 (0.92 to 1.38) 1.22 (0.92 to 1.62)
No 0.91 (0.80 to 1.03) 1.02 (0.90 to 1.15)
Autism spectrum disorder
Yes 1.18 (0.76 to 1.82) 1.25 (0.75 to 2.08)
No 0.95 (0.85 to 1.05) 1.04 (0.93 to 1.16)
Epilepsy
Yes 0.88 (0.73 to 1.07) 1.17 (0.91 to 1.49)
No 1.03 (0.90 to 1.17) 1.01 (0.89 to 1.15)
a For definition of severe health needs, see Chapter 2, Definition of severe health needs, and Figure 5 for further details.
For definition of communal accommodation, see Chapter 2, Other subgroups of interest, for further details.
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Chapter 7 Who gets health checks and what
is recorded?
Introduction
The final part of the analysis in the report considers two further questions: (1) what gets recorded on a
patient’s electronic record during a health check and (2) what predicts who gets a health check?
To answer these questions, we focused on health checks that took place during 2009–11, only including 274
practices that had a minimum involvement (≥ 20% of registered patients with ID with a health check) in the
DES (see Figure 3). We also required patients to be registered at the beginning of follow-up (1 January 2009)
for at least 1 year, thereby ensuring that these health checks were not being performed on recently registered
patients. This identified 5583 first health checks on established patients with ID, from which we summarised
what was being electronically recorded on their record around the time of the check (Figure 36).
Estimated impact of
health check on recording 
(adjusted for age and sex)
Ri1 = 2006–08
rate/recording
Ri2 = 2009–11
rate/recording
Adults with ID 
with checks
(n = 5026)
Adults with ID 
without checks
(n = 2728)
Ri3 = 2006–08
rate/recording
Ri4 = 2009–11
rate/recording
Comparison with patients
without checks and analysis 
of what predicts checks
Adults with ID with health 
checks (in practices with 20%)
(n = 5583)
2009 2011
Only patients registered
throughout 2009–11
Description of health
checks contents and 
duration
n = 274 practices with
≥20% of registered patients 
with ID with a health check
Change in rate
= Ri2/Ri1
Change in rate
= Ri4/Ri3
FIGURE 36 Summary of cohort design for analyses investigating impact of health checks on recording of
health measures.
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We then estimated what difference the health check had made to the overall recording of some selected
process measures by further restricting to the 5026 patients with health checks who were still registered at
31 December 2011. This allowed a comparison of two distinct periods (see Figure 36): one before health
checks were introduced (2006–8) and one during the period when the check took place (2009–11). The
change in their records between these two periods was then contrasted with the records of 2728 adults
with ID from the same practices who did not get a health check during 2009–11. Finally, we present an
analysis that investigates which factors, if any, predict who from this combined group of 7754 adults with
ID received a health check during 2009–11.
The characteristics of the three groups of adults with ID used in the analyses described above are given
in Table 40. As described previously (see Table 37), patients with and without health checks differ
significantly with respect to severe health needs, epilepsy and living arrangements.
TABLE 40 Characteristics of adults with ID with and without health checks between January 2009 and December
2013 used in descriptive analysis
Characteristic
First health check during 2009–11, n (%) No health check during 2009–11, n (%)
All patients Registered 2009–11 Registered 2009–11
All 5583 (100) 5026 (100) 2783 (100)
Gender
Women 2404 (43.1) 2153 (42.8) 1116 (40.9)
Men 3179 (56.9) 2873 (57.2) 1612 (59.1)
Age (years) (at health check)
18–34 1578 (28.3) 1489 (29.6) 1053 (38.6)
35–54 2555 (45.8) 2351 (45.8) 1127 (41.3)
55–84 1450 (26.0) 1186 (23.6) 548 (20.1)
Down syndrome
Yes 725 (13.0) 644 (12.8) 219 (8.0)
No 4858 (87.0) 4382 (87.2) 2509 (92.0)
Severe health needsa
Yes 1485 (26.6) 1336 (26.6) 388 (14.2)
No 4098 (73.4) 3690 (73.4) 2340 (85.8)
Communal accommodationa
Yes 1766 (31.6) 1551 (30.9) 245 (9.0)
No 3817 (68.4) 3475 (69.1) 2483 (91.0)
Autism spectrum disorder
Yes 457 (8.2) 401 (8.0) 127 (4.7)
No 5126 (91.8) 4625 (92.0) 2601 (9.5)
Epilepsy
Yes 1201 (21.5) 1080 (21.5) 372 (13.6)
No 4382 (78.5) 3946 (78.5) 3946 (86.4)
a For definition of severe health needs, see Chapter 2, Definition of severe health needs, and Figure 5 for further details.
For definition of communal accommodation, see Chapter 2, Other subgroups of interest, for further details.
WHO GETS HEALTH CHECKS AND WHAT IS RECORDED?
NIHR Journals Library www.journalslibrary.nihr.ac.uk
94
What is recorded during a health check?
To investigate what was being recorded during the 5583 first health checks carried out between 2009 and
2011, we extracted all information 14 days either side of the recorded date of the health check. Although the
majority of information was being recorded on the date of the health check, by allowing 2 weeks either side
of this date we were able to account for (1) health checks that took place across multiple days and (2) results
of tests that were apparent on the system only after the check had taken place.
We then attempted to summarise the total information recorded by identifying common categories that
were being used (Table 41). These categories were defined to be as broad as possible to try to capture
whether a specific health area or concern had been addressed during the check. So, for example, the
category ‘alcohol’ would count Read codes estimating alcohol consumption as well as any codes around
lifestyle advice in relation to alcohol. ‘Ears’ would cover hearing tests and assessments, examination or
symptoms of the ears and whether or not they had been seen by an audiologist. In the end we identified
22 common categories (see Table 41) that we thought were applicable to all adults with ID. A further five
categories (medication review, breast examination, cervical smear, epilepsy and influenza vaccination) were
summarised for specific subgroups only. A list of the Read codes used is given in Appendix 9.
We also observed a pattern associated with health checks in some practices where there was consistently
little or no recorded information on the electronic patient record around the time of the check. We think
that these checks are probably being performed away from the GP surgery, as this absence of informative
recording was more common in practices with large clusters of adults with ID living in communal or shared
accommodation. We do not necessarily believe that no tests or examinations are being carried out in these
checks, but can only summarise them as being ‘non-informative’ based on what was recorded in the
patient electronic record. We automated identification of these as those in which none of the top 10
categories listed in Table 41 were being recorded. A total of 458 (8.2%) checks were identified as
‘non-informative’.
The most common category of recorded information during the health check was weight or BMI related,
for which 4323 health checks had related information (see Table 41). This represented 77.4% of all
2009–11 health checks, or 84.4% of the 5125 ‘informative’ health checks only. This was followed by
blood pressure, alcohol, smoking and mobility, for all of which related information was given in more than
half of the health checks. Only 4 in 10 health checks (40.6%) had a record of a health action plan being
offered, declined, reviewed or completed. Only a small proportion (< 15%) of health checks had recorded
information relating to mental health and bowels or bladder.
Across practices, there was considerable variation in the volume of recorded information around the time
of the health checks. Among the 22 common categories identified from Table 41, 49 (18%) of the 274
practices had health checks that averaged fewer than six categories. By contrast, 53 (19%) had health
checks that averaged more than 12 different categories being recorded.
Recorded length and general practitioner involvement in health checks
We sought to determine the length of the health check and summarise who was involved in carrying it
out. To do this, we first excluded the 458 non-informative health checks, as our assumption was that the
lack of electronic information on the system reflected that these checks that were primarily taking place
outside the GP surgery. From the remaining checks, we further excluded 179 with missing or zero duration
length, which resulted in 4946 health checks. We then identified the singular day on which the majority of
the top 10 categories listed in Table 41 appeared. In the rare event of a tie, we used the date on which
the Read code for the health check appeared.
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TABLE 41 Most frequently recorded health categories identified at time of first health check between January
2009 and December 2011
Category identified Details n (%)
Top 10 categories
Weight/BMI Measured, gain/loss, BMI measured, health education/
weight management/advice
4323 (77.4)
Blood pressure Measured 4279 (76.6)
Alcohol Consumption, advice/counselling, screen, intervention 3952 (70.8)
Smoking Tobacco consumption, health education/advice 3334 (59.7)
Mobility How mobile, assessment, walking aid 3099 (55.5)
Ears Hearing, blocked/waxy ears, seen by audiologist 3060 (54.8)
Eyes Visual symptoms, wears glasses, examination,
ophthalmological monitoring, normal vision
2949 (52.8)
Carer Details, paid/voluntary, does not have carer 2535 (45.4)
Pulse Measured/examined 2396 (42.9)
Height Measured 2385 (42.7)
Other common categories
Health action plan Offered, declined, reviewed or completed 2269 (40.6)
Behaviour Problems, change, assessment 2056 (36.8)
Dental Dental examination, advice, seen by dentist 2027 (36.3)
Communication Speech, writing, responding 1733 (31.0)
Exercise How much, able to exercise, health education/advice 1522 (27.3)
Diet Diet, allergies, appetite, advice/health education 1512 (27.1)
Blood test Taken, requested or results recorded 1503 (26.9)
Urine test Obtained, sent to laboratory, dipstick, results recorded 1393 (25.0)
Mental health Symptoms/none, mood, depression screening, mental
health review
772 (13.8)
Bowels and bladder Health education, continence, catheter, assessment 739 (13.2)
Respiratory Examination, rate of respiration, breath sounds,
respiratory flow rates
664 (11.9)
Sexual related Sexually active, contraception, health education 587 (10.5)
Specific subgroupsa
Medication review (on repeat
medication)
Medication monitoring, medication review, epilepsy
(and others) medication
1123 (26.1)
Breast examination (women) Examination/self-examination, mammography 493 (20.5)
Cervical smear (women) Given, offered, refused, not indicated 404 (16.8)
Epilepsy (epilepsy prior to 2009) Monitoring, fit frequency, last fit, seizure free 537 (44.7)
Influenza vaccination (health
check September–January only)
Given 387 (19.1)
a Denominators for subgroups: medication review, n = 4297; breast/cervical smear, n= 2404; epilepsy, n= 1201; and
influenza vaccination, n= 2028.
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Of the 4946 health checks recorded during 2009–11 containing informative electronic information on
duration, approximately half (n = 2464, 49.8%) appeared to be conducted solely by the GP. A further 686
(13.9%) had information indicating both GP and nurse involvement, whereas 1287 checks (26.1%) had
only nurse involvement indicated. For about 1 in 10 checks (n = 509, 10.3%) neither a GP nor a nurse was
directly recorded, with ‘administrator’ being the most common role indicated. Across subgroups (Figure 37),
the percentage with GP involvement in the health check remained around 6 in 10 for most categories.
Of the 4946 health checks with duration recorded, about 3 in 10 (n = 1399, 28.3%) were estimated to
be > 30 minutes in duration for the singular day that contained the most information recorded. Across
subgroups (see Figure 37), the largest variation in duration was by living arrangement. Here, adults with
ID living in communal or shared accommodation were recorded as less likely to have a check lasting
30 minutes (19.3%) than those not recorded as such (32.2%).
Women
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FIGURE 37 Percentage of first health checks during 2009–11 that involved a GP and were > 30 minutes’ duration
by subgroups.
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Process measures before and after health checks
Using the identified categories from Table 41, we now wished to summarise the added benefit of health
checks in reference to how the information was recorded prior to the introduction of health checks. To do
this, we compared the recording of these categories during 2006–8 versus 2009–11 for the 5026 adults
with ID who received a health check during 2009–11 in practices that had a minimum level (20%) of
participation in the DES. We contrasted the absolute change in recording with the corresponding one seen
in the 2728 adults with ID from the same set of practices who did not receive a check during this time
(see Figure 36). This is summarised in Table 42.
The biggest impact that health checks had was on the recording of health issues regarding mobility (+67.3%
difference), eyes (+60.1%), carer details (+59.8%) and ears (58.3%). Prior to health checks there had been
minimal information on mobility or carer details, with < 5% of patients having any associated information for
these categories. Although adult patients who did not receive a health check up to the end of 2011 had
significant increases in all these categories differences ranging from +9% to +10%, the level of change was
much smaller than for patients with health checks. Other categories for which the observed change differed
notably between these groups of patients were alcohol, pulse, dental, behaviour and communication.
Categories for which the health check appeared to have minimal impact on recording over time were
mental health and medication review. During 2009–11, only one in three (35.7%) adults with ID who
received a health check had any recording concerning mental health. Although we have identified data
issues regarding the completeness of medication reviews on the system (see Chapter 2, Missing entity data
in the Clinical Practice Research Datalink), the observed change in recording was similar (+4%) between
patients with and patients without health checks.
Vaccination rates for influenza among adults with ID with health checks improved from 49.7% to 60.6%, an
increase (+10.9%) that was not notably different from that in those without checks (+7.2%). However, overall
coverage was much higher among those with health checks (60.6% vs. 37.7% in 2009–11), due in part to
greater health needs among those with checks (e.g. 27% vs. 14% for severe health needs; see Table 40).
Diagnoses, consultations and prescribing before and after health checks
We now investigated whether or not the introduction of health checks had an impact on the diagnosing of
common QOF conditions over time. This was done by comparing the change in prevalence rates for selected
QOF conditions from 2006–8 to 2009–11 for the 5026 adults with ID who received a health check during
2009–11 (which, by definition, has to be positive) with the change in prevalence in the 2728 adults with
ID without a health check during this time (see Figure 36). There was no consistent pattern in the increase
in prevalence between the groups, with both groups showing an absolute increase of 1–2% for most
conditions (Table 43). The most notable disparity was for a diagnosis of depression, for which patients with ID
without health checks had a greater increase (+2.41%) than patients with ID with health checks (+1.59%).
Figure 38 shows the percentage of patients in 2008 and 2011 with a consultation, a prescription (any,
repeats only or psychotropic only) and any referrals made in primary care in 2008 and 2011, by whether or
not they received a health check during 2009–11.
There were clear baseline differences between the two groups in 2008, whereby adults with ID who
would go on to receive a health check were already more likely to consult in the year (87.2% vs. 78.7%)
or receive any prescription (87.6% vs. 77.0%). By 2011, both groups showed small increases over time,
which were generally higher in the health checks group. For example, the percentage of patients with a
consultation (not counting the health check itself) increased from 87.2% to 90.2% in the health checks
group, compared with 78.7% to 79.8% in the non-health checks group. The percentage of patients with
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TABLE 42 Change in frequently recorded health categories between 2006–8 and 2009–11 in adults with ID with
and without health checks between January 2009 and December 2011
Category identified
Adults with ID with health check
2009–11 (n= 5026)
Adults with ID without health check
2009–11 (n= 2728)
% 2006–8 % 2009–11 ± change % 2006–8 % 2009–11 ± change
Top 10 categories
Weight/BMI 59.9 95.3 +35.4 50.7 54.8 +4.1
Blood pressure 69.8 95.3 +25.6 60.3 64.4 +4.1
Alcohol 38.8 89.9 +51.1 34.3 40.2 +5.9
Smoking 73.8 92.4 +18.5 69.9 72.4 +2.5
Mobility 4.8 72.1 +67.3 3.3 12.2 +8.9
Ears 17.3 75.6 +58.3 11.1 20.7 +9.6
Eyes 14.4 74.6 +60.1 11.1 21.0 +9.9
Carer 3.4 63.2 +59.8 2.6 11.6 +9.0
Pulse 16.1 67.4 +51.3 14.0 25.6 +11.7
Height 35.4 65.4 +30.0 30.6 27.6 –3.1
Other common categories
Health action plan 1.8 60.0 +58.2 1.5 13.5 +12.0
Behaviour 4.6 53.5 +48.9 2.3 8.9 +6.6
Dental 1.6 53.6 +52.0 0.8 8.7 +7.9
Communication 0.9 44.5 +43.6 0.5 5.3 +4.8
Exercise 21.9 46.4 +24.6 20.2 20.7 +0.5
Diet 24.2 47.1 +22.9 19.0 21.5 +2.5
Blood test 62.3 77.6 +15.4 51.8 58.7 +6.9
Urine test 39.0 58.7 +19.6 30.8 32.4 +1.6
Mental health 29.2 35.7 +6.6 22.5 26.3 +3.8
Bowels and bladder 15.3 30.2 +14.9 11.7 13.4 +1.7
Respiratory 11.6 25.0 +13.4 12.9 15.0 +2.1
Sexual related 7.9 21.0 +13.1 8.8 10.7 +1.9
Specific subgroupsa
Medication review 60.7 65.1 +4.4 46.6 50.8 +4.2
Breast examination 8.6 41.8 +33.2 9.1 14.0 +4.9
Cervical smear 52.7 65.5 +12.8 50.0 54.7 +4.7
Epilepsy 96.9 98.6 +1.7 97.3 96.8 –0.5
Influenza vaccination 49.7 60.6 +10.9 30.5 37.7 +7.2
a Denominators for subgroups medication review and influenza vaccination are now based on all patients. However,
cervical smear and breast examination are based on 2153 women with health checks and 1116 women without health
checks. Epilepsy is based on 1080 patients with health checks and 372 patients without health checks.
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TABLE 43 Change in prevalence of selected QOF conditions between 2006–8 and 2009–11 in adults with ID with
and without health checks between January 2009 and December 2011
Category identified
Adults with ID with health check
2009–11 (n= 5026)
Adults with ID without health check
2009–11 (n= 2728)
% 2006–8 % 2009–11 ± change % 2006–8 % 2009–11 ± change
Diabetes 6.03 7.54 +1.51 5.61 7.29 +1.68
Hypertension 10.07 12.14 +2.07 11.07 12.83 +1.76
Chronic kidney disease 2.43 3.94 +1.51 2.27 3.48 +1.21
Hyperthyroidism 8.81 10.27 +1.46 5.50 6.67 +1.17
IHD 0.99 1.49 +0.50 2.02 2.46 +0.44
Osteoporosis 1.37 2.03 +0.66 1.25 1.72 +0.47
Depression 15.10 16.69 +1.59 17.16 19.57 +2.41
Severe mental illness 7.86 8.50 +0.64 6.23 6.78 +0.55
Epilepsy 26.34 27.12 +0.78 18.15 18.73 +0.58
COPD 0.44 0.80 +0.36 1.32 1.80 +0.48
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FIGURE 38 Percentage of patients with consultations, prescriptions and referrals in 2008 and 2011 in adults with ID
with and adults with ID without health checks 2009–11.
WHO GETS HEALTH CHECKS AND WHAT IS RECORDED?
NIHR Journals Library www.journalslibrary.nihr.ac.uk
100
a referral rose from 16.0% to 20.3% for those with health checks, compared with an increase from
15.1% to 16.9% for those without health checks.
We also compared the recording of being seizure free for patients with ID with epilepsy before and after
health checks. During 2006–8, 632 of 1080 (58.5%) were seizure free, a figure that rose to 694 of 1080
(64.3%) during 2009–11. This is an absolute increase of 5.8% compared with a 2.7% increase in 372
epilepsy patients without health checks over the same period (which rose from 55.9% to 58.6%).
Finally, we compared the mean level of consultations, prescribing and referrals (made within primary care)
in 2008 and 2011, and the associated absolute change, for adults with ID with and adults with ID without
health checks (Table 44). To assess if the change in mean level of each outcome differed between groups,
we carried out a conservative test based on the change in outcome for each individual. The changes were
ranked, and a Wilcoxon rank-sum test was carried out to see if they differed between groups.
Although there was no evidence that health checks had led to any significant change in the mean level of
consultations over time (p = 0.71), there was some evidence that the change in the overall mean level of
prescribing was greater among patients with health checks (p < 0.001), although not for psychotropic
prescribing.
Change in estimated economic costs before and during health checks
We also revisited our estimates of annual NHS costs in relation to health checks. Here, we use the costings
identified for 2011 (see Appendix 5) and apply these to both 2008 and 2011 for the groups of adults with
ID with and adults with ID without health checks. To assess if the change in costs differs between groups,
we again ranked the changes for each individual, and carried out a Wilcoxon rank-sum test to see if they
differed between groups (Table 45).
Primary care costs for consultations and prescribing rose for both groups, but the mean change within
individual patients was greater for adults with ID with health checks (p < 0.001). However, this difference
was not replicated when we looked at secondary care costs among patients with linkage to the HES data.
Although the cost of elective admissions (based on 2011 costings) remained flat over time for the two
groups, there were large increases of approximately 50% for non-elective admissions. Although the overall
mean increase was higher for adults with ID without health checks (+£161.2 vs. £136.9 per patient), there
was no statistical difference of the comparison of the within-individual change using the Wilcoxon
rank-sum test (p = 0.90).
TABLE 44 Change in mean number of consultations, medications and referrals between 2008 and 2011 in adults
with ID with and with ID without health checks
Category identified
Adults with ID with health
check 2009–11 (n= 5026)
Adults with ID without health
check 2009–11 (n= 2728)
Difference in
change,a p-value2008 2011 ± change 2008 2011 ± change
Consultations 5.38 5.93 +0.55 4.64 5.38 +0.74 0.71
Drug classes 5.09 5.90 +0.81 4.04 4.54 +0.50 < 0.001
Drug classes (repeats only) 3.02 3.62 +0.60 2.23 2.66 +0.43 < 0.001
Psychotropic prescriptions 0.65 0.69 +0.04 0.45 0.50 +0.05 0.44
Referrals (made in primary care) 0.23 0.30 +0.07 0.21 0.25 +0.04 0.08
a p-value for Wilcoxon rank-sum test with individual change between groups.
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Predictors of first health check during 2009–11
We now investigate what factors were predictors of receiving a first health check during 2009–11 among
7754 adults with ID registered throughout practices with a minimum level (20%) of participation in the
DES. A logistic model with practice fitted as a random effect (see Chapter 2, Statistical analysis) was used
to produce mutually adjusted ORs for all factors investigated. We carried out sensitivity analyses excluding
patients from practices with exceptionally high participation in the DES (> 90%), but this made no material
difference to our conclusions.
Table 46 summarises the baseline factors that were important in predicting the receipt of a first health
check between 2009 and 2011. Middle-aged and older patients (aged ≥ 35 years at the beginning of
follow-up) were more likely to get a health check than younger patients (68.0% vs. 58.7%). The strongest
associations were seen among patients with pre-existing epilepsy (87.6%) and those living in communal or
shared accommodation (86.4%). Patients who were already being seen in primary care frequently prior to
the introduction of health checks (≥ 6 consultations in 2008) were subsequently more likely to get a health
check during 2009–11 (69.3%). There was no evidence of a trend with level of area deprivation (p = 0.85).
Predictors of repeated health check during 2010–11
Finally, we investigated the influence of baseline factors on a repeated health check. To do this, we
focused on the 3995 patients who received a first health check during 2009 or 2010 from Table 46. For
patients with a health check during 2009 (n = 1900), we searched to see if they received another one
during 2010. For patients with a health check during 2010 (n = 2095), a subsequent one during 2011 was
searched for. Overall, 2425 patients (60.7%) with a first health check during 2009 or 2010 received a
second health check during the following calendar year.
Table 47 summarises the baseline factors that were important in predicting a repeated health check
between 2010 and 2011. The factors that predicted a first health check showed smaller associations here,
with communal living (68.6%) and epilepsy (64.6%) again showing higher attainment. This time, there
was a significant trend with deprivation (p < 0.001), with patients living in more deprived areas being less
likely to get a repeated check (54.2%).
TABLE 45 Change in mean NHS costs (£ per person) between 2008 and 2011 in adults with ID with and adults with
ID without health checks
Category identified
Adults with ID with health
check 2009–11 (n= 5026)
Adults with ID without health
check 2009–11 (n= 2728)
Difference in
change,a p-value2008 2011 ± change 2008 2011 ± change
Primary care costs
Mean consultations 159.4 216.7 +57.3 146.1 180.4 +34.3 < 0.001
Mean prescribing 455.3 559.7 +104.4 310.2 399.5 +89.3 < 0.001
Secondary care costsb
Elective admissions 204.0 194.8 –9.2 197.9 196.1 –1.8 0.80
Non-elective admissions 292.7 429.6 +136.9 311.2 472.4 +161.2 0.90
a p-value for Wilcoxon rank-sum test with individual change between groups.
b Analyses restricted to patients with linked HES data only: n= 4218 with health checks; n= 2179 without health checks.
Note that costs are estimated as mean £ per patient based on fixed 2011 costings. For more details on how these were
estimated, see Appendix 5.
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TABLE 46 Baseline predictors of health checks for adults with ID between January 2009 and December 2011
Characteristic Total
With a
health check % Adjusted ORa (95% CI)
All 7754 5026 64.8 –
Gender
Women 3269 2153 65.9 –
Men 4485 2873 64.1 1.01 (0.90 to 1.13)
Age (years) (in 2009)
18–34 2669 1567 58.7 –
35–54 3483 2370 68.0 1.33 (1.17 to 1.51)
55–84 1602 1089 68.0 1.19 (1.01 to 1.39)
Down syndrome
Yes 863 644 74.6 2.11 (1.75 to 2.55)
No 6891 4382 63.6 –
Severe health needsb
Yes 1338 1117 83.5 2.39 (2.00 to 2.86)
No 6416 3909 60.9 –
Communal accommodationb
Yes 1796 1551 86.4 4.35 (3.61 to 5.23)
No 5958 3475 58.3 –
Autism spectrum disorder
Yes 528 401 76.0 1.63 (1.28 to 2.09)
No 7226 4625 64.0 –
Epilepsy
Yes 1052 921 87.6 3.46 (2.79 to 4.28)
No 6702 4105 61.3 –
Deprivationb
1 (least deprived fifth) 802 483 60.2 –
2 1126 790 70.2 1.33 (1.04 to 1.69)
3 1240 848 68.4 1.22 (0.96 to 1.56)
4 1519 993 65.4 1.07 (0.84 to 1.36)
5 (most deprived fifth) 1661 1073 64.6 1.12 (0.88 to 1.43)
Test for trend p= 0.85
Consultations (during 2008)
0–1 2219 1284 57.9 –
2–5 2958 1955 66.1 1.17 (1.03 to 1.34)
≥ 6 2577 1787 69.3 1.30 (1.12 to 1.51)
a Logistic model with random effect fitted for practice. OR mutually adjusted for all characteristics listed in the table.
b For definition of severe health needs, see Chapter 2, Definition of severe health needs, and Figure 5 for further details.
For definition of communal accommodation, see Chapter 2, Other subgroups of interest, for further details. Deprivation
was defined as IMD quintile.46
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TABLE 47 Baseline predictors of a repeated health check between January 2010 and December 2011 among adults
with ID with a first health check between January 2009 and December 2010
Characteristic Total
With a repeated
health check % Adjusted ORa (95% CI)
All 3995 2425 60.7 –
Gender
Women 1729 1063 61.5 –
Men 2266 1362 60.1 0.94 (0.81 to 1.09)
Age (years) (in 2009)
18–34 1207 681 56.4 –
35–54 1910 1186 62.1 1.30 (1.09 to 1.54)
55–84 878 558 63.6 1.41 (1.13 to 1.76)
Down syndrome
Yes 511 325 63.6 1.24 (0.99 to 1.56)
No 3484 2100 60.3 –
Severe health needsb
Yes 593 325 64.6 1.03 (0.86 to 1.24)
No 3077 1832 59.5 –
Communal accommodationb
Yes 1368 938 68.6 1.60 (1.32 to 1.94)
No 2627 1487 56.6 –
Autism spectrum disorder
Yes 329 205 62.3 1.20 (0.91 to 1.58)
No 3666 2220 60.6 –
Epilepsy
Yes 748 483 64.6 1.19 (0.98 to 1.45)
No 3247 1942 59.8 –
Deprivationb
1 (least deprived fifth) 336 203 60.4 –
2 649 446 68.7 1.36 (0.97 to 1.90)
3 720 482 66.9 1.08 (0.77 to 1.51)
4 803 443 55.2 0.79 (0.57 to 1.09)
5 (most deprived fifth) 840 455 54.2 0.71 (0.50 to 1.00)
Test for trend p< 0.001
Consultations (during 2008)
0–1 984 560 56.9 –
2–5 1566 950 60.7 1.12 (0.93 to 1.36)
≥ 6 1445 915 63.3 1.23 (1.01 to 1.51)
a Logistic model with random effect for practice. OR mutually adjusted for all characteristics listed in the table.
b For definition of severe health needs, see Chapter 2, Definition of severe health needs, and Figure 5 for further details.
For definition of communal accommodation, see Chapter 2, Other subgroups of interest, for further details. Deprivation
was defined as IMD quintile.46
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Chapter 8 Discussion
Introduction
In this final section, we now summarise the results from the study (see Chapters 3–7) and discuss them
further, including strengths and limitations, placing them in context with the existing literature. Finally,
we highlight implications that we have identified. To recap, the study originally had two overall aims
(see Table 1):
l aim 1 – to describe the health, health-care quality, equity of health care, mortality rates and NHS costs
for adults with ID in a national sample
l aim 2 – to evaluate the process and outcome effectiveness of annual health checks for adults with ID
in primary care.
For each aim, we now discuss in turn a summary of the findings from the study, its strengths and
limitations, how the results compare with other literature and, finally, implications arising from the study.
Aim 1: health, health-care quality, mortality and NHS costs
Summary of findings
We used data from 408 English general practices to show that, compared with an age-, gender- and
practice-matched group of patients without ID, adults with ID:
l had higher overall levels of most chronic diseases and multimorbidity, although recording was lower for
CHD and cancer
l had greater overall primary and secondary care utilisation and costs, particularly prescribing
l had higher levels of psychotropic prescribing, particularly antipsychotics and benzodiazepines
l were less likely to have longer doctor consultations and had lower continuity of care with the
same doctor
l were estimated to contribute approximately double the amount of NHS costs across primary and
secondary care
l did not demonstrate the same pattern of greater disease prevalence and prescribing with increases in
area deprivation.
We then used data from national hospital admissions and mortality data sets linked to primary care records
in 343 practices to create a retrospective longitudinal study between 2009 and 2013, and show that,
compared with an age-, gender- and practice-matched group of patients without ID, adults with ID:
l had a risk of death more than three times higher, even after adjusting for differences in comorbidity
l had more than one-third of their deaths classed as potentially amenable to health-care interventions
l were three times as likely to be admitted to hospital for an emergency admission, five times as likely for
admissions classed as potentially preventable (ACSCs)
l had one-third of their emergency admissions classed as potentially preventable
l did not appear to differ in the primary care utilisation and management before admissions for two
common ACSCs (UTIs and LRTIs), despite being at an increased risk of complications.
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Strengths and limitations
We have provided a systematic description of the health needs and consultation patterns of adults with ID
in English primary care, which has addressed a variety of data gaps that have been highlighted for this
group, including chronic disease prevalence.82 By primary care, we specifically mean health care delivered
through the general practice and, thus, other types of primary care (e.g. dentistry and optometry) will not
be covered in our summary analyses. The inclusion of controls without ID, or conditions related to ID such
as autism, enabled direct age and gender comparisons within the same English population, which is an
advantage over approaches that have relied on whole external populations for comparable estimates of
chronic disease in the general population.83 By matching on general practice, we were able to overcome
potential variations in the practice recording of health promotion and chronic conditions that are likely to
exist in our data, in addition to dissimilarities in consultation access between different practices.
Another potential strength of our approach was the inclusion of a large unselected group of patients with ID
identified as such in primary care. As ID (as ‘learning disability’) has been included in QOF since 2006, and
the associated prevalence has stabilised (see Appendix 1), it seems reasonable to presume that we have
included most adults with severe ID in our study. However, our reliance on primary care data to identify ID
could also be viewed as a limitation, as there are noted concerns about the under-recording of ID on primary
care systems (see Chapter 2, Quality and Outcomes Framework and learning disability).39,50 Thus, our results
must be viewed in the context of ID identified and recorded by GPs, which will represent the most important
group of adults with ID. However, we think it is unlikely that any under-recording of ID could explain away
any of the key differences in health-care utilisation that we have observed and detailed here.
There are other limitations that relate to the under-recording or incomplete recording of other
characteristics in primary care that we sought to measure in our study. We detailed issues regarding the
recording of medication reviews in CPRD (see Chapter 2, Missing entity data in the Clinical Practice
Research Datalink), which led to the suggestion that we may be underestimating these, but this would not
invalidate comparisons between adults with ID and adults without ID. Key characteristics such as living
arrangements or severity of ID were not routinely recorded, so we had use additional information, when
available, to bolster these measures. For example, for severity of ID we created a proxy measure of severe
health needs that would capture severity through a combination of other recorded health needs (see
Figure 5). However, the evidence from the systematic review of health checks for people with ID in 201412
suggested that the identification of some chronic conditions and health needs is incomplete in adults with
ID, and so our results should be interpreted as conservative estimates of the true extent of need. For living
arrangements, we were restricted to identifying only patients who were recorded as living in shared or
communal accommodation by either a specific Read code or clustering of address flag. This approach,
although crude, nevertheless allowed us to identify large differences between patients with ID classified
this way and those not classified this way. Patients who were not classified this way, however, will have
heterogeneous living arrangements, in terms of carers or family support.
Our study attempted to summarise consultation length by using the recorded duration on the underlying
computer system that the CPRD practices use (Vision). This, however, must be viewed as an approximation,
as the system may also be counting periods when the GP views the electronic record before and after the
relevant face-to-face consultation with the patient. We also observed that some duration entries were
implausibly zero or overlong, presumably as a result of user error. We attempted to mitigate this by
summarising length into binary categories (1–10 vs. > 10 minutes). Despite some uncertainty over
consultation length, we do not believe that the aforementioned errors would be disproportionate between
adults with ID and controls, and thus our relative comparisons and observed differences are valid.
We also estimated continuity of care by anonymously identifying the GP or nurse during the recorded
consultation from their unique system identification on the Vision system. Although this simplistic approach
addresses continuity of care with the same clinician, known as relational continuity, it does not address measures
of management continuity. These would include the consistency of clinical management or co-ordination of
care, which will also make a significant contribution to a patient’s experience of care over time.84
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We also presented a comparison of estimated NHS costs between adults with ID and adults without ID
during a single calendar year (2011) using published costings to allocate costs to recorded events.
Although events taking place at the GP surgery such as consultations and prescribing are, on the whole,
clearly identified on the patient record and could be costed accordingly, events outside the practice, such
as outpatient attendance or visits to accident and emergency, were inconsistently recorded, and as a result
could not always be identified. Furthermore, we were unable to ascertain the costs of other primary care
activities such as laboratory tests. Thus, our estimates of cost must be acknowledged as a significant
underestimate, although we do not believe that the under-recording of events would differ disproportionally
between patients with ID and patients without ID. For this reason, we chose to compare relative differences
in costs as opposed to absolute differences. The doubling of estimated costs compared with the general
population appeared to be primarily driven by a similar relative difference in the underlying admission rate.
Despite our caveat about our NHS costs estimates, we were still able to highlight an association of falling
costs with increasing levels of area deprivation among adults with ID living in shared or communal
accommodation, which is the inverse of what is observed in the general population.
We also provided a comprehensive description of the patterns in mortality and emergency hospital
admissions for a large cohort of adults with ID in England between 2009 and 2013. The linkage of primary
care data to routine data sources of mortality and secondary care use directly addresses a key data gap
that has been recently highlighted in a 2015 review of mortality for people with ID in England,25 and
featured as a recommendation (number 16) in the CIPOLD.22 Our detailed comparison of emergency
hospitalisation rate for adults with ID with the general population extends an area of limited research.85
Our work makes a significant contribution by quantifying mortality and hospitalisation disparities for adults
with ID compared with the general population, an area in which accurate and detailed information is
essential for future planning and policy-making.86
This study’s utilisation of linked primary care data allows for better ascertainment of adults with ID, which
in the UK has been historically been poor in mortality data25 and thought to be low among hospital
admissions data.13 In our study, we found a low proportion (31%) with a recording of ID or associated
condition as a secondary cause on their death certificates, similar to that found by others.25 Likewise, only
66% of adults with ID with a hospital admission in our study had ID recorded on their record, emphasising
the limitation of studies based on hospitalisation records or death certificates alone. The linked primary
care records in our study also allows for control and stratification by factors not routinely available in
hospital or mortality data, such as comorbidity and smoking.
For the mortality analyses, one of the main limitations of our study is the potentially incomplete and
inaccurate recording in death certification data. For example, in our study many patients with Down
syndrome had this condition recorded as their underlying cause of death and respiratory diseases given as
a secondary cause, when the latter was probably the more appropriate underlying cause. This miscoding
would have had no impact in our analyses of avoidable mortality, as either condition would still have been
classified as an amenable, and hence avoidable, death. However, it could also be argued that some deaths
among adults with ID are ultimately less avoidable owing to the conditions associated with ID. For
example, immune defects common in adults with Down syndrome may make such adults more prone to
infection87 and, subsequently, less amenable to treatment.
In our analysis of hospital admissions, a small number had an uninformative primary diagnosis of ID, so we
were unable to determine a more specific reason for their admission. In our comparison of primary care
utilisation prior to hospitalisation for two common infections, we suspected that urine dipstick tests were
poorly recorded across both groups and likely to be underestimated. This analysis was unmatched and,
although we adjusted for age and gender differences between patients with ID and controls in those
presenting, we cannot be sure how comparable the scenarios are for the two groups. Similarly, although
epilepsy was a common reason for admission, we chose not to compare epilepsy admissions between
adults with and adults without ID, as we had reservations about how comparable the severity of the
condition would be between groups. In addition, epilepsy management, such as drug and dose changes,
are mostly initiated and managed by non-primary care specialists.
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Comparison with other studies
Disease prevalence
A number of studies in the UK and internationally have described the prevalence of health problems in
people with ID.19,20,83,88–92 These have shown high levels of comorbidity, although direct comparisons of
estimated prevalence with the general population has generally been difficult owing to population
selection and disease definition. Only a recent Scottish study in primary care of 8014 adults with ID has
been able to provide comprehensive standardised prevalence rates by age groups,92 and produced findings
for 2007 similar to our own published findings for 2012.66
In addition, the recent studies in Scotland,92 Ireland83 and the Netherlands91 have all considered
multimorbidity in adults with ID. These studies considered a wider range of conditions than our study
and, as a result, reported higher levels of multimorbidity than we did. This makes any direct comparison
difficult; however, the relative doubling of multimorbidity (defined as two or more conditions) between
adults with and adults without ID in the Scottish study92 were similar to our findings, in which adults with
ID were 1.8 times more likely to have multiple QOF conditions. The Dutch study finding of greater
multimorbidity among adults with Down syndrome91 was the opposite of what we found, presumably
owing to this study involving older adults only (≥ 50 years), whereas our patients with Down syndrome
were primarily younger (73% were < 50 years old).
Looking at individual conditions, our estimate of the prevalence of epilepsy in adults with ID (18.5%)
compared favourably with an estimate of 18.8% found in the recent Scottish primary care study.92 Both
are lower than an estimate of 26% found in Leicestershire from a regionally based register in 2006,18 but
this may reflect regional and methodological differences. There has also been a concern that epilepsy has
been historically overdiagnosed in people with ID, estimated at around 3 in 10 from a review in 2011,93
and so our more recent findings may represent an improvement in diagnosis.
We also demonstrated an excess of recorded mental health problems among patients with ID, which
require good access to specialist services and present a challenge to primary care in managing such
patients, for which GPs may lack sufficient support.94 Our high prevalence of recorded mental health
problems such as schizophrenia (6.8%) is similar to that found in the Scottish primary care study (5.6%),92
and consistent with an earlier population-based survey95 undertaken in Glasgow in the early 2000s, which
found that 4.4% of 1023 adults with ID received a clinical diagnosis of a psychotic disorder, including
schizophrenia. Although the recording of depression ever in the patient record for adults with ID (18%)
was similar to that reported in the Scottish primary care study (16%),92 we found no difference when
compared with our matched controls, whereas in Scotland adults with ID were significantly more likely to
have a diagnosis than population controls.92 When we restricted to diagnoses made in the last year, we
actually found that adults with ID were less likely to receive a depression diagnosis. This may have reflected
the reluctance of some GPs to make a diagnosis, which during 2011 would have required the further use
of assessment tools in QOF,47 which may not be appropriate for some patients with ID (and would not
have been the case for the Scottish study reported in 2007).92
There has been limited information on the physical and sensory disability prevalence among adults with
ID from the UK. The Scottish study of primary care data estimated hearing loss at 8.2% and visual
impairment at 3.2%,92 which compares favourably with our estimates of deafness (8.3%) and bilateral
visual loss or low vision (4.7%). Internationally, our estimates of severe visual problems was close to the
prevalence of blindness (5.0%) reported in a detailed Dutch study of visual impairment among adults with
ID.20 Similarly, our recorded prevalence of behavioural problems was similar to the prevalances reported in
earlier regional studies in England96 and Norway.97
The lower recording of cancer, IHD and COPD in adults with ID was surprising, especially given the high
prevalence of comorbid risk factors for IHD, such as diabetes, obesity, hypothyroidism, chronic kidney
disease and stroke. However, any apparent higher risk may be offset by the much lower recorded rates
DISCUSSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
108
of smoking and alcohol use among adults with ID. The lower prevalence of these conditions was also
observed in comparisons with the general population in Scotland with age- and sex-standardised ORs of
0.69 for cancer, 0.43 for CHD and 0.84 for COPD,92 which compare with our PRs of 0.65 (cancer and IHD)
and 0.84 for COPD. Internationally, a recent Dutch longitudinal study of older adults with IHD estimated the
incidence of CHD to be 6.5 per 1000 person-years, compared with 7.3 from general population estimates.98
In addition to the noted difference in lifestyle factors, there are two other possible explanations for the lower
prevalence of these conditions. One would be that the data reflect inadequate identification among adults
with ID,99 and the recorded prevalence is a poor estimate of the true underlying prevalence. For cancer, for
example, a diagnosis may be delayed through communication difficulties regarding symptoms with their
carers or family members.100 Alternatively, the data correctly reflect reality, but owing to the premature
mortality among adults with ID there is a survivor-type effect within the population with ID. If a significant
proportion of younger adults with ID who would have gone on to develop cancer or IHD in later life never
reach the advanced age at which these diseases are typically diagnosed within the general population, then
the prevalence of these conditions in later life would be lower. This argument is given some credence by the
observation that a higher prevalence of both cancer and ID was seen when the comparison was restricted to
younger adults only, although numbers with the conditions were small (see Table 7).
We also showed that, compared with the general population, adult patients with ID were more likely to be
recorded both as obese (BMI of > 30 kg/m2) and as underweight (BMI of < 20 kg/m2). Our estimate that 36.4%
of adults with ID measured were obese is similar to other UK findings,101,102 but far exceeds a pooled prevalence
estimate of 15% among adolescents with ID from several countries.103 Although the association between ID
and being underweight in adulthood is generally accepted owing to poor feeding and swallowing,17 we were
not aware of any population estimates of its prevalence. Older patients with ID are known to suffer an earlier
onset of frailty than the general population,104 and our higher prevalence of recorded osteoporosis reflects the
high prevalence of low bone quality that has been measured among older patients with ID.105 A recent Dutch
study98 showed that a low BMI among older patients with ID was predictive of 3-year mortality.
Consultations
Our overall estimate, of a 70% higher rate in GP consultations between adults with and adults without ID
of the same age and gender, matched that found in a Dutch study19 of 71 general practices during 2001.
We were able to further demonstrate that this higher consultation rate was not explained by the higher
prevalence of conditions included in the QOF.
This finding of higher consultations contrasted with two small earlier UK studies, one in London106 that
sampled 187 adults with ID from 40 practices and another based on 142 adults in the east of England.107
Neither found an increase in consultation among their adults with ID when the authors compared their
study results with expected consultation levels estimated using national data.108 Our study has the
advantage of directly comparing consultation behaviour within practices, accounting for any practice
variations or trends. In addition to the methodological differences, these older studies may also reflect
temporal changes in consultation behaviour for adults for ID that may have taken place in the UK.
Our analysis of recorded consultation length showed that although adults with ID had more consultations
of a long duration (> 10 minutes) overall with a GP or nurse during the year than their matched controls,
they were less likely to have a longer consultation when their higher overall consultation level was taken
into account. In other words, any given consultation with a GP or nurse is likely to be shorter on average
for an adult patient with ID. For continuity of care, patients with ID were consistently less likely to see the
same doctor, no matter how many consultations they had during the year. This may partly reflect a greater
propensity for these patients to consult for acute problems for which an urgent appointment is more
important than continuity per se. Although this may be true, the ability to see their regular GP was
highlighted by our patient group in the study as an important factor in their health care (see Table 3).
Discussions with the patient group also found that allotted appointment times were not always adequate
for discussing their health issues. Both increased consultation times through double appointments and
enhanced continuity of care have been highlighted as reasonable adjustments that general practices could
be expected to make in improving the access of health care for people with ID.109
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Prescribing
The prescribing of psychotropic medication for challenging behaviour in adults with ID is much discussed
and controversial in nature, with concerns of overprescribing within this group.110 Additionally, there has
been observed a low level of recorded ancillary information in the electronic GP records of patients with ID
to justify the level of prescribing observed.111 In the UK, the scale of the prescribing of psychotropic drugs
to patients with ID nationally has been previously described in the CPRD data between 2009 and 2012,112
and more recently in another primary care database (THIN) from 1999 to 2013.111 The study based on CPRD
data found that, among adults with ID over a 4-year period, 41.3% of follow-up time was exposed to at
least one psychotropic drug (including antiepileptic drugs). We provided an alternative summary (and did not
count antiepileptic drugs), describing instead the proportion of adults with ID who received a psychotropic
drug at any time during single year (2011), and found a similar 4 in 10 proportion. This was lower than that
reported in Scotland during 2002–4 (49.5%),95 but more similar to other international cross-sectional
findings from the Netherlands (32%),113 Norway (37%)114 and Australia (35%).115 Although these studies
generally showed that antipsychotics were the most frequent type of psychotropic medication being
prescribed to this group, in our study antipsychotics and antidepressants were equally likely to be prescribed.
The most comprehensive comparison of prescribing trends between adults with and adults without ID in a
primary care setting that we are aware of is a 2001 Dutch primary care study.19 This study of 868 patients
with ID found that 82% received any prescription during the year, compared with 69% of age-, gender-
and practice-matched controls. By contrast, we found 86% and 67%, respectively, and similarly found
antipsychotic drugs to be the most common class of drug prescribed to this group.
Among antipsychotics, the most common drugs prescribed to adult patients with ID in 2011 were the
atypical/second generation antipsychotics risperidone and olanzapine, which are effective in reducing
aggressive behaviour in patients with ID in comparison with typical/first-generation drugs.116 However,
typical/first-generation antipsychotics such as chlorpromazine and haloperidol were still widely prescribed
to adults with ID, although these were almost non-existent in the general population. Many patients with
ID are treated long term with antipsychotics for many years,117 and the prevalence of adverse effects
resulting from such drugs is thought to be high. A recent Dutch study118 reported associations between
psychotropic drugs and quality of life, with a large majority of patients with ID (> 90%) on psychotropic
drugs experiencing an adverse event during a 2-year follow up.
The greater prescribing of benzodiazepines among adults with ID will be partly attributable to the higher
prevalence of epilepsy in this group, as benzodiazepines such as clobazam are licensed for the prevention
and treatment of seizures in epilepsy.119 Although we found the rate of antidepressant prescribing to be
double that for adults with ID compared with the general population, the prescribing of low-dose
amitriptyline was an exception, being lower in adults with ID. As amitriptyline is often prescribed for
neuropathic pain,120 our finding may indicate that patients without ID are more often prescribed
amitriptyline for this important indication.
Mortality
Our finding of an increased overall risk of death associated with ID is consistent with numerous
contemporary findings, both in the UK and internationally, that show premature mortality for this group.14
In the UK, studies of mortality among people with ID have used a number of data sources, including local
registers, death certification data alone and national registers.25 The largest existing UK study to date121
was based on the follow-up of a regional disease in Leicestershire between 1993 and 2006, identifying
503 deaths among adults with ID, and found an increased risk of death of just under three [standardised
mortality ratio (SMR) 2.77] compared with the general population.122 This was slightly lower than our
age- and gender-adjusted HR of 3.62, which may be attributable to regional as well as period and other
methodological differences. Internationally, a recent large retrospective longitudinal study123 in New South
Wales, Australia, used linked health data for 817 deaths among people with ID aged 5–69 years to
produce a SMR of 3.15.
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Gender differences that may have an impact on mortality within the population with ID are not well
understood.124 In our study we observed higher age- and gender-adjusted mortality rates for women
(139.5 per 10,000 persons per year) than for men (127.3), although no statistical difference remained
when we adjusted for differences in comorbidity between the genders. This was similar to a recent US
study124 utilising information from four state level-disability service systems, which found higher mortality
rates for women with ID than for men with ID (18.9 vs. 16.2 per 1000). However, simply comparing overall
mortality rates could hide any potential gender disparity, as men of a similar age in the general population
may have a higher underlying mortality rate than women from being more likely to engage in higher-risk
lifestyles or behaviours, a difference that may not exist within the population with ID.124
Therefore, although more deaths are observed among adult men with ID in many studies,82,122,123,125 when
the authors’ analyses compare observed mortality with expected deaths in their control populations, using
SMRs, they observe much higher expected mortality for women with ID. For example, in the New South
Wales study,123 the authors reported a SMR of 4.26 for women versus a SMR of 2.52 for men, whereas
the Leicestershire study122 produced a similarly higher SMR for women (3.24) compared with men (2.28).
A comparable gender disparity was also seen for SMRs in all ages in a recent study in Ireland126 using
national databases of people with ID and census data. In our study, we also observed more deaths among
adult men with ID than among women with ID (365 vs. 291; see Table 22), but a greater relative mortality
risk for women (HR 4.10; see Table 23) relative to their general population controls than the corresponding
estimate for men (HR 3.30). Although our analysis seemingly has the advantage of directly comparing
adults with ID with age-, gender- and practice-matched controls, rather than to a larger reference
population, a potential drawback is that it is then based on a smaller number of deaths within its control
population as we only have a sample of all adults without ID. This may account for differences in the
estimated mortality in the general population, especially at younger ages, and why our gender difference
was not as notable as that found previously in the Leicestershire study.122 Regardless of these
methodological differences, the gender relationship between ID and mortality is complex and warrants
further investigation.123
We found an elevated risk of mortality in adults with Down syndrome, which was approximately three
times higher than that in adults with ID without Down syndrome. Mortality in people with Down
syndrome has been widely studied.125,127–130 A large Danish study129 of 3530 persons with Down syndrome
found a HR of 8.94 for standard trisomy 21 versus the general population for mortality between 1968 and
2009, which compares closely with the HR of 9.21 (see Table 23) that we found before any adjustment for
comorbidity. A smaller American study130 of 169 adults with Down syndrome residing in the community
found an adjusted risk of death almost four times as high (3.77) as that for other adults with ID without
Down syndrome. A recent study in Ontario, Canada,125 of 172 deaths among people of all ages with ID
also found an elevated risk for Down syndrome, but only among those aged > 60 years.
Among patients with ID with autism spectrum disorder, we found some evidence that their risk of
mortality was lower than that for patients with ID without autism (HR 0.56; see Table 24), even after
adjusting for the age differences between the groups. However, we are cautious about overinterpreting
this finding, as very few of this younger subgroup died during our study (n = 15, 1.0%). Their risk of death
was still estimated to be twice that of their matched controls without ID (HR 2.2; see Table 23). A doubling
of mortality risk with autism spectrum disorder compared with the general population has been shown in
several population cohorts worldwide;131 however, this risk increases in studies that were able to further
restrict the comparison to subjects with a co-existing ID131 or neurological disorders.132 Although a recent
large Swedish case–control study131 reported an OR of 5.8, the median age of death for the group with
co-existing ID (40 years) suggests that insufficient follow-up in our study (3 years) may account for our
imprecise findings among the younger subgroup of adults with ID with autism, who had an average age
of only 30.5 years at the beginning of follow-up.
We also estimated a higher risk of mortality for adults with ID with epilepsy than for adults with ID without
epilepsy. There is established concern about epilepsy as a condition more commonly associated with death
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for people with ID,75 particularly the contribution of sudden unexpected death associated with epilepsy
(SUDEP).133,134 A Swedish study135 of 1478 people with ID found associations between epilepsy and
mortality between 1987 and 1992, with an estimated SMR of 5.0 for those with epilepsy compared with
1.6 for those without epilepsy. This compares with the HRs we found of 6.0 and 3.2 before adjusting for
mortality (see Table 23). In the Leicestershire study,133 elevated SMRs for adults with ID with epilepsy were
seen in both men (SMR 3.2) and women (SMR 5.6), with both rising dramatically when the outcome was
restricted to SUDEP, identified from case notes and post-mortem reports. In Ontario, elevated mortality
with epilepsy for people with ID compared with that for those without epilepsy was about 1.8 times higher
for ages 20–60 years,125 compared with our estimate of 1.6–1.7 (see Table 24).
Our description of cause-specific mortality by comparison of ICD-10 categories is broadly similar to findings
from the Leicestershire study,122 with the smaller number of deaths within some categories accounting for
some variation. No association with cancer was found in the earlier studies in Lecistershire,122 nor was it
found a large 35-year follow-up study in Finland.15 Although we found a small excess of mortality from
cancer in adults with ID in our study, it varied by type, and was notably smaller for lung and prostate
cancer. Cancer is thought to be a less prominent cause of death for people with ID, perhaps owing to the
premature mortality within this group.75 However, we still demonstrated increased associations with some
cancers (particularly colorectal; see Table 25), which suggests that the associations with different
neoplasms are more nuanced. Our findings may also highlight an important change resulting from an
ageing population of people with ID due to increases in life expectancy.136
A high proportion of deaths amenable to health-care intervention was described in CIPOLD.137 However,
the inquiry was only able to compare this proportion with the national UK average, and could not quantify
either the absolute or the relative risk. Our study extends this work, and provides quantitative estimates of
this risk for adults with ID (see Figure 28), with the rate of such deaths being almost six times higher
among adults with ID than they were for adults of the same age and gender within the general population
without ID. However, existing definitions of amenable mortality do not include some important treatable
causes of deaths among people with ID, including UTIs and aspiration, and so are likely to underestimate
the true burden of amenable mortality. However, at the same time it may be that some causes of death
are less preventable or amenable in adults with ID owing to the underlying cause of the ID itself. For
example, the immune defects observed in people with Down syndrome may lead to infections being more
common, more severe and less amenable to treatment.130
The difference in the relative contribution of preventable and amenable deaths to avoidable mortality
compared with the general population may be partly explained by differences in lifestyle exposures. For
example, we found that adults with recorded ID in primary care were also far less likely to be recorded as
smokers or consumers of alcohol on their electronic patient record. Adherence to current medical
guidelines may also differ owing to communication difficulties with patients with ID.99 However, the high
absolute risk of deaths amenable to health-care intervention reflects established concerns over difficulties
accessing health care, delays in diagnosis and poorer management experienced by people with ID.8,22
Hospital admissions
There are few recent studies about emergency hospital usage by adults with ID.138 In England, the only
previous national study, by Glover and Evison,13 used earlier hospital data from 2005–9 and, although
large, it relied solely on the identification of ID from hospital data. Using the linked data sets in our study,
we estimated that approximately one in three adults with ID who has an emergency admission in England
does not have ID recorded anywhere on his or her hospital record. This may explain the small difference in
crude admission rates for emergency ACSCs between our study (61 per 1000 per year) and that found
in the earlier 2005–9 study by Glover and Evison13 (76 per 1000 per year), as less severe cases of ID are
presumably less likely to be recorded in hospital data. However, when Glover and Evison13 compared
admission rates for ACSCs with those for the general population, they also found a similar five times
relative difference to what we found (see Table 31).
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In terms of different ACSCs involved, the findings in Glover and Evison13 were broadly similar to those that
we observed, with emergency admissions for epilepsy and convulsions accounting for 41% of ACSCs,
compared with 36% in our study. Both studies found much higher emergency admissions for constipation
and pneumonia, but we did not observe the same rates of admission seen for complications of diabetes,
although they were still higher for adults with ID than for the general population.
There are three other large-scale studies139–141 on hospitalisations of adults with ID that we are aware of,
but none differentiated between emergency and planned admissions. Our focus on preventable emergency
admissions means that any comparison is difficult, as we would not expect good primary care management
to decrease planned admissions for ACSCs. However, the large Canadian study142 from Manitoba found
elevated hospitalisation rates during 1999–2003 for both epilepsy (RR 54) and constipation (RR 7.9)
compared with the general population, both of which will be dominated by emergency admissions, and
as a result gave a similar picture to the pattern of emergency admissions in our study.
Costs
We are not aware of any other studies that have compared NHS costs between age- and gender-matched
patients with ID and age- and gender-matched patients without ID.
Implications
We have identified the following implications from our cross-sectional analysis of disease prevalence,
consultations and prescribing, and NHS costs.
l Our findings on prevalence of chronic disease raise concerns about the inadequate identification of
some conditions such as cancer and IHD. The lower prevalence of cancer in particular needs further
exploration, as this may indicate late diagnosis or poorer survival. A particular focus could be on
colorectal cancer, for which higher mortality rates were observed.
l The main burden of excess chronic disease for adult patients with ID is provided by epilepsy and severe
mental illness such as schizophrenia. Ways to address these challenges for primary care and to improve
access to specialist services need consideration.
l Although psychotropic prescribing was much higher for adults with ID, the prescribing of low-dose
amitriptyline was lower. As the latter drug is often prescribed for neuropathic pain, one interpretation
might be that diagnoses of pain in patients with ID are missed, and that these patients are less likely to
communicate their symptoms well.
l The high burden of obesity among adults with ID is a concern, but it also presents an ongoing
opportunity to build on weight loss interventions for patients with ID.143 Additionally, adults with ID are
more likely to be underweight, which also needs recognition and action.
l The higher level of chronic disease in adults with ID than in the general population is not adequately
captured by the Charlson index, emphasising this may not be the most appropriate measure of
comorbidity and mortality risk for this group.
l As higher consultation levels for adults with ID were not explained by comorbidity, this implies that the
resource implications of caring for adult patients with ID are unlikely to be addressed through the
present remuneration systems developed for QOF. Additionally, the high levels of need and utilisation
by patients in communal establishments will lead to variable demands on practices, depending on local
variations in the density of communal establishments.
l Practices could take steps to improve access to longer consultations and continuity of care for patients
with ID, as part of a reasonable adjustment.109 This may be achieved by simple flags on computerised
primary care records that prompt receptionists to offer double appointments when possible and bypass
on-call doctor arrangements for specific patients.
l The higher levels of prescribing and prescribing costs in primary care for adults with ID, combined with
the low levels of recorded medication reviews for this group, suggest that there is potential for changes
to practice that could improve quality of care and potentially reduce NHS prescribing costs. In particular,
the higher prescribing of psychotropic drugs among adults with ID is a concern and warrants
further investigation.
DOI: 10.3310/hsdr05250 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 25
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Carey et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
113
l The high excess costs for adults with ID for emergency hospital admissions confirm the importance of
examining emergency hospital admissions as an outcome for the effectiveness of health checks.
l The inverse association of NHS costs with increasing deprivation among adults with ID living in
communal or shared accommodation needs further explanation, as it may represent inequitable health
care of patients from this subgroup who live in poorer areas.
l The lack of comparable data in the literature on NHS costs for adults with ID suggests that more
research is needed in this important area, which is vital for planning services and resources.
We have identified the following implications from our longitudinal results of mortality and hospital admissions.
l The consistently higher mortality risk for adults with ID seen at all ages reiterates the overall greater
health-care need of people with ID. Consistent guidance on the recording of ID as a contributory, but
not underlying, cause on death certificates would be helpful for the ongoing surveillance of the health
of people with ID in all countries.144
l The higher burden of respiratory deaths among adults with ID is important to highlight, as national
strategies in developed countries often give a lower priority to respiratory health. The large contribution
of pneumonia and aspiration represents a potential focus for improving health care for people with ID.
l The much greater risk of death from urinary and neurological causes among adults with ID highlights
further potential opportunities to improve care for this population through better management of UTIs
and by optimising seizure control in people with ID.
l Our finding that more than one-third of deaths among adults with ID were amenable to health care
emphasises that strategies for improving health among people with ID need to prioritise access to and
quality of health care as well as preventative interventions. Existing population-wide strategies for
working-age adults in high-income countries focus on cardiovascular risk and lifestyle factors, which,
although important for people with ID, do not address their different health-care needs. Addressing the
health and mortality disparities experienced by adults with ID is a key challenge for health-care systems
and a potentially important indicator of health-care system equity and effectiveness.
l The higher emergency admission rate for adults with ID, which is even more marked for preventable
admissions, highlights a specific area in which improvements could be made. As the life expectancy
of adults with ID increases,136 it is essential that preventable admissions are fully described, so that
appropriate interventions, specific to adults with ID, can be developed.
l We observed that one in three adults with a diagnosis of ID from primary care had no mention of ID
on his or her hospital record. The inadequate flagging of these patients is seen as barrier to effective
and safe hospital care.40 Improving the sharing of information about diagnoses of ID across NHS
services, particularly from GP systems, should continue to be part of a reasonable adjustment to
improve the health-care needs for these patients.40
l Although the primary care utilisation and management prior to an admission for a UTI or LRTI for an
adult patient with ID was not noticeably different from that for patients without ID, the primary care
records for the former group did identify them as being at higher risk of UTI or LRTI. As integrated risk
stratification software is increasingly available in primary care,145 this could be reasonably extended to
better incorporate patients with ID, thereby facilitating the most appropriate initial management and
follow-up monitoring.146
Aim 2: health checks and effectiveness of health checks
Summary of findings
We used several methodological approaches to investigate the impact of health checks for adults with ID
and found:
l there was no evidence that the introduction of health checks was associated with a fall in overall
emergency hospitalisation, except for adults with severe health needs
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l the change in the rate of potentially preventable emergency admissions was lower than expected after
health checks, both within individuals and at a practice level
l there were large variations in recorded information on the patient record around the time of the health
check, both between individuals and between practices
l adults with ID who would go on to receive health checks were already consulting more and had higher
prescribing levels and NHS costs than other adults with ID who did not go on to have health checks
l adults with ID who received health checks had larger increases in prescribing levels and costs than
adults with ID without health checks, but patterns with consultation levels were less clear
l among practices carrying out health checks, adults with ID who had more severe health needs or who
were living in communal establishments were more likely to receive a health check
l practices in the most deprived areas were more likely to offer health checks during 2009–12 than
those in the least deprived areas; however, among patients who received a health check during
2009–10, those living in more deprived areas were less likely to receive a follow-up health check
in 2010–11.
Strengths and limitations
We believe that our study is the first to report on the health outcome benefits of health checks for adults
with ID rather than just on process measures.90 Although the systematic reviews by Robertson et al.12,147
showed the effectiveness of health checks in detecting unrecognised health needs in people with ID, they
highlighted the lack of evidence regarding whether or not the provision of health checks translated into
important longer-term benefits, such as a reduction in avoidable hospitalisations or mortality. For health
checks among the general population (for 40- to 74-year-olds), a recent study148 using CPRD data showed
that their introduction increased the identification of cardiovascular risk factors, but an earlier Cochrane
systematic review149 for similar general health checks failed to find evidence that they reduced mortality,
hospitalisation or disability.
A strength of our analysis of health checks and hospital admissions was that we reached a similar
conclusion from two different approaches, one based on practice-level comparisons and the other based
on individuals. As these two strategies used slightly different patient groups and definitions of time, the
same conclusion would not necessarily be expected. An example of how the different groups behaved in
the analyses could be seen in the trends in emergency hospital admissions over time. In the analyses of
individual patients with ID, emergency hospital admissions were rising post health check for those with
checks, or post index date for those without health checks (see Table 38). On the other hand, the practice-
level analyses showed an apparent fall in admissions during 2011–12 (see Table 36). The observed rise in
admissions in the same individuals is partly explained by their ageing over time, plus the fundamental
requirement for them to be alive at the time of health check (or on the index date). This means that any
deaths during the study for this group of patients can occur post health check only, and these would
probably be associated with a rise in admissions beforehand. By contrast, the observed practice trends
were based on an open cohort of all patients with ID aged 18–84 years in each calendar year, keeping
average age effectively constant and allowing mortality within patients during each year.
Our analysis of health checks and hospital admissions has some limitations. The analysis at practice level
was unmatched, and would probably be subject to residual confounding from unmeasured factors and
characteristics at both practice and individual level. We observed that practices that regularly performed
health checks were more likely to have adults with ID recorded with severe health needs, or who were
recorded as living in communal establishments, than practices who did not participate (see Table 35).
However, this may reflect different levels of recording in these practices, as the group of practices that
went on to regularly carry out health checks in our study already had lower emergency hospital admissions
rates among their patients with ID at the outset in 2009 (see Table 36). These practices might have further
reduced admissions anyway, and the subsequent adoption of health checks may simply be a marker of
other improvements in their care over the study period.
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In order to control for any practice-level changes over time, we matched individual adults with ID receiving
health checks with population controls in the same practice. This analysis now adjusts for any temporal
change, be it artefact or real, across practices or hospitals that might have taken place during the study.
However, this adjustment would still fail to account for any changes specific to people with ID that might
have happened. These could feasibly have occurred in the UK as a result of two high-profile independent
inquiries that have taken place during the last decade.8,22 Therefore, our analysis also crucially included
patients with ID without health checks as a second control group not exposed to health checks. Instead,
we assigned them a random health check date based on the distribution of observed dates for health
checks. As this group of patients showed no similar reduction in ACSCs compared with their matched
controls, it provided additional evidence for the effectiveness of health checks. On the other hand, as our
finding that adults with Down syndrome increased emergency admissions by 55% post health check was
also replicated in adults with Down syndrome without health checks, we concluded that this trend was
specific to patients with Down syndrome and not to health checks. This increase in emergency admissions
for patients with Down syndrome may reflect premature ageing associated with the condition, such as
early-onset Alzheimer’s disease,150 combined with better survival into middle age, in part due to advances
in childhood cardiac surgery.128
Although we have provided a description of the information recorded on the electronic patient record at
the time of the health check, this may not represent all of the important events that actually took place.
It also cannot be assumed that the amount of information recorded directly correlates with the overall
quality of the health check. There may be reasons specific to certain practices why some features of the
health check are not regularly recorded electronically. For example, we observed that a cluster of practices
that featured a high proportion of patients living in communal establishments recorded zero information
besides the system flag to facilitate payment. We do not believe that these health checks were truly empty
in their content. Therefore, our findings need to be seen in the context of the limitations of recorded
electronic information.
Our analysis comparing changes in specific recorded process measures between adults with ID with and
adults with ID without health checks was unmatched, and has limitations as a result of the potential
non-comparability of the two groups. Before health checks were introduced, patients who would go on to
receive health checks in our study already had higher levels of recording for many process measures, as
well as higher levels of prescribing. Additionally, they were more likely to have severe health needs or to
be resident in communal accommodation. This makes any comparison between the two groups of patients
with ID difficult to interpret. As a result, we kept the statistical approach austere, focusing on change
within individuals, and using non-parametric tests to compare the change between the groups. Sensitivity
analyses, investigating the change in consultation and prescribing levels comparing with the matched
population controls, in the same manner as the analysis of hospital admissions in Chapter 6, produced
similar findings to those of the unmatched analyses.
Although we did not attempt a formal economic costing of the effectiveness of the health check scheme,
we estimated annual NHS costs before and after health checks. As already noted, there were already cost
disparities before the scheme began, with patients who would go on to receive health checks already
having higher primary care costs. Our comparison of within-person changes in costs showed higher
increases for both primary care consultation and prescribing costs for patients with health checks.
Although the mean overall costs for non-elective hospital admissions appeared to have increased less for
health check patients, our statistical comparison of within-patient cost showed no evidence of a difference,
owing to the majority of patients having zero costs in both periods.
Comparison with the literature
Health checks and hospital admissions
Reducing emergency hospital admissions to contain health-care costs is a major international concern, but
evidence for successful community interventions has been limited.151 Although our primary outcome of
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overall emergency hospital admission showed no change after the introduction of health checks for adults with
ID, the evidence for a reduction in potentially preventable admissions was more consistent, and plausible. Given
that admissions for ACSCs represent less than one in five emergency admissions in the UK,41 it is perhaps not
surprising that we failed to detect a change among the broader group of all emergency admissions.
Within the general population, there has been a lack of evidence to support case management as an
effective intervention for reducing emergency admissions.151 Similar to the DES for annual health checks, GPs
in England have been recently incentivised to case manage patients identified as high risk (approximately
2%) as part of UK policy to reduce emergency admissions.29 Despite this, it has been argued that the focus
should move towards admissions for conditions that are more amenable to prevention in the community,151
such as ACSCs. Although we were not able to determine the proportion of adults with ID who were being
classified as high risk by GPs, we have confirmed their higher overall emergency admission rates to hospital,
and estimated that about one in three of these was for an ACSC. Admissions for epilepsy contributed about
4 in 10 emergency admissions for ACSCs for adults with ID, so one possible explanation is that health
checks are facilitating better overall management of epilepsy and seizures among patients with ID. Similar to
earlier findings from CPRD data from 2007,24 our cross-sectional analysis during 2011 showed that adults
with ID had lower recorded rates of being recorded as seizure free during the year than adults with epilepsy
from the general population. This difference may be attributable to differences in disease severity and
seizure types that are harder to manage.24 Our longitudinal analysis suggested minor improvements in
seizure-free recording since health checks had been introduced. However, any such benefit would be
important, as the improved service provision of patients with ID with epilepsy has been identified as a
mechanism for reducing excess mortality among all people with ID.152
It has been argued that regular health checks for adults with ID are an efficient way of closing the health
inequality gap that this group may experience; however, this may also be widened if more easily managed
patients are more likely to get health checks.153 It is, therefore, reassuring that we found that those with
more complex health needs were more likely to receive a health check. In our study, the decrease in
emergency admission rates for ACSCs was more marked (27%) when we directly compared participating
with non-participating practices, which suggests that there may be a ‘practice-level benefit’ of health
checks, whereby changes in care have benefited all patients with ID within the practice irrespective of
whether or not they have the health check. However, this may be an oversimplification, as a recent serious
case review in the UK into the deaths of two adults with ID found that they had been invited to a health
check but had failed to attend.154 Interestingly, our analysis of individuals suggested that health checks
produced the greatest benefit in reducing emergency admission to hospital in those with more severe and
complex needs.
Health checks and process measures
The systematic review by Robertson et al.12 identified many worldwide studies showing that similar health
checks for adults with ID have had meaningful impacts on health promotion and screening activity in
primary care. In the UK, for example, a small Scottish trial of an annual intervention for adults with ID32
reported large increases in the performance of vision and hearing tests,155 similar to our findings of
increased recording in these areas for patients with health checks compared with those without. However,
many of the studies in the review are now 10–20 years old, and the additional beneficial gains seen
historically may not necessarily apply to English primary care, in which the recording of such conditions is
now incentivised.
Post introduction of the DES for annual health checks in England (2009), two large studies further
investigated the effect of health checks on process measures. The study by Chauhan et al.156 used data
from 171 practices in six primary care trusts to identify approximately 4000 adults with ID in both 2010
and 2011. The study by Buszewicz et al.90 used English data from the THIN database to compare recording
during 2009–11 among 4645 patients with ID with health checks from 222 incentivised practices with 611
patients with ID from 48 non-incentivised practices. Both studies90,156 found increased recording of a wide
range of health assessments, such as sight and hearing.
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We found that although health checks appeared to have increased prescribing levels among adults with ID
over time, there was little impact on medication reviews over time. This contrasted with the study by
Buszewicz et al.,90 which found more reviews among patients with health checks. We acknowledge that
the recording of medication reviews on CPRD may not be complete (see Chapter 2, Missing entity data in
the Clinical Practice Research Datalink), and this may explain the discrepancy seen in reviews recorded
during 2009–11 in our study (65%) and that seen in Buszewicz et al.90 (84%) over the same period.
The 3-year recording of any medication review in our study was much higher than what we observed
recorded during the checks themselves (26% for patients on repeat medication). As medication reviews
are incentivised elsewhere in QOF,47 it may be that many patients have already had a relevant review by
the time they receive the check.
The systematic review by Robertson et al.12 also concluded that health checks had been effective in
detecting a range of previously undetected conditions such as cancer and heart disease. Although Chauhan
et al.156 found that health checks were associated with an increased identification of conditions incentivised
by QOF, such as diabetes, Buszewicz et al.90 found increases in post-2009 diagnoses only for conditions
likely to be a focus of health checks for patients with ID, such as constipation or gastrointestinal disorders.
We found little evidence to suggest that health checks were associated with increased diagnoses during
2009–11 for a range of QOF conditions. The lower prevalence of recorded cancer in adults with ID in our
study suggests that improvements in timely diagnoses of cancer in people with ID may still be possible.157
Our finding of increased prescribing levels and associated costs in adults with ID who had health checks
compared with those who did not have health checks is novel, and further investigation is needed to
confirm whether or not the checks are driving this increase. The pattern with consultations in primary care
was less clear. The suggestion was that the checks had led to greater costs associated with consultations,
with no change in the number of consultations themselves.
Although we estimated annual NHS costs from available data, we did not attempt to estimate the costs of
health checks themselves, and thus assess the cost-effectiveness of the health check scheme. The large
variation in recording procedures across practices for health checks needs to be better understood to
enable better cost estimates of health checks on a large scale. Both in the UK158,159 and internationally,160
small trials of health check intervention have suggested that there were no associated higher costs in terms
of service use compared with standard care.158,159 However, these studies may not have fully accounted for
longer-term hospitalisation costs, which in turn could have led to an underestimation of any potential
economic savings.159 Therefore, costs implications and benefits of health checks remain unclear and require
further evaluation.
A few studies have recently investigated factors influencing uptake and attendance of health checks. A
3-year study explored variations in uptake in Northern Ireland,161 where overall uptake of their DES of health
checks has been higher than in England (64% of eligible patients had received a check by 2013–14). Similar
to our findings, they found higher uptake with age, and that patients living in nursing or residential homes
(82%) were significantly more likely to have a health check than those living independently (63%). They
also found that patients living in more deprived areas were less likely to have had a check, whereas we
found a relationship with deprivation only when we focused on repeated checks over time.
Attendance at health checks, once a check has been offered, was investigated in a recent Australian
meta-analysis of three community trials,162 and showed that Down syndrome was the only consistent
characteristic associated with health check attendance. By comparison, the recent study of English primary
care data found that non-attendance was associated with being younger and living in more deprived
areas.90 Our analysis of repeated health checks could be thought of as a proxy attendance measure, and
similarly found that repeated checks were less likely with younger age and deprivation.
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Implications
We have identified the following implications from our analysis of health checks and hospital admissions.
l Annual health checks for adults with ID can improve access to care and may be influential in reducing
preventable admissions to hospital, which make up one-third of all emergency hospitalisations for
adults with ID. Although the evidence has been weak for community-initiated case management
interventions in reducing preventable admissions in the general population, our results argue for the
continued implementation of annual health checks for all patients with ID. As we did not undertake a
formal cost analysis in this study, future research could helpfully estimate whether or not the cost of
health checks is offset by savings from fewer emergency hospitalisations.
l Ensuring that all eligible adults, especially those with the most severe or complex needs, receive an
annual health check will continue to address key issues of health inequality and discrimination for
adults with ID. This can be achieved both within practices already participating in the DES, and by
encouraging wider practice uptake of the health check DES towards a suggested and necessary target
of 90%.153
We have identified the following implications from our analysis of health checks and process measures.
l Although there is published guidance on what the GP should cover during a health check,10 our study
has shown that there is substantial variation in the information recorded. This suggests that the
experience of a health check may differ across practices, and our discussions with patient and user
groups consistently reinforced this view (see Chapter 2, Patient and public involvement). So, although
the patient view of health checks has been shown to be mainly positive,163 better standardisation
through reinforcing guidance and practice may lead to improvements in the overall patient experience
of the health check, and possibly in health outcomes.
l The low levels of recording with regard to mental health during health checks contrasts with its
importance in terms of burden of disease for adults with ID from our cross-sectional analyses and from
our patient and carer group discussions (see Chapter 2, Patient and public involvement). Improved
access from primary care to specialist mental health services for patients with ID would encourage
greater detection and recording of mental health problems as part of health checks.
l Despite aspiration being a frequent cause of emergency admission to hospital, as well as a cause of
death, among adults with ID, it was not clear that annual health checks were specifically recording any
issues around eating, drinking and swallowing. We estimated that 1 in 20 adults with ID had dysphagia
recorded, lower than some estimates,164 so the recent call for dysphagia-related questions to be
included in the annual health check has merit.107
Overall study limitations
We have described in detail the limitations of the study in relation to its two original aims: (1) health,
health-care quality, mortality and NHS costs and (2) health checks and effectiveness of health checks.
We summarise the key limitations again here.
l Our study population of adults with ID is based on patients with ID who are known to their GP, and so
may be missing patients with milder forms of ID who are not in regular contact with primary care.
Additionally, our description of primary care does not include other non-GP-led services, such as
optometry and dentistry, which will be important for adults with ID.
l Our description of many outcomes, such as disease prevalence or content of health check, is based
entirely on recorded information from the GP electronic patient record. Although this may not capture
everything that is occurring for these patients, the lower recording of some outcomes is still of
importance (e.g. delayed cancer diagnosis).
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l The recording of key characteristics for this group, such as the severity of their ID and their living
arrangements, was incomplete, and we had to rely on proxies (severe health needs, communal
accommodation) to try to describe these. For ethnicity, one in four adults with ID had no recording,
and we chose not to investigate further by ethnic group.
l For patients not recorded as living in shared or communal accommodation, we were unable to further
determine the level of independence of their living arrangements, such as living with a family carer.
l Our estimates of NHS costs must be viewed as conservative and an underestimate of the true cost.
l Our headline finding of reduced emergency admissions for ACSCs associated with the introduction of
health checks is derived from observational data and, although we have tried to adjust for confounding
and temporal factors, we cannot replicate the conditions of a randomised trial to test their effectiveness.
Research recommendations
Overall, we wanted to emphasise the following recommendations for research that this study identified.
l We think that further research regarding health checks should focus on two important observations
from our study. The first would be in relation to practices that are participating in the DES but are
unable to get the majority of their patients with ID to attend an annual health check. Ensuring that all
eligible patients are being appropriately invited, and determining reasons for non-attendance, could be
investigated. Second, it is necessary to understand the recording variations in the patients’ medical
records around the time of health checks. This could confirm our findings of low recordings of key
areas such as mental health and medication reviews. If confirmed, further research could also identify
barriers to carrying out standardised health checks, and suggest recommendations for improvement.
l We would also suggest that the lower prevalence of cancer and IHD in adults with ID compared with
the general population requires further investigation. It would be important to determine whether or
not patients are being diagnosed later, as well as assessing if survival time from diagnosis differs
between patients with and patients without ID.
l The potential factors contributing to the observed lower continuity of care and shorter appointment times
with their GP for adults with ID could be explored by further surveys of all key parties involved. What are the
common barriers for patients and carers, and what steps can practices make as reasonable adjustments?
l The high levels of psychotropic prescribing among adults with ID, particularly among patients whose
medical records have no recent indication or medication review, is a concern. Health checks may have
been expected to address this, but further understanding is needed, particularly in relation to a reliance
on some first-generation antipsychotics.
l The high rate of emergency hospital admissions that are potentially preventable for adults with ID
suggests that a continued targeted approach, such as annual health checks, for this group of patients
may be effective in reducing admissions. Further research could helpfully focus on conditions with high
admission rates such as epilepsy and UTI, identifying possible interventions.
l The significant contribution of respiratory causes, such as pneumonia and aspiration, to emergency
admissions and mortality makes improved access to staff with dysphagia training desirable.
l Further detailed research relating to NHS costs for adults with ID could be carried out. The inverse
association with deprivation among patients living in communal living needs explanation. As this study
suggested that preventable emergency hospitalisations may reduce as a result of health checks, a
formal cost–benefit analysis would be appropriate.
Conclusions
In summary, our study has addressed the paucity of information on the quality of health care for adults
with ID, and has also evaluated the effectiveness of annual health checks in improving outcomes as well as
processes of care. Compared with the general population, adults with ID have more chronic diseases,
greater utilisation of both primary and secondary care and associated costs, and higher rates of mortality.
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However, the lower recorded rates of cancer and CHD in primary care are of potential concern as they
may represent missed early diagnoses, and this finding requires further investigation. With more than
one-third of deaths potentially amenable to health-care interventions, continued improvements in access
to, and quality of, health care are urgently required. In primary care, better continuity of care and longer
appointment times are important examples that we identified.
We found evidence that the introduction of health checks for adults with ID may have been influential in
reducing preventable emergency admissions to hospital during the study. However, we failed to find any
evidence of a wider reduction across all emergency admissions. Although health checks were introduced to
reduce health inequalities, the current incentivised scheme means that not every eligible adult with ID
receives one. Furthermore, the recording of health measures associated with the health check varies
considerably by practice, with low recording of medication reviews and mental health, and may reflect
differences in patient experience. Future research is needed to confirm this finding. Improvements in the
standardisation of health checks, and encouraging wider practice uptake of the health check scheme, will
continue to address health inequalities and possibly improve health outcomes.
Dissemination
The analyses and results from this study have already been actively disseminated in multiple ways,
including the following:
l January 2016: The Society for Academic Primary Care, London Annual Scientific Meeting – an oral
presentation of ‘Do health checks for adults with intellectual disability reduce emergency hospital
admissions? Evaluation of a natural experiment’ was given by Iain Carey.
l January 2016: The Society for Academic Primary Care, London Annual Scientific Meeting – an oral
presentation of ‘Disparities in mortality and deaths amenable to healthcare intervention in adults with
intellectual disability’ was given by Fay Hosking.
l April 2016: the paper ‘Health characteristics and consultation patterns of people with intellectual
disability: a cross-sectional database study in English general practice’66 was published by the British
Journal of General Practice.
l June 2016: the paper ‘Do health checks for adults with intellectual disability reduce emergency hospital
admissions? Evaluation of a natural experiment’81 was published online by the Journal of Epidemiology
and Community Health.
l June 2016: Mencap Local Adults First, Merton – an oral presentation of ‘St George’s Learning Disability
Study’ was given by Iain Carey.
l July 2016: Skills for Life conference, St George’s Hospital – an oral presentation of ‘St George’s
Learning Disability Study’ was given by Carole Beighton with assistance from ResearchNet.
l August 2016: the paper ‘Mortality among adults with intellectual disability in England: comparisons
with the general population’74 was published by the American Journal of Public Health.
l September 2016: Society for Social Medicine 60th Annual Scientific Meeting, University of York, UK –
an oral presentation of ‘Do health checks for adults with intellectual disability reduce emergency
hospital admissions? Evaluation of a natural experiment’ was given by Iain Carey.
l September 2016: Society for Social Medicine 60th Annual Scientific Meeting, University of York, UK –
an oral presentation of ‘Disparities in mortality and deaths amenable to healthcare intervention in
adults with intellectual disability’ was given by Fay Hosking.
l September 2017: ‘Preventable emergency hospital admissions among adults with intellectual disability:
comparisons with the general population in England’ was published by Annals of Family Medicine.
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Appendix 1 Adult prevalence of intellectual
disability estimated using Quality and Outcomes
Framework learning disability register data
Prevalence of intellectual disability estimated using the Quality
and Outcomes Framework in England from 2006–7 to 2014–15
Year
Number of
practices
Total list
size
Number of
adultsa
Register
count
Prevalence
of ID (%) QOF indicator
2014–15 7779 56,817,654 NA 252,446 0.44b LD003: the contractor establishes
and maintains a register of
patients with learning disabilities
2013–14 7921 56,324,887 44,667,478 214,352 0.48 LD001: the contractor establishes
and maintains a register of
patients aged ≥ 18 years with
learning disabilities
2012–13 8020 56,012,096 44,238,483 206,132 0.47 LD1: the practice can produce a
register of patients with learning
disabilities
2011–12 8123 55,525,732 43,855,136 198,877 0.45 LD1: the practice can produce a
register of patients with learning
disabilities
2010–11 8245 55,169,643 43,578,391 188,819 0.43 LD1: the practice can produce a
register of patients with learning
disabilities
2009–10 8305 54,836,561 42,613,280 179,064 0.42 LD1: the practice can produce a
register of patients with learning
disabilities
2008–9 8229 54,310,660 40,041,250 160,165 0.40 LD1: the practice can produce a
register of patients with learning
disabilities
2007–8 8294 54,009,831 NA 144,909 0.36c LD1: the practice can produce a
register of patients with learning
disabilities
2006–7 8372 53,681,098 NA 139,321 0.35c LD1: the practice can produce a
register of patients with learning
disabilities
NA, not applicable.
a Patients aged ≥ 18 years.
b In 2014–15 the published prevalence was for all patients and not restricted to adults only.
c These have been estimated using the 2008–9 proportion of adults of all patients, as the published estimates are
seemingly based on a denominator of all patients and are not restricted to adults only.
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Appendix 2 Read codes used in the definition of
intellectual disability
Listing of all Read codes used in the definition of intellectual disability
Read code Description QOF LDa
13Z3.00 Low I.Q.
6664.00 Mental handicap problem
69DB.00 Learning disability health exam
918e.00 On learning disability register Y
9HB..00 Learning disabilities administration status
9HB0.00 Learning disabilities health action plan declined
9HB1.00 Learning disabilities health action plan offered
9HB2.00 Learning disabilities health action plan reviewed
9HB3.00 Learning disabilities health assessment
9HB4.00 Learning disabilities health action plan completed
9HB5.00 Learning disabilities annual health assessment
9HB6.00 Learning disabilities annual health assessment declined
9HB6.11 Learning disabilities annual health check declined
9HB7.00 Did not attend learning disabilities annual health assessment
9HB7.11 Did not attend learning disabilities annual health check
9hL..00 Exception reporting: learning disability quality indicators
9hL0.00 Exc learn disability quality indicators: informed dissent
9hL1.00 Exc learn disability quality indicators: patient unsuitable
9mA..00 Learning disability annual health check invitation
9mA0.00 Learning disability annual health check verbal invitation
9mA1.00 Learning disability annual health check telephone invitation
9mA2.00 Learning disability annual health check letter invitation
9mA2000 Learning disability annual health check invitation 1st letter
9mA2100 Learning disability annual health check invitation 2nd letter
9mA2200 Learning disability annual health check invitation 3rd letter
C03..11 Cretinism
C031.00 Goitrous cretin
C03z.12 Cretinism
C372.11 Lesch – Nyhan syndrome
C372000 Hypoxanthine-guanine-phosphoribosyltransferase deficiency
C372011 Lesch – Nyhan syndrome
C372300 Lesch-Nyhan syndrome
C372z00 Other disorder of purine or pyrimidine metabolism NOS
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Read code Description QOF LDa
E141.00 Disintegrative psychosis
E141.11 Heller’s syndrome
E141000 Active disintegrative psychoses
E141100 Residual disintegrative psychoses
E141z00 Disintegrative psychosis NOS
E3..00 Mental retardation Y
E30..00 Mild mental retardation, IQ in range 50–70 Y
E30..11 Educationally subnormal Y
E30..12 Feeble-minded Y
E30..13 Moron Y
E31..00 Other specified mental retardation Y
E310.00 Moderate mental retardation, IQ in range 35–49 Y
E310.11 Imbecile Y
E311.00 Severe mental retardation, IQ in range 20–34 Y
E312.00 Profound mental retardation with IQ less than 20 Y
E312.11 Idiocy Y
E31z.00 Other specified mental retardation NOS Y
E3y..00 Other specified mental retardation Y
E3z..00 Mental retardation NOS Y
Eu7..00 [X]Mental retardation Y
Eu70.00 [X]Mild mental retardation Y
Eu70.11 [X]Feeble-mindedness Y
Eu70.12 [X]Mild mental subnormality Y
Eu70000 [X]Mld mental retard with statement no or min impairm behav Y
Eu70100 [X]Mld mental retard sig impairment behav req attent/treatmt Y
Eu70y00 [X]Mild mental retardation, other impairments of behaviour Y
Eu70z00 [X]Mild mental retardation without mention impairment behav Y
Eu71.00 [X]Moderate mental retardation Y
Eu71.11 [X]Moderate mental subnormality Y
Eu71000 [X]Mod mental retard with statement no or min impairm behav Y
Eu71100 [X]Mod mental retard sig impairment behav req attent/treatmt Y
Eu71y00 [X]Mod retard oth behav impair Y
Eu71z00 [X]Mod mental retardation without mention impairment behav Y
Eu72.00 [X]Severe mental retardation Y
Eu72.11 [X]Severe mental subnormality Y
Eu72000 [X]Sev mental retard with statement no or min impairm behav Y
Eu72100 [X]Sev mental retard sig impairment behav req attent/treatmt Y
Eu72y00 [X]Severe mental retardation, other impairments of behaviour Y
Eu72z00 [X]Sev mental retardation without mention impairment behav Y
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Eu73.00 [X]Profound mental retardation Y
Eu73.11 [X]Profound mental subnormality Y
Eu73000 [X]Profound ment retrd wth statement no or min impairm behav Y
Eu73100 [X]Profound ment retard sig impairmnt behav req attent/treat Y
Eu73y00 [X]Profound mental retardation, other impairments of behavr Y
Eu73z00 [X]Prfnd mental retardation without mention impairment behav Y
Eu7y.00 [X]Other mental retardation Y
Eu7y000 [X]Oth mental retard with statement no or min impairm behav Y
Eu7y100 [X]Oth mental retard sig impairment behav req attent/treatmt Y
Eu7yy00 [X]Other mental retardation, other impairments of behaviour Y
Eu7yz00 [X]Other mental retardation without mention impairment behav Y
Eu7z.00 [X]Unspecified mental retardation Y
Eu7z.11 [X]Mental deficiency NOS Y
Eu7z.12 [X]Mental subnormality NOS Y
Eu7z000 [X]Unsp mental retard with statement no or min impairm behav Y
Eu7z100 [X]Unsp mentl retard sig impairment behav req attent/treatmt Y
Eu7zy00 [X]Unspecified mental retardatn, other impairments of behav Y
Eu7zz00 [X]Unsp mental retardation without mention impairment behav Y
Eu81400 [X]Moderate learning disability Y
Eu81500 [X]Severe learning disability Y
Eu81600 [X]Mild learning disability Y
Eu81700 [X]Profound learning disability Y
Eu81z00 [X]Developmental disorder of scholastic skills, unspecified Y
Eu81z11 [X]Learning disability NOS Y
Eu81z12 [X]Learning disorder NOS Y
Eu81z13 [X]Learn acquisition disab NOS Y
Eu84112 [X]Mental retardation with autistic features
Eu84200 [X]Rett’s syndrome
Eu84300 [X]Other childhood disintegrative disorder
Eu84311 [X]Dementia infantalis
Eu84312 [X]Disintegrative psychosis
Eu84313 [X]Heller’s syndrome
Eu84400 [X]Overactive disorder assoc mental retard/stereotype movts
PJ0..00 Down’s syndrome – trisomy 21
PJ0..11 Mongolism
PJ0..12 Trisomy 21
PJ0..13 Trisomy 22
PJ00.00 Trisomy 21, meiotic nondisjunction
PJ01.11 Trisomy 21, mitotic nondisjunction
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Read code Description QOF LDa
PJ02.00 Trisomy 21, translocation
PJ02.11 Partial trisomy 21 in Down’s syndrome
PJ0z.00 Down’s syndrome NOS
PJ0z.11 Trisomy 21 NOS
PJ1..00 Patau’s syndrome – trisomy 13
PJ10.00 Trisomy 13, meiotic nondisjunction
PJ11.00 Trisomy 13, mosaicism
PJ11.11 Trisomy 13, mitotic nondisjunction
PJ12.00 Trisomy 13, translocation
PJ12.11 Partial trisomy 13 in Patau’s syndrome
PJ1z.00 Patau’s syndrome NOS
PJ1z.11 Trisomy 13 NOS
PJ2..00 Edward’s syndrome – trisomy 18
PJ20.00 Trisomy 18, meiotic nondisjunction
PJ21.00 Trisomy 18, mosaicism
PJ21.11 Trisomy 18, mitotic nondisjunction
PJ22.00 Trisomy 18, translocation
PJ22.11 Partial trisomy 18 in Edward’s syndrome
PJ2z.00 Edward’s syndrome NOS
PJ2z.11 TRISOMY 18 NOS
PJ30.00 Antimongolism syndrome
PJ30.11 Deletion of long arm of chromosome 21
PJ31.00 Cri-du-chat syndrome
PJ31.11 Deletion of short arm of chromosome 5
PJ32.00 Deletion of short arm of chromosome 4
PJ32.11 Wolff – Hirschorn syndrome
PJ33100 Deletion of long arm of chromosome 18
PJ33111 18p- syndrome
PJ33200 Deletion of short arm of chromosome 18
PJ33211 18q- syndrome
PJ33300 Smith-Magenis syndrome
PJ33400 Jacobsen syndrome
PJ33500 Greig cephalopolysyndactyly syndrome
PJ33700 3p deletion syndrome
PJ33800 Chromosome 4q deletion syndrome
PJ33900 Langer-Giedion syndrome
PJ33A00 Kleefstra syndrome
PJ3z.00 Monosomies and deletions from the autosomes NOS
PJ50.00 Whole chromosome trisomy syndromes
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PJ50000 Trisomy 6
PJ50100 Trisomy 7
PJ50200 Trisomy 8
PJ50300 Trisomy 9
PJ50400 Trisomy 10
PJ50500 Trisomy 11
PJ50600 Trisomy 12
PJ50700 Other trisomy C syndromes
PJ50800 Trisomy 22
PJ50w00 Whole chromosome trisomy, meitotic nondisjunction
PJ50x00 Whole chromosome trisomy, mosaicism
PJ50x11 Whole chromosome trisomy, mitotic nondisjunction
PJ50y00 Other specified whole chromosome trisomy syndrome
PJ50z00 Whole chromosome trisomy syndrome NOS
PJ51.00 Partial trisomy syndromes
PJ51000 Major partial trisomy
PJ51100 Minor partial trisomy
PJ51200 10q partial trisomy syndrome
PJ51300 Trisomy 4p syndrome
PJ51400 Trisomy 9p syndrome
PJ51500 15q partial trisomy syndrome
PJ51z00 Partial trisomy syndrome NOS
PJ52.00 Trisomies of autosomes NEC
PJ52z00 Trisomy of autosomes NEC NOS
PJ9..00 Mowat-Wilson syndrome
PJyy200 Fragile X chromosome
PJyy400 Fragile X syndrome
PKy0.11 Prader-Willi Syndrome
PKy0.12 Prader-Willi syndrome
PKy4.00 William syndrome
PKy9300 Prader – Willi syndrome
Pyu0200 [X]Other reduction deformities of brain
PyuA000 [X]Oth specif trisomies & partial trisomies of autosomes
R034y11 [D]Global retardation
ZS34.00 Developmental disorder of scholastic skill
ZS34.11 Learning disability
LD, learning disability; Y, yes.
a Indicates if the code was used by the QOF on their learning disability register. Note that the Read code Eu818 ([X]Specific
learning disability) was subsequently introduced into QOF in 2014–15 and, therefore, was not counted in our study.
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Top 20 occurring non-administration Read codes that were used to define
intellectual disability that did not appear in the Quality and Outcomes
Framework definition of learning disability
Read code Read rubric
Total patients in
initial extraction
% who appear on QOF
learning disability register
PJ0..00 Down’s syndrome – trisomy 21 1824a 81
ZS34.11 Learning disability 1527 66
6664.00 Mental handicap problem 837 73
PJ0z.00 Down’s syndrome NOS 329a 81
13Z3.00 Low I.Q. 204 32
ZS34.00 Developmental disorder of scholastic skill 156 68
PJyy200 Fragile X chromosome 87 34
PJyy400 Fragile X syndrome 69 49
PKy4.00 William syndrome 57 59
PJ0..11 Mongolism 50 78
Eu84200 [X]Rett’s syndrome 47 68
PKy9300 Prader – Willi syndrome 40 53
Eu84112 [X]Mental retardation with autistic features 38 81
PJ0..12 Trisomy 21 33 79
R034y11 [D]Global retardation 26 49
PJ33300 Smith-Magenis syndrome 16 70
PKy0.11 Prader-Willi Syndrome 11 61
PJ31.00 Cri-du-chat syndrome 10 71
Eu84400 [X]Overactive disorder assoc mental
retard/stereotype movts
6 60
C03z.12 Cretinism 6 17
a Not all of these patients were subsequently determined to have Down syndrome (see Chapter 2, Exclusions identified
after first data extraction).
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Appendix 3 Read codes used to define
intellectual disability subgroups
Read codes used for subgroups which identify a range of severe health
needs for patients with intellectual disability
Read code Description Subgroup
13C5.00 Confined to chair Severe mobility
13C5.11 Chairbound Severe mobility
13C6.00 Bed-ridden Severe mobility
13C6.11 Bedbound Severe mobility
13CC.00 Immobile Severe mobility
13CD.00 Mobility very poor Severe mobility
13CE.00 Mobility poor Severe mobility
14U5.00 H/O: gastrostomy PEG feeding
1593.00 H/O: stress incontinence Continence
16F..00 Double incontinence Continence
19E2.00 Soiling – encopresis Continence
19E2.11 Encopresis symptom Continence
19E2.12 Soiling symptom Continence
19E3.00 Incontinent of faeces Continence
19E3.11 Incontinent of faeces symptom Continence
1A22.00 Enuresis Continence
1A22000 Nocturnal enuresis Continence
1A22011 Bedwetting Continence
1A22100 Daytime enuresis Continence
1A23.00 Incontinence of urine Continence
1A24.00 Stress incontinence Continence
1A24.11 Stress incontinence – symptom Continence
1A26.00 Urge incontinence of urine Continence
1B75.00 Loss of vision Severe visual loss
1B77.00 Deteriorating vision Severe visual loss
1C13.00 Deafness Severe hearing impairment
1C13300 Bilateral deafness Severe hearing impairment
1C17.00 Hearing aid problem Severe hearing impairment
2836.00 O/E – quadriplegia Severe mobility
2BL..11 O/E – deaf Severe hearing impairment
2BL3.00 O/E – significantly deaf Severe hearing impairment
2BL4.00 O/E – very deaf Severe hearing impairment
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Read code Description Subgroup
2BL5.00 O/E – completely deaf Severe hearing impairment
2DG..00 Hearing aid worn Severe hearing impairment
2DH0.00 Uses hearing loop Severe hearing impairment
3930.00 Bowels: incontinent Continence
3931.00 Bowels: occasional accident Continence
3940.00 Bladder: incontinent Continence
3941.00 Bladder: occasional accident Continence
3960.00 Dependent: chair/bed transfer Severe mobility
3980.00 Immobile Severe mobility
3981.00 Independent in wheelchair Severe mobility
3982.00 Minimal help in wheelchair Severe mobility
398A.00 Dependent on helper pushing wheelchair Severe mobility
6688.00 Registered partially sighted Severe visual loss
6688.11 Registered partially blind Severe visual loss
6689.00 Registered blind Severe visual loss
6689.11 Registered severely sight impaired Severe visual loss
668C.00 Certificate of vision impairment Severe visual loss
668D.00 Registered sight impaired Severe visual loss
7007300 Insertion of auditory implant to brainstem Severe hearing impairment
7308400 Placement of hearing implant in external ear Severe hearing impairment
7308500 Attention to hearing implant in external ear Severe hearing impairment
7308600 Removal of hearing implant from external ear Severe hearing impairment
7311A00 Insertn bone anchors subcutaneous bone anchored hearing aid Severe hearing impairment
7317C00 Placement of hearing implant in middle ear Severe hearing impairment
7317D00 Attention to hearing implant in middle ear Severe hearing impairment
7317E00 Removal of hearing implant from middle ear Severe hearing impairment
7319.00 Attachment of bone anchored hearing prosthesis Severe hearing impairment
7319000 Insertion fixtures bone anchored hearing prosthesis Stage 1 Severe hearing impairment
7319100 Insertion fixtures bone anchored hearing prosthesis Stage 2 Severe hearing impairment
7319200 Reduction soft tissue for bone anchored hearing prosthesis Severe hearing impairment
7319300 Attention to fixtures for bone anchored hearing prosthesis Severe hearing impairment
7319400 One stage insert fixtures bone anchored hearing prosthesis Severe hearing impairment
7319500 Fitting external hearing prosthesis bone anchored fixtures Severe hearing impairment
7319y00 Other specified attachment bone anchored hearing prosthesis Severe hearing impairment
7319z00 Attachment of bone anchored hearing prosthesis NOS Severe hearing impairment
7617.00 Gastrostomy operations PEG feeding
7617.12 Creation of gastrostomy PEG feeding
7617000 Creation of permanent gastrostomy PEG feeding
7617100 Creation of temporary gastrostomy PEG feeding
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7617400 Attention to gastrostomy tube PEG feeding
7617500 Removal of gastrostomy tube PEG feeding
7617600 Change of gastrostomy tube PEG feeding
7617700 Maintenance of percutaneous endoscopic gastrostomy tube PEG feeding
7617z00 Gastrostomy operation NOS PEG feeding
7619.11 Gastrotomy NEC PEG feeding
761E300 Temporary percutaneous endoscopic gastrostomy PEG feeding
761E400 Permanent percutaneous endoscopic gastrostomy PEG feeding
761E600 Fibreoptic endoscopic percutaneous insert gastrostomy (PEG) PEG feeding
761E900 Fibreoptic endoscopic removal of gastrostomy tube PEG feeding
761EA00 Fibreoptic endoscopic percutaneous insertion of gastrostomy PEG feeding
8CJ2.00 Percutaneous endoscopic gastrostomy feeding PEG feeding
8D2..00 Auditory aid Severe hearing impairment
8D2..11 Auditory aid provision Severe hearing impairment
8D2..12 Hearing aid provision Severe hearing impairment
8D21.00 Provide head worn hearing aid Severe hearing impairment
8D22.00 Provide body worn hearing aid Severe hearing impairment
8D23.00 Ear fitting hearing aid Severe hearing impairment
8D24.00 Replace hearing aid battery Severe hearing impairment
8D25.00 Physiolog. hearing assistance Severe hearing impairment
8D2Z.00 Auditory aid NOS Severe hearing impairment
8D3..00 Visual aid Severe visual loss
8D3..13 Visual aid provision Severe visual loss
8D31.00 Physiolog. visual assistance Severe visual loss
8D3Z.00 Visual aid NOS Severe visual loss
8D73.00 Nocturnal bladder warning syst Continence
8D73.11 Enuretic alarm Continence
8D73.12 Enuresis alarm Continence
8D9..13 Wheel chair Severe mobility
8D92.00 Self propelled wheel chair Severe mobility
8D93.00 Pedal powered wheel chair Severe mobility
8D94.00 Powered wheel chair Severe mobility
8D95.00 Wheel chair unspecified Severe mobility
8D9A.00 Attendant powered wheel chair Severe mobility
8D9B.00 Wheelchair seating Severe mobility
8E3..00 Deafness remedial therapy Severe hearing impairment
8E3Z.00 Deafness remedial therapy NOS Severe hearing impairment
8F6..11 Blind rehabilitation Severe visual loss
8F61.00 Blind rehabilitation Severe visual loss
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Read code Description Subgroup
8F62.00 Blind lead dog rehabilitation Severe visual loss
8HHC.00 Referred for wheelchair assessment Severe mobility
8HlE.00 Referral to visual impairment multidisciplinary team Severe visual loss
8M41.00 Hearing aid requested Severe hearing impairment
9m08.00 Excluded from diabetic retinopathy screening as blind Severe visual loss
9N0b.00 Seen in hearing aid clinic Severe hearing impairment
9NfB.00 Requires deafblind communicator guide Severe hearing impairment
9NfB.00 Requires deafblind communicator guide Severe visual loss
9NlD.00 Seen by visual impairment teacher Severe visual loss
9R43.00 Wheelchair in need of repair Severe mobility
9R44.00 Wheelchair in good repair Severe mobility
9RA..00 Wheelchair applied for Severe mobility
A560200 Rubella deafness Severe hearing impairment
E276.00 Non-organic enuresis Continence
E276000 Non-organic primary enuresis Continence
E276100 Non-organic secondary enuresis Continence
E276z00 Non-organic enuresis NOS Continence
E277.00 Non-organic encopresis Continence
E277000 Non-organic continuous encopresis Continence
E277100 Non-organic discontinuous encopresis Continence
E277z00 Non-organic encopresis NOS Continence
E311.00 Severe mental retardation, IQ in range 20–34 Severe/profound
E312.00 Profound mental retardation with IQ less than 20 Severe/profound
E312.11 Idiocy Severe/profound
Eu72.00 [X]Severe mental retardation Severe/profound
Eu72.11 [X]Severe mental subnormality Severe/profound
Eu72000 [X]Sev mental retard with statement no or min impairm behav Severe/profound
Eu72100 [X]Sev mental retard sig impairment behav req attent/treatmt Severe/profound
Eu72y00 [X]Severe mental retardation, other impairments of behaviour Severe/profound
Eu72z00 [X]Sev mental retardation without mention impairment behav Severe/profound
Eu73.00 [X]Profound mental retardation Severe/profound
Eu73.11 [X]Profound mental subnormality Severe/profound
Eu73000 [X]Profound ment retrd wth statement no or min impairm behav Severe/profound
Eu73100 [X]Profound ment retard sig impairmnt behav req attent/treat Severe/profound
Eu73y00 [X]Profound mental retardation, other impairments of behavr Severe/profound
Eu73z00 [X]Prfnd mental retardation without mention impairment behav Severe/profound
Eu81500 [X]Severe learning disability Severe/profound
Eu81700 [X]Profound learning disability Severe/profound
Eu9y000 [X]Nonorganic enuresis Continence
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Eu9y100 [X]Nonorganic encopresis Continence
F132100 Progressive myoclonic epilepsy Epilepsy
F132111 Unverricht – Lundborg disease Epilepsy
F137.00 Symptomatic torsion dystonia Cerebral palsy
F137.11 Athetoid cerebral palsy Cerebral palsy
F137.12 Athetosis – congenital Cerebral palsy
F137.13 Vogt’s disease Cerebral palsy
F137000 Athetoid cerebral palsy Cerebral palsy
F137011 Vogt’s disease Cerebral palsy
F137100 Double athetosis Cerebral palsy
F137111 Congenital athetosis Cerebral palsy
F137y00 Other specified symptomatic torsion dystonia Cerebral palsy
F137z00 Symptomatic torsion dystonia NOS Cerebral palsy
F23..00 Congenital cerebral palsy Cerebral palsy
F23..11 Congenital spastic cerebral palsy Cerebral palsy
F23..12 Infantile cerebral palsy Cerebral palsy
F23..13 Littles disease Cerebral palsy
F23..14 Cerebral atonia Cerebral palsy
F230.00 Congenital diplegia Cerebral palsy
F230.11 Paraplegia – congenital Cerebral palsy
F230000 Congenital paraplegia Cerebral palsy
F230100 Cerebral palsy with spastic diplegia Cerebral palsy
F230z00 Congenital diplegia NOS Cerebral palsy
F231.00 Congenital hemiplegia Cerebral palsy
F232.00 Congenital quadriplegia Cerebral palsy
F232.11 Tetraplegia – congenital Cerebral palsy
F233.00 Congenital monoplegia Cerebral palsy
F233.11 Congenital spastic foot Cerebral palsy
F234.00 Infantile hemiplegia NOS Cerebral palsy
F23y.00 Other congenital cerebral palsy Cerebral palsy
F23y000 Ataxic infantile cerebral palsy Cerebral palsy
F23y100 Flaccid infantile cerebral palsy Cerebral palsy
F23y200 Spastic cerebral palsy Cerebral palsy
F23y300 Dyskinetic cerebral palsy Cerebral palsy
F23y400 Ataxic diplegic cerebral palsy Cerebral palsy
F23y500 Worster-Drought syndrome Cerebral palsy
F23y511 Congenital suprabulbar paresis Cerebral palsy
F23yz00 Other infantile cerebral palsy NOS Cerebral palsy
F23z.00 Congenital cerebral palsy NOS Cerebral palsy
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Read code Description Subgroup
F240.00 Quadriplegia Severe mobility
F240.11 Tetraplegia Severe mobility
F240100 Spastic tetraplegia Severe mobility
F241.00 Paraplegia Severe mobility
F241100 Spastic paraplegia Severe mobility
F242.00 Diplegia of upper limbs Severe mobility
F243.00 Monoplegia of lower limb Severe mobility
F244.00 Monoplegia of upper limb Severe mobility
F25..00 Epilepsy Epilepsy
F250.00 Generalised nonconvulsive epilepsy Epilepsy
F250200 Epileptic seizures – atonic Epilepsy
F250300 Epileptic seizures – akinetic Epilepsy
F250500 Lennox-Gastaut syndrome Epilepsy
F250y00 Other specified generalised nonconvulsive epilepsy Epilepsy
F250z00 Generalised nonconvulsive epilepsy NOS Epilepsy
F251.00 Generalised convulsive epilepsy Epilepsy
F251000 Grand mal (major) epilepsy Epilepsy
F251011 Tonic–clonic epilepsy Epilepsy
F251200 Epileptic seizures – clonic Epilepsy
F251300 Epileptic seizures – myoclonic Epilepsy
F251400 Epileptic seizures – tonic Epilepsy
F251500 Tonic–clonic epilepsy Epilepsy
F251y00 Other specified generalised convulsive epilepsy Epilepsy
F251z00 Generalised convulsive epilepsy NOS Epilepsy
F253.00 Grand mal status Epilepsy
F253.11 Status epilepticus Epilepsy
F254.00 Partial epilepsy with impairment of consciousness Epilepsy
F254000 Temporal lobe epilepsy Epilepsy
F254100 Psychomotor epilepsy Epilepsy
F254200 Psychosensory epilepsy Epilepsy
F254300 Limbic system epilepsy Epilepsy
F254400 Epileptic automatism Epilepsy
F254500 Complex partial epileptic seizure Epilepsy
F254z00 Partial epilepsy with impairment of consciousness NOS Epilepsy
F255.00 Partial epilepsy without impairment of consciousness Epilepsy
F255000 Jacksonian, focal or motor epilepsy Epilepsy
F255011 Focal epilepsy Epilepsy
F255012 Motor epilepsy Epilepsy
F255100 Sensory induced epilepsy Epilepsy
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F255200 Somatosensory epilepsy Epilepsy
F255300 Visceral reflex epilepsy Epilepsy
F255311 Partial epilepsy with autonomic symptoms Epilepsy
F255400 Visual reflex epilepsy Epilepsy
F255500 Unilateral epilepsy Epilepsy
F255600 Simple partial epileptic seizure Epilepsy
F255y00 Partial epilepsy without impairment of consciousness OS Epilepsy
F255z00 Partial epilepsy without impairment of consciousness NOS Epilepsy
F257.00 Kojevnikov’s epilepsy Epilepsy
F25B.00 Alcohol-induced epilepsy Epilepsy
F25C.00 Drug-induced epilepsy Epilepsy
F25D.00 Menstrual epilepsy Epilepsy
F25E.00 Stress-induced epilepsy Epilepsy
F25F.00 Photosensitive epilepsy Epilepsy
F25X.00 Status epilepticus, unspecified Epilepsy
F25y.00 Other forms of epilepsy Epilepsy
F25y000 Cursive (running) epilepsy Epilepsy
F25y100 Gelastic epilepsy Epilepsy
F25y200 Locl-rlt(foc)(part)idiop epilep&epilptic syn seiz locl onset Epilepsy
F25y300 Complex partial status epilepticus Epilepsy
F25y500 Panayiotopoulos syndrome Epilepsy
F25yz00 Other forms of epilepsy NOS Epilepsy
F25z.00 Epilepsy NOS Epilepsy
F25z.11 Fit (in known epileptic) NOS Epilepsy
F2B..00 Cerebral palsy Cerebral palsy
F2B0.00 Spastic quadriplegic cerebral palsy Cerebral palsy
F2B1.00 Spastic hemiplegic cerebral palsy Cerebral palsy
F2By.00 Other cerebral palsy Cerebral palsy
F2Bz.00 Cerebral palsy NOS Cerebral palsy
F49..00 Blindness and low vision Severe visual loss
F49..11 Impaired vision Severe visual loss
F49..12 Low vision Severe visual loss
F49..13 Partial sight Severe visual loss
F49..14 Sight impaired Severe visual loss
F490.00 Blindness, both eyes Severe visual loss
F490000 Unspecified blindness both eyes Severe visual loss
F490100 Both eyes total visual impairment Severe visual loss
F490400 Better eye: near total VI, Lesser eye: near total VI Severe visual loss
F490600 Better eye: profound VI, Lesser eye: total VI Severe visual loss
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F490900 Acquired blindness, both eyes Severe visual loss
F490z00 Blindness both eyes NOS Severe visual loss
F491.00 Better eye: low vision, Lesser eye: profound VI Severe visual loss
F491000 One eye blind, one eye low vision Severe visual loss
F491100 Better eye: severe VI, Lesser eye: blind, unspecified Severe visual loss
F491300 Better eye: severe VI, Lesser eye: near total VI Severe visual loss
F491400 Better eye: severe VI, Lesser eye: profound VI Severe visual loss
F491500 Better eye: moderate VI, Lesser eye: blind, unspecified Severe visual loss
F491700 Better eye: moderate VI, Lesser eye: near total VI Severe visual loss
F491z00 One eye blind, one eye low vision NOS Severe visual loss
F492.00 Low vision, both eyes Severe visual loss
F492000 Low vision, both eyes unspecified Severe visual loss
F492200 Better eye: severe VI, Lesser eye: severe VI Severe visual loss
F492300 Better eye: moderate VI, Lesser eye: low vision unspecified Severe visual loss
F492400 Better eye: moderate VI, Lesser eye: severe VI Severe visual loss
F492500 Better eye: moderate VI, Lesser eye: moderate VI Severe visual loss
F492z00 Low vision, both eyes NOS Severe visual loss
F493.00 Visual loss, both eyes unqualified Severe visual loss
F494.00 Legal blindness USA Severe visual loss
F497.00 Severe visual impairment, binocular Severe visual loss
F498.00 Moderate visual impairment, binocular Severe visual loss
F49z.00 Visual loss NOS Severe visual loss
F49z.11 Acquired blindness Severe visual loss
F4H7300 Cortical blindness Severe visual loss
F581211 Noise induced deafness Severe hearing impairment
F59..11 Deafness Severe hearing impairment
F590.11 Conductive deafness Severe hearing impairment
F591.13 Perceptive deafness Severe hearing impairment
F591211 Nerve deafness Severe hearing impairment
F591400 Congenital sensorineural deafness Severe hearing impairment
F591500 Ototoxicity – deafness Severe hearing impairment
F591511 Drug ototoxicity – deafness Severe hearing impairment
F591800 Congenital prelingual deafness Severe hearing impairment
F592.00 Mixed conductive and sensorineural deafness Severe hearing impairment
F593.00 Deaf mutism, NEC Severe hearing impairment
F594.00 High frequency deafness Severe hearing impairment
F595.00 Low frequency deafness Severe hearing impairment
F596.00 Maternally inherited deafness Severe hearing impairment
F598.00 Moderate acquired hearing loss Severe hearing impairment
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Read code Description Subgroup
F599.00 Severe acquired hearing loss Severe hearing impairment
F59A.00 Profound acquired hearing loss Severe hearing impairment
F59A.11 Deafened Severe hearing impairment
F59z.00 Deafness NOS Severe hearing impairment
F59z.11 Chronic deafness Severe hearing impairment
Fyu9.00 [X]Cerebral palsy and other paralytic syndromes Cerebral palsy
Fyu9000 [X]Other infantile cerebral palsy Cerebral palsy
Fyu9100 [X]Other specified paralytic syndromes Cerebral palsy
FyuU000 [X]Deaf mutism, not elsewhere classified Severe hearing impairment
K198.00 Stress incontinence Continence
K586.00 Stress incontinence – female Continence
Kyu5A00 [X]Other specified urinary incontinence Continence
P40z.11 Deafness due to congenital anomaly NEC Severe hearing impairment
R00A.00 [D]Poor mobility Severe mobility
R00C.00 [D]Immobility Severe mobility
R076.00 [D]Incontinence of faeces Continence
R076000 [D]Encopresis NOS Continence
R076100 [D]Sphincter ani incontinence Continence
R076z00 [D]Incontinence of faeces NOS Continence
R083.00 [D]Incontinence of urine Continence
R083000 [D]Enuresis NOS Continence
R083100 [D]Urethral sphincter incontinence Continence
R083200 [D]Urge incontinence Continence
R083z00 [D]Incontinence of urine NOS Continence
SJ15.12 Deafness – traumatic – NOS Severe hearing impairment
Z1J..00 Procedures to aid continence Continence
Z6R3.00 Wheelchair dancing therapy Severe mobility
Z6R8100 Wheelchair sport Severe mobility
Z6X1.00 Wheelchair transfer practice Severe mobility
Z6Z..00 Wheelchair education Severe mobility
Z6Z1.00 Wheelchair use training Severe mobility
Z6Z1200 Propelling wheelchair training Severe mobility
Z6Z1300 Controlling electric wheelchair training Severe mobility
Z8B5.00 Ability to use hearing aid Severe hearing impairment
Z8B5100 Able to use hearing aid Severe hearing impairment
Z8B5200 Unable to use hearing aid Severe hearing impairment
Z8B5300 Does use hearing aid Severe hearing impairment
Z8B5311 Uses hearing aid Severe hearing impairment
Z8B5400 Does not use hearing aid Severe hearing impairment
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Read code Description Subgroup
Z8B5500 Difficulty using hearing aid Severe hearing impairment
Z911.00 Hearing aid procedure Severe hearing impairment
Z911100 Fit hearing aid Severe hearing impairment
Z911300 Adjust hearing aid settings Severe hearing impairment
Z911400 Changing hearing aid battery Severe hearing impairment
Z911500 Checking hearing aid Severe hearing impairment
Z911700 Switching on hearing aid Severe hearing impairment
Z911800 Turning off hearing aid Severe hearing impairment
Z911900 Putting on hearing aid Severe hearing impairment
Z911A00 Listening for feedback whistle of hearing aid Severe hearing impairment
Z911B00 Attention to hearing aid Severe hearing impairment
Z911E00 Fit ear mould for existing hearing aid Severe hearing impairment
Z96..00 Provision for visual and hearing impairment Severe visual loss
Z961.00 Provision of guide help for visual and hearing impairment Severe visual loss
Z9E2.00 Optical low vision aid provision Severe visual loss
Z9E3.00 Provision of optical low vision aid – near Severe visual loss
Z9E3100 Provision of magnifier low vision aid – near Severe visual loss
Z9E3200 Provision of low vision hand magnifier Severe visual loss
Z9E3300 Provision of low vision stand magnifier Severe visual loss
Z9E3500 Provision of spectacle low vision aid – near Severe visual loss
Z9E3600 Provision of telescopic spectacles Severe visual loss
Z9E3700 Provision of spectacle magnifier Severe visual loss
Z9E3900 Near low vision aid – clip-on spectacle magnifier Severe visual loss
Z9E3A00 Provision of spectacle telescope Severe visual loss
Z9E3B00 Near low vision aid – integral spectacle telescope Severe visual loss
Z9E3C00 Near low vision aid – clip-on spectacle telescope Severe visual loss
Z9E3D00 Near low vision aid – extra cap for telescope Severe visual loss
Z9E3E00 Provision of headband telescope Severe visual loss
Z9E4.00 Provision of optical low vision aid – distance Severe visual loss
Z9E5.00 Provision of non-optical low vision aid Severe visual loss
Z9E5200 Provision of closed circuit television Severe visual loss
Z9E5300 Provision of image intensifier Severe visual loss
Z9E5400 Provision of ancillary low vision aid Severe visual loss
Z9E5700 Provision of work board Severe visual loss
Z9E6.00 Provision of visual appliance Severe visual loss
Z9E6500 Provision of audiotaped services Severe visual loss
Z9E6600 Provision of talking book Severe visual loss
Z9E8100 Hearing aid provision Severe hearing impairment
Z9E8111 Auditory aid provision Severe hearing impairment
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
154
Read code Description Subgroup
Z9EA.00 Provision of incontinence appliance Continence
Z9EA100 Provision of nocturnal bladder warning system Continence
Z9EA111 Provision of enuresis alarm Continence
Z9EA112 Provision of enuretic alarm Continence
Z9EH400 Provision of wheelchair Severe mobility
Z9MO.00 Enuresis support Continence
ZC65200 Gastrostomy feeding PEG feeding
ZC65300 Percutaneous endoscopic gastrostomy feeding PEG feeding
ZC65311 PEG – Percutaneous endoscopic gastrostomy feeding PEG feeding
ZC65400 Button gastrostomy feeding PEG feeding
ZC65500 Jejunostomy feeding PEG feeding
ZE83200 Hearing for loud voice impaired Severe hearing impairment
ZE84200 Hearing for voice impaired Severe hearing impairment
ZE87.00 Hearing loss Severe hearing impairment
ZE87.11 Deafness Severe hearing impairment
ZE87.13 Hard of hearing Severe hearing impairment
ZE87.16 HL – Hearing loss Severe hearing impairment
ZE87.17 HOH – Hard of hearing Severe hearing impairment
ZL22400 Under care of continence nurse Continence
ZN56800 Blind telephone user Severe visual loss
ZN56900 Deaf telephone user Severe hearing impairment
ZO2..00 Unable to mobilise Severe mobility
ZO4..00 Does not mobilise Severe mobility
ZO72.00 Unable to mobilise indoors Severe mobility
ZO74.00 Does not mobilise indoors Severe mobility
ZO75.00 Difficulty mobilising indoors Severe mobility
ZO92.00 Unable to mobilise using mobility aids Severe mobility
ZO93.00 Does mobilise using aids Severe mobility
ZO94.00 Does not mobilise using mobility aids Severe mobility
ZO96.00 Ability to mobilise using wheelchair Severe mobility
ZO96.11 Wheelchair mobility Severe mobility
ZO96100 Able to mobilise using wheelchair Severe mobility
ZO96200 Unable to mobilise using wheelchair Severe mobility
ZO96300 Does mobilise using wheelchair Severe mobility
ZO96311 Mobilises using wheelchair Severe mobility
ZO96400 Does not mobilise using wheelchair Severe mobility
ZO96500 Difficulty mobilising using wheelchair Severe mobility
ZOC6200 Unable to get in and out of a chair Severe mobility
ZOC6400 Does not get in and out of a chair Severe mobility
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Read code Description Subgroup
ZOC8200 Unable to get out of a chair Severe mobility
ZOC8400 Does not get out of a chair Severe mobility
ZOC9200 Unable to get on and off a bed Severe mobility
ZOC9400 Does not get on and off a bed Severe mobility
ZOCA200 Unable to get on a bed Severe mobility
ZOCB200 Unable to get off a bed Severe mobility
ZOCB400 Does not get off a bed Severe mobility
ZOD2.00 Unable to move in bed Severe mobility
ZOD4.00 Does not move in bed Severe mobility
ZOD6200 Unable to roll over in bed Severe mobility
ZOD6211 Unable to turn over in bed Severe mobility
ZOD7500 Difficulty turning onto side in bed Severe mobility
ZOD8200 Unable to move up and down bed Severe mobility
ZT12711 Voice associated with hearing loss Severe hearing impairment
ZV44100 [V]Has gastrostomy PEG feeding
ZV45G00 [V]Presence of external hearing-aid Severe hearing impairment
ZV45N00 [V]Bone anchored hearing aid in situ Severe hearing impairment
ZV46200 [V]Dependence on wheelchair Severe mobility
ZV4L011 [V] Poor mobility Severe mobility
ZV53200 [V]Fitting or adjustment of hearing aid Severe hearing impairment
ZV53800 [V]Fitting or adjustment of wheelchair Severe mobility
ZV53D00 [V]Adjustment and management of implanted hearing device Severe hearing impairment
ZV55100 [V]Attention to gastrostomy PEG feeding
PEG, percutaneous endoscopic gastrostomy.
Read codes used to identify living arrangements that were deemed to be
communal or shared
Read code Description
13F4.00 Warden attended
13F4.11 Lives in warden-controlled accommodation
13F4000 Resident in sheltered accommodation
13F5.00 Part III accommodation
13F5.11 Part 3 accommodation
13F5100 Part III accommodation arranged
13F5111 Part 3 accommodation arranged
13F5200 Resident in part III accommodation
13F6.00 Nursing/other home
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
156
Read code Description
13F6100 Lives in a nursing home
13F7.00 Residential institution
13F7100 Lives in a welfare home
13F7200 Lives in an old peoples home
13F7300 Lives in a childrens home
13F7400 Admitted to a children’s home
13F8100 Long-stay hospital inpatient
13F9.00 Living in hostel
13F9.11 Living in sheltered accomodatn
13FK.00 Lives in a residential home
13FS.00 Long stay hospital inpatient
13FT.00 Lives in an old peoples home
13FV.00 Lives in a welfare home
13FX.00 Lives in care home
13FY.00 Lives in a children’s unit
Z177100 24-hour care
Z177500 Custodial care
Z177C00 Residential care
Z177D00 Local authority residential care
Z177D11 LA – local authority residential care
ZU37.00 Lives in a community
ZU37100 Lives in a school community
ZU37200 Lives in boarding school
ZV60600 [V]Institution resident
ZV60611 [V]Boarding school resident
ZV60700 [V]Sheltered housing
ZU37100 Lives in a school community
Read codes used to identify autism
Read code Description
E140.00 Infantile autism
E140.11 Kanner’s syndrome
E140.12 Autism
E140.13 Childhood autism
E140000 Active infantile autism
E140100 Residual infantile autism
E140z00 Infantile autism NOS
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Read code Description
E2F5.00 Mixed development disorder
Eu83.00 [X]Mixed specific developmental disorders
Eu84.00 [X]Pervasive developmental disorders
Eu84000 [X]Childhood autism
Eu84011 [X]Autistic disorder
Eu84012 [X]Infantile autism
Eu84013 [X]Infantile psychosis
Eu84014 [X]Kanner’s syndrome
Eu84100 [X]Atypical autism
Eu84111 [X]Atypical childhood psychosis
Eu84511 [X]Autistic psychopathy
Eu84y00 [X]Other pervasive developmental disorders
Eu84z00 [X]Pervasive developmental disorder, unspecified
Eu84z11 [X]Autistic spectrum disorder
Read codes used to identify Down syndrome
Read code Description
PJ0..00 Down’s syndrome – trisomy 21
PJ0..11 Mongolism
PJ0..12 Trisomy 21
PJ0..13 Trisomy 22
PJ00.00 Trisomy 21, meiotic nondisjunction
PJ01.00 Trisomy 21, mosaicism
PJ01.11 Trisomy 21, mitotic nondisjunction
PJ02.00 Trisomy 21, translocation
PJ02.11 Partial trisomy 21 in Down’s syndrome
PJ0z.00 Down’s syndrome NOS
PJ0z.11 Trisomy 21 NOS
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Appendix 4 Definition of a consultation in
Clinical Practice Research Datalink
The three conditions below must all be satisfied
for a consultation to have taken place
Consultation file
STAFF ROLE must equal
0 = Senior partner
1 = Partner
2 = Assistant
3 = Associate
4 = Non-commercial local rota
5 = Commercial deputising service
6 = Locum
7 = GP registrar
9 = Sole practitioner
10 = Practice nurse (N)
11 = Health visitor
12 = Community nurse (N)
45 = Carer
46 = Salaried partner
49 = GP retainer
CONSTYPE must equal
1 = Clinic
3 = Follow-up/routine visit
9 = Surgery consultation
10 = Telephone call from a patient
11 = Acute visit
18 = Emergency consultation
21 = Telephone call to a patient
27 = Home visit
30 = Nursing home visit
31 = Residential home visit
55 = Telephone consultation
Consultation file
CONSULTATION TYPE
= Nurse 
if STAFFROLE = (10 or 12)
= Telephone
if CONSTYPE = (10, 21 or 55)
OR
Read Codes = (8CAK, 8CAN, 8H9*, 9N31*, 9N3A,
9N3F, 9b0m, 9b0n, 9b0o)
Clinical, test, therapy
and immunisation files
Must have one of the following:
READ CODE
Except any of these:
• 69DB (learning disability health
   examination)
• 8B3H.00 (medication requested)
• 9* Administration Read Codes 
   (except 9N11, 9N12, 9N1C, 
   9N1D, 9N1E, 9N1F, 9N1G, 9N1H,
   9N1t, 9N1w, 9N1x, 9N2. , 9N21,
   9N22, 9N2D, 9N2L, 9N2N, 9N2O,
   9N2l, 9N31, 9N3A, 9N3F, 9N5. ,
   9N51, 9N52, 9N53, 9N54, 9N55,
   9N58, 9N5B, 9N7. , 9N79, 9N7A,
   9N7B, 9N7H, 9NF4, 9NF5, 9NF6,
   9NF7, 9NF8, 9NF9, 9NFB, 9NV. ,
   9Na. , 9Na1, 9Na3, 9Nt0, 9Nt3,
   9b0m, 9b0n, 9b0o)
OR
NON-REPEAT THERAPY
(ISSUE SEQ=0)
FIGURE 39 Summary of how consultations were identified in CPRD.
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Appendix 5 Economic costs
Summary of calculation estimates for costing analysis
Area Calculation details
Primary care consultations GP consultations: £3.70 per minute (maximum length 60 minutes). If ≤ 5 minutes,
or not recorded, assume £43.00 per consultation
Nurse consultations: £0.88 per minute (maximum length 60 minutes). If ≤ 5 minutes,
or not recorded, assume £10.34 per consultation
GP home visits £110.00 per visit
Prescribing (primary care) Use net ingredient cost per quantity when a quantity tablets or capsules are issued
Use net ingredient cost per item for other drug formulations
Use a default average cost of £9.85 per item where it was not possible to easily
merge CPRD and prescription cost analysis data
Other primary care-led activity Referrals (community services only) costed at £33 each (maximum of one per day)
Outpatients (evidence of attendance) were costed at £139 each (maximum of
one per day)
A&E or casualty attendance £112 each (maximum of one per day)
Hospital admissions Use NHS Reference Costs for 2011–12 classified by HRG4, calculated from ICD-1058
and OPCS-4 codes.59 When a hospitalisation has multiple episode, use the episode
with the maximum cost
Some exceptions failed to merge and were coded differently: cystic fibrosis (2009–10
costings used), dialysis (2009–10 costings used), non-specialist mental health service
provider (2012–13 costings used)
Admissions that could not be assigned by the above were costed by defaults
estimated by PSSRU:54 elective impatient stays = £3191; non-elective inpatient long
stay (≥ 2 days)= £2461; non-elective inpatient short stay (0–1 day)= £586; elective
day cases = £680
A&E, accident and emergency; OPCS-4, OPCS Classification of Interventions and Procedures version 4; PSSRU, Personal
Social Services Research Unit.
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Appendix 6 Patient and public involvement
quotations
Quotations from ResearchNet and Carers Support Merton regarding
patient and public involvement
Patient and public
involvement group Quotation
Carers Support Merton I genuinely felt, and I’ve said this to various people, but this wasn’t just a tick box exercise,
ooh yes, I’ve consulted carers, it was a genuine . . . let’s see how you can get involved and I’d
like to incorporate your ideas in it, so it did feel like genuine involvement which was great
CP3
. . . it was a very positive experience all around and umm . . . I’m absolutely delighted that
both parents and people with a learning disability viewpoints actually were taken in to the
study and I’m sure we made it a better study as a result. I think that should be an exemplar
for all LD studies as you feel you’re being listened to and helping shape what’s important
rather than having it come from top down what people think is best
CP1
Definitely. I would definitely work with this team from St George’s again as I know that they
are serious about what they are doing. You know that they are serious about involving
parents and they have listened to us. I just hope the research makes an impact
CP2
To actually involve the carers and the people themselves. If there was a way of flagging that
up and making that best practice, that would be fantastic
CP4
ResearchNet What did you feel about helping to guide this research project using your expertise?
IDP1: Loved every minute
IDP3: Loved it
IDP5: Loved everything about it
IDP2: 50/50
What was/what’s 50/50 [name], what didn’t you like?
IDP2: Umm . . . I think . . . something . . . something what . . .
Was it because we were asking you to share things, your personal story?
IDP2: I don’t know, maybe yes
Did you feel it was a waste of time?
IDP2: No
IDP1: No, far from it
IDP4: Not at all
IDP3: We . . . we are actually being listened to and taken note of
IDP2: It’s important to get our views across and we’re not just numbers on
someone’s spreadsheet
IDP5: Exactly. Well said . . .
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Appendix 7 Cause of death groupings
Listing of International Classification of Diseases, Tenth Edition
codes used to identify and group causes of death
ICD-10 code Main grouping ICD-10 code Secondary group of interest
A00–B99 Infectious and parasitic disorders
C00–D48 Neoplasms C16 Oesophageal cancer
C17 Stomach cancer
C18–21 Colorectal cancer
C25 Pancreatic cancer
C33–34 Lung cancer
C43–44 Skin cancers
C50 Breast cancer
C53 Cervical cancer
C61 Prostate cancer
C64–68 Urinary tract cancers
C81–96 Lymphoma
E00–90 Endocrine, nutritional and metabolic diseases
F00–99 Mental and behavioural disorders F00–03 Dementia
G00–99 Diseases of the nervous system G40–41 Epilepsy
I00–99 Diseases of the circulatory system I20–25 Ischaemic heart disease
I60–69 Cerebrovascular disease
I61, I63–64 Stroke
J00–99 Diseases of the respiratory system J09–11 Influenza
J40–47 Chronic lower respiratory disease
J41–44, J47 COPD
J69 Pneumonitis due to solids and liquids
K00–93 Diseases of the digestive system K70–77 Diseases of liver
M00–99 Diseases of the musculoskeletal system and
connective tissue
N00–99 Diseases of the genitourinary system
Q00–99 Congenital malformations, deformations and
chromosomal abnormalities
V01–Y98 External causes of morbidity and mortality V01–99 Transport accidents
W00–X59 Other external causes of accidental injury
X60–84 Intentional self-harm
All other Other (skin, blood, residual codes)
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Appendix 8 Ambulatory care-sensitive conditions
for emergency hospital admission
Listing of International Classification of Diseases, Tenth Edition codes
used to identify and group ambulatory care-sensitive conditions
Condition ICD-10 code
Angina I20, I24.0, I24.8–24.9
Aspiration J69.0, J69.8
Asthma J45–46
Cellulitis L03–04, L08, L88, L98.0, L98.3
Congestive heart failure I11.0, I50, J81
Constipation K59.0
Convulsions/epilepsy G40–41, R56, O15
COPD J41–44, J47
Dehydration and gastroenteritis E86, K52.2, K52.8, K52.9
Dental conditions A69.0, K02–06, K08, K09.8, K09.9, K12–13
Diabetes complications E10.0–10.8, E11.0–11.8, E12.0–12.8, E13.0–13.8, E14.0–14.8
Ear, nose and throat infections H66–67, J02–03, J06, J31.2
Gangrene R02
Gastro-oesophageal reflux disease K21
Hypertension I10, I11.9
Iron deficiency anaemia D50.1, D50.8–50.9
Influenza J10–11
Nutritional deficiencies E40–43, E55, E64.3
Pelvic inflammatory disease N70, N73–74
Perforated/bleeding ulcers K25.0–25.2, K25.4–25.6, K26.0–26.2, K26.4–26.6, K27.0–27.2, K27.4–27.6,
K28.0–28.2, K28.4–28.6
Pneumonia and other acute LRTI J13–14, J15.3–15.4, J15.7, J15.9, J16.8, J18.1, J18.8, J20–20.2, J20.8, J20.9, J22
Tuberculosis and other vaccine
preventable
A15–16, A19, A35–37, A80, B05–06, B16.1, B16.9, B18.0–18.1, B26, G00.0,
M01.4
UTI/pyelonephritis N10–12, N13.6, N39.0
Note
Only the ICD-10 code entered as primary cause of admission was used to define emergency admissions for ACSCs.
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Appendix 9 Read codes used to define categories
summarising content of health checks
Read code listing of health check content categories
Category identified Read codes (* indicates all codes in hierarchy)
Weight/BMI 162*, 22A*, 66C*, 679P.00, 67I9.00
Blood pressure 246*
Alcohol 136*, 388u.00, 6792.00, 67H0.00, 8CAM.00, 9k1*
Smoking 137*, 6791*, 67H1.00, 67H6.00, 8CAL.00
Mobility 13C*, 398*, 399*, 39A*, 39B*, 68O*, ZO*
Ears 1C1*, 1C2*, 1C3*, 1C4*, 1CD..00, 1CE..00, 2BL*, 2BM*, 2D. . .11, 2D13.00, 2D16.00
2D5*, 2D6*, 2D7*, 2D8*, 2D9*, 2DG..00, 2DH*, 2DZ..00, 313*, 7P12*, 9N2T.00, Z174500,
ZE*, ZF*, ZV41200, ZV41300
Eyes 1B7*, 1B8*, 22E*, 2B6*, 2B7*, 2B8*, 2B9*, 2BA*, 2BB*, 2BC*, 2BD*, 2BE*, 2BF*, 2BG*,
2BH*, 2BI*, 2BJ*, 2BT*, 312*, 668*, 9N2U.00, 9N2V.00, Z174300, ZL47*, ZV41*
Carer 8O7..00, 9180*, 918F*, 918J*, 918K.00, 918L.00, 918V.00
Pulse 24* except 246*
Height 229*
Health action plan 9HB0.00–9HB4.00
Behaviour 1B1X.00, 1P*, 3AB*, Z15*, ZV40.11, ZV40300
Dental 254*, 3165.00, 67IG.00, 9N2C.00, Z174600, Z174700, Z174800, ZL9G500
Communication 13o*, 1B9*, 8E2*, ZT4*
Exercise 138*, 6798.00, 67H2.00, 8CA5*
Diet 13A*, 13B*, 161*, 1F*, 6799.00, 67H7.00, 8CA4*
Blood test 4131.00, 41D0.00, 4142.00 – 4145.00, 42*, 44*, 7L17*
Urine test 41D1.00, 4146.00, 46*, 4JJ*, 68K*
Mental health 1B1*, 1BD*, 1BE*, 1BF*, 1BG*, 1BH*, 1BI..00, 1BJ..00, 1BK..00, 1BL..00, 1BM..00, 1BN*,
1BO..00, 1BP..00, 1BP0.00, 1BQ..00, 1BR*, 1BS*, 1BT*, 1BU..00, 225*, 6891*, 6896.00, 6A6*,
8CM2.00, 8CR7.00, ZQ3E.00
Bowels and bladder 16F..00, 19E*, 19F*, 1A.*, 1A.*, 1A1*, 1A2*, 1A3*, 1A4*, 26. . .00, 26. . .12, 393*, 394*,
39H*, 679H*, 8C14*, 8D7*, ZQ3B.00, ZQ3C.00
Respiratory 23*, 339*
Sexual related 1AB*, 61*, 6777.00, 679K.00, 679S.00, 67IJ*, 8CAw.00
Medication review 66c*, 8B31400, 8B3S*, 8B3V.00, 8B3h.00, 8B3j.00, 8B3k.00, 8B3l.00, 8B3x.00, 8B3y.00, 8BI*,
8BM*, 9N73.00
Breast examination 1A8*, 26. . .11, 26B*, 6795.00, 6862*, 8CAz.00, 9OH*, Z1P1400
Cervical smear 4149.00, 4JRL.00, 4K2*, 4K3*, 4K4*, 4K55.00, 6793.00, 685*, 8I6K.00, 9O8*, ZG52100, ZV762*
Epilepsy 667*
Influenza vaccination 65E*, ZV048*
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